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Summary  
The ventral pallidum (VP) is a key output structure of the basal ganglia and has multiple 
connections with cortical and limbic regions. The VP is modulated by extrinsic 
neurotransmitters, including dopamine and serotonin, but the cellular mechanisms 
underlying this modulation are only partially understood. This thesis describes an in 
vitro electrophysiological investigation of such extrinsic modulation employing 
extracellular multi electrode recordings of the VP and pharmacological manipulations.  
Our data provide novel information on how dopamine modulates VP neurons acting 
both pre- and post-synaptically. Presynaptic excitatory effects of dopamine are mediated 
by D1-like and D2-like receptors, through effects on glutamate release and subsequently 
ionotropic and metabotropic glutamate receptor activation. Postsynaptic, direct effects 
are mediated by D2-like receptors and induce decreases in firing frequency within the 
VP. Our data identifies two populations of neurons in the VP, which can be consistently 
separated by their spike half-width profile and their responses to D2-like receptor 
agonists.  
With regard to serotonin, both excitatory and inhibitory responses to its application 
were observed in the VP. Our data suggests that excitatory effects of Serotonin (5HT) 
are presynaptic, while the inhibitory responses to 5HT are postsynaptic, direct effects. 
Our data also suggest that 5HT1a, 5HT5A and 5HT7 receptors are responsible for 
increases in firing frequency to 5HT application and 5-HT2c receptors are likely 
candidates for the decrease in firing frequency to 5HT application in the VP.  
We also investigated the effects of electric activation of NAc inputs to the VP. Our data 
are consistent with the literature, showing that NAc inputs inhibit VP neurons.  
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Overall, these results cast light on the cellular mechanism by which dopamine and 
serotonin modulate VP neurons and have important implications for our understanding 
of the role the VP plays in reward processing and related dysfunctions.  
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1 Chapter 1: General introduction 
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1.1 The Basal Ganglia: 
 
The aim of this sections is to give a brief overview of the anatomy, physiology and 
function of the basal ganglia, followed by an outline of the ventral pallidum in more 
detail. 
 
1.2 Anatomy of the basal ganglia 
 
Morphologically the basal ganglia consists of four main nuclei: the striatum, globus 
pallidus, substantia nigra and subthalamic nucleus.  The striatum is the main input 
structure of the basal ganglia and is subdivided into ventral and dorsal extents. The 
dorsal striatum is split into the  caudate and putamen, these are divided by the grey 
matter of the internal capsule (Voogd, 1985), which produces the characteristic striped 
pattern, and gives the striatum its name. The ventral striatum consists of the nucleus 
accumbens (NAc), which is further sub-divided into the nucleus accumbens core 
(NAcC) and nucleus accumbens shell (NAcS). The shell wraps around the core at its 
ventral and medial edges and borders on to the rostral edge of the amygdala. The core is 
therefore partially surrounded by the shell and is classically considered to be the main 
component of the ventral striatum (George & Paxinos, 1998). The basal ganglia also 
includes the globus pallidus (GP) which has a dorsal and ventral division. The dorsal 
division is known as the globus pallidus (GP) and is sub-divided into GPi and GPe 
(internal and external). The internal segments is the most medial and the external 
segment is more lateral. Ventral to the anterior commissure the GP becomes the ventral 
pallidum (VP) and lies within the substantia innominata (Bolam, et al., 2000; Yelnik, 
2002). The basal ganglia also consists of the STN (subthalamic nucleus) and SN 
(substantia nigra). The SN is again subdivided into pars compacta  (SNc) and pars 
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reticulate (SNr), with SNc being more dorsal and SNr being more ventral (Bolam et al., 
2000).  
 
1.3 Physiology of the basal ganglia:  
 
The basal ganglia consists of two main output structures and two main input structures. 
As previously mentioned, the striatum is the principal input area of the basal ganglia 
(Zahm & Brog, 1992). It receives multiple excitatory glutamatergic inputs from the 
cerebral cortex and thalamus. It also has serotonergic inputs from the dorsal raphe 
nuclei (DRN), dopaminergic input from the sustantia nigra pars compacta (SNc) and 
ventral tegmental area (VTA) (Redgrave et al., 2010) and shares reciprocal GABAergic 
connections with the GPe and VP (Kupchik & Kalivas, 2016; Tepper et al., 2007). The 
striatum’s outputs are inhibitory and target the GPe and SNr. 
The other input area of the basal ganglia is the STN that also receives major excitatory 
inputs from cortical and subcortical regions (thalamus and brainstem) and receives 
dopaminergic input from the SNc, serotonergic input from the DRN and GABAergic 
inputs from the GPe (Bolam et al., 2000). The STN’s main output targets are the GPi 
and the SNr, where it sends excitatory glutamatergic outputs (Tepper et al., 2007). It 
also sends excitatory outputs to the GPe (Redgrave et al., 2010). 
The basal ganglia also has two key output nuclei: the GPi and the SNr, these receive 
inhibitory inputs from the striatum and GPe, and excitatory inputs from the STN. They 
both send inhibitory, GABAergic outputs to the thalamus, which then feeds back to the 
striatum, STN and cortical regions with glutamatergic inputs (Gerfen & Bolam, 2010).   
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1.4 Function of the basal ganglia 
 
The basal ganglia is involved in multiple functions, such as sensory processing, motor 
control and reward learning. It is generally considered that the basal ganglia consists of 
multiple looped circuits that are reciprocally connected (Redgrave, 2007). These circuits 
are believed to carry cortical information relating to these functions, which are 
integrated within the basal ganglia (Redgrave et al., 2011).  
 
1.4.1 The basal ganglia and reward learning:  
 
Several of the basal ganglia nuclei are considered to be involved in reward processing. 
Two key nuclei are the striatum (especially its ventral divisions) and the ventral division 
of the GPe, known as the VP. The basal ganglia integrates sensory information with 
memory and knowledge about reward values, before developing this information to 
produce a motor plan, which is output to motor control structures to enact actions. 
These selected actions are appropriate in light of the processing that has occurred in 
relation to the reward value of the sensory information in the basal ganglia (Delgado, 
2007).   
Drugs of abuse have also been shown to modulate the reward function of the basal 
ganglia by mimicking natural rewards. Drugs of abuse, such as cocaine, modulate the 
basal ganglia pathways involved in reward learning, resulting in LTP and LTD. This 
results in  some of the behavioural aspects of addiction (Creed et al., 2016) 
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1.5 The ventral pallidum 
 
As previously mentioned the VP is considered the ventral extent of the GP/GPe and is 
one of the main output structures of the basal ganglia (Heimer et al.,1982). It is 
implicated in aspects of learning, reward, pleasure and addiction (Berridge & 
Kringelbach, 2013; Creed et al., 2016; Itoga et al., 2016; Smith et al., 2009). It is 
perfectly placed to integrate information from cortical regions with information from 
forebrain and limbic regions (Smith et al., 2009) and as such has been postulated as a 
central region for the integration of signals related to reward and addiction (Ambroggi 
et al., 2016) and is suggested as a central region in converting motivational signals into 
appropriate behavioural responses (Kalivas et al., 1999). In the following section I will 
give an overview of what we currently know about the VP, including, connectivity, 
functional roles, neuron types and neurochemistry. 
 
1.5.1 Organisation of the VP: 
 
The VP was described first in the rodent by Heimer and Wilson (1975) (cited in: 
Bengtson & Osborne, 2000), who identified it as the ventral extent of the GPe, that 
resided below the anterior commissure. It is considered to be part of the basal forebrain 
(Duque et al., 2007; Pang et al., 1998; Root et al., 2015; Zaborszky et al.,2012), which 
is a heterogeneous set of structures including: the medial septum, BLA (basal lateral 
amygdala), substantia innominata, diagonal band nuclei and the peripalladial regions 
(Zaborszky et al., 2012). Because of this the VP is considered to express neurons 
common to other basal forebrain regions. On the other hand the VP is also considered to 
be part of the striatipallidal system of the basal ganglia and be a key output structure for 
the basal ganglia. It is therefore also believed to include neurons similar in morphology 
and electrophysiology to those found in the ventral striatum (Kupchik & Kalivas, 2013).  
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Just like the dorsal extent of the pallidum, the VP contains two distinct regions, 
delineated by their projections and by staining. One region stains for substance-p and 
projects chiefly to the thalamus, while the other stains for enkephalin and projects 
chiefly to the STN (Haber & Elde, 1981; Haber et al., 1985; Mai et al., 1986) 
It is due to its connectivity that the VP is considered a key region for integration of 
information related to reward and the motivational salience of stimuli, as well as being a 
key region in relation to addiction and hedonic responses. This is because it integrates 
GABA, glutamate, opioid, serotonin and dopamine signals from multiple regions. It has 
glutamatergic inputs from limbic regions, such as the BLA, dopaminergic inputs from 
the SNc and VTA (Klitenick et al., 1992; Smith & Kieval, 2000), a large GABAergic 
input from the NAc (Bolam et al., 1986; Churchill et al., 1990a; Churchill & Kalivas, 
1994), which recent evidence shows includes both D1 and D2 expressing MSNs that 
also release substance P and enkephalin into the VP (Creed et al., 2016; Kupchik et al., 
2015).It also has glutamatergic input from the STN (Groenewegen et al., 1993; Zahm et 
al., 1996), Serotonergic inputs from the dorsal raphe nuclei (DRN) (Vertes, 1991) and 
glutamatergic inputs from the medial pre-frontal cortex (mPFC)(Yang et al., 2014).  
The VP also outputs to all these regions, with most being either GABAergic or 
glutamatergic, bar its reciprocal connections with the BLA, thalamus and mPFC, where 
some of its outputs are considered to be Ch4 cholinergic neurons (McKinney et al., 
1983).  It also outputs to other regions, such as the lateral hypothalamus and Lateral 
Habenula (Haber et al., 1985). The VP is therefore well placed to drive ascending 
signals to the mPFC and thalamus as well as descending signals to the VTA  and 
brainstem regions that drive reward related behaviour (Panagis et al., 1997).  
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1.6 Functional roles of the VP: 
 
1.6.1 Role of the VP in reward processing: 
 
There are multiple lines of evidence to suggest the VP plays an integral role in reward 
processing and reward related behaviours, such as conditioned place preference and 
instrumental responses. Indeed Smith et al., (2009) suggests it may constitute a “limbic 
final common pathway” for the processing of reward.  
FIGURE 1.1: A Schematic representation of the VP’s neuronal connectivity. Adapted from 
Root et al., (2015).  
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The VP responds robustly to reward and reward predicting cues, changing its firing 
patterns to code Pavlovian cues that represent a predictive reward (Tindell et al., 2004; 
Tindell et al., 2005). Richard et al., (2016a) have also shown that activity in VP neurons 
is essential for cue-elicited reward seeking. Interestingly, Richard et al., (2016a) found 
that cue-elicited responses in VP neurons occur at a shorter latency than responses in 
NAc neurons, suggesting that they are not simply responding to the NAc input, 
highlighting the broader (mesolimbic) integrative nature of the VP in reward 
processing. Lesion studies combined with conditioned place preference paradigms have 
also shown that the VP is integral to reward related processing. McAlonan et al., (1993) 
found that animals lesioned in either the anterior or posterior VP displayed attenuated 
conditioned place preference responses. Self-stimulation studies, such as that by 
(Panagis et al., 1995) also support the involvement of the VP in reward processing as 
animals would actively self-stimulate, using a lever; in 98% of the sites the stimulation 
electrode was placed in the VP. 
Farrar et al., (2008) has also shown that inhibition of VP circuitry via GABAA infusion 
decreased the lever pressing behaviour of animals for a preferred food and instead 
switched their behaviour towards increased intake of a least preferred food that required 
less effort. This suggests that the VP may be key to effort and motivational drive to 
pursue rewarding stimuli. 
There is also evidence from humans and other primates to support the role the VP plays 
reward. Neuroimaging studies have shown that the VP is active during reward tasks that 
require motivation (Beaver et al., 2006; Pessiglione et al., 2007). Others have also 
shown that single neurons in the VP code expected reward value, for example 
Tachibana & Hikosaka, (2012) provide evidence to suggest that VP neuronal activity 
increases in line with the size of the expected reward. They also show that the VP codes 
the information on expected reward value, which in turn is used to alter motor 
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responses. This fits well with Smith et al's., (2009) suggestion that the VP may 
constitute the “limbic final common pathway” for processing of reward and action 
appropriate motor responses.  
 
1.6.2 Role of the VP in pleasure/liking responses: 
 
Evidence also implicates the VP in the pleasure-processing aspects of reward. 
Pleasurable stimuli, such as sucrose, have been shown to increase firing within the VP 
(Itoga et al., 2016; Tindell et al., 2006). The same increases in firing have also been 
seen in the VP in response to saline in salt depleted animals (Tindell et al., 2009), 
suggesting that it encodes and integrates information based on internal states and results 
in appropriate motor responses.  
Lesions of the VP have been shown to reduce hedonic responses to rewarding stimuli 
(Cromwell & Berridge, 1993; Smith et al., 2009). Lesion studies also suggest that the 
VP is essential for normal pleasure responses, as damage to posterior regions of the VP 
result in elimination of positive orofacial responses to sweet tastes (Ho & Berridge, 
2014). Neurochemical modulation of the VP has also been shown to modulate 
pleasure/liking responses. Shimura et al., (2006) found that GABAA antagonists 
increased the ingestion of liked sucrose solutions, while GABAA agonists injected into 
the VP decreased the ingestion of a liked sucrose solution. Inui and Shimura, (2014) 
have also shown that specific delta opioid receptor inhibition in the VP increases the 
palatability of saccharin and its ingestion. Further to this, there is evidence from human 
imaging studies that suggest that the VP responds to pleasurable stimuli. Calder et al., 
(2007) presented images of pleasurable food to participants and measured BOLD 
responses across brain regions, finding an increased response in certain sub regions of 
the VP. Other studies with human participants also support the notion that the VP plays 
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a key role in pleasure responses beyond the rodent. Miller et al., (2006) reports a human 
case study where an overdose of methadone induced lesions to the pallidum resulting in 
reduced craving for drugs of abuse and reduced pleasure responses, including 
depressive symptomology. Research suggests that it is perhaps not the whole of the VP 
that modulates pleasure responses to rewarding stimuli. Evidence suggests that there are 
distinct regional differences. For example, Smith and Berridge’s., (2005) study maps the 
VP for hedonics and suggests the posterior VP, when stimulated with DAMGO, 
produces the greatest increase in pleasure responses to sucrose. This is supported by 
Peciña et al., (2006). 
 
1.6.3 Role of the VP in addiction to drugs of abuse: 
 
There are several lines of evidence implicating the VP in responses to drugs of abuse 
and the suggestion that the VP is a key site in the incentive salience theory of addiction 
(Tindell et al., 2009).  
Drugs of abuse, such as cocaine are known to modulate the firing of VP neurons. 
Johnson & Napier, (1996) found that intravenous cocaine administration altered the 
firing in 80% of VP neurons. Root et al., (2012) also found that this change in firing to 
administration of cocaine reduced as the level of cocaine decayed after administration. 
Research has also shown that drugs of abuse alter neurochemical levels in the VP and 
the ability of neurochemicals to modulate activity in the VP. Stout et al., (2016) has 
shown that there are distinct neurochemical changes within the VP in response to 
cocaine sensitization. A cocaine challenge, after cocaine sensitization, produced 
dramatic increases in dopamine levels within the VP. There is also evidence to show 
that, as well as dopamine, serotonin levels increase as a result of cocaine self-
administration within the VP (Sizemore et al., 2000), and McDaid et al., (2005) has 
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shown cocaine sensitisation promotes the ability of glutamate to increase firing in the 
VP and inhibits the ability of GABA to reduce firing . 
The VP is also involved in drug seeking reinstatement, for example Tang et al., (2005) 
have shown that µ opioid-receptor antagonists, directly injected into the VP, blocked 
reinstatement of cocaine self-administration and stimulation of the VP with morphine 
reinstated this self-administration. Microinjections of µ opioid-receptor antagonists and 
D1-like dopamine receptor antagonists directly into the VP have also been shown to 
completely abolish sensitization to drugs of abuse, such as morphine (Johnson & 
Napier, 2000).  
Further evidence of the VP’s role in addictive responses comes from lesion studies of 
the VP. Hubner and Koob, (1990) have shown that Ibotenic acid lesions of the VP, after 
animals had been trained to self-administer cocaine or heroin, dramatically reduces self-
administration of cocaine and heroin, this furthers the notion that the VP is essential for 
drug seeking behaviour. Hiroi and White, (1993) also carried out lesioning studies of 
the VP. Animals were given NMDA lesions in the VP, either pre or post training in a 
conditioned place preference task for amphetamine. Animals with a lesions pre-
conditioning did not acquire a conditioned place preference, those that were lesioned 
post conditioning did. This suggests that the VP is involved in acquisition of 
conditioned place preferences to amphetamine and not in the execution once 
conditioned.  Chemogenetic silencing of the VP has also been shown to reduce the 
reinstatement of drug seeking (Mahler et al., 2014). McFarland and Kalivas, (2001) also 
showed that chemogenetic silencing of the VP via administration of GABA agonists 
reduced drug seeking behaviour in cocaine sensitized animals.   
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1.7 Neurons of the VP: 
 
The VP is commonly considered to be part of the basal forebrain (Duque et al., 2007; 
Pang et al., 1998; Root et al., 2015; Zaborszky et al., 2012), which is a heterogeneous 
set of structures that includes: the medial septum, BLA (basal lateral amygdala), 
substantia innominata, diagonal band nuclei and the peripalladial regions (Zaborszky et 
al., 2012). Because of this it contains neurons of the basal forebrain, such as the CH4 
cholinergic neurons (Gritti et al., 1993; McKinney et al., 1983) . However it is also 
considered to be part of the striatipallidal system of the basal ganglia and is believed to 
also include neurons similar in morphology and electrophysiology to those found in the 
ventral striatum (Kupchik & Kalivas, 2013b). Because of this intriguing mix of cell 
types many studies that have focused broadly on the basal forebrain may draw false 
conclusion about cell types found within the VP as they may well be over 
generalisations, based upon cell types found within the wider basal forebrain territories.  
The main population of neurons in the VP express markers for GABA, these are thought 
to constitute approximately 80% (Gritti et al., 1993; Root et al., 2015). It is believed that 
these probably make up several subpopulations, some being spiney projection neurons 
(SPNs), projecting to areas outside the VP, such as the lateral hypothalamus, thalamus 
and STN (Bevan et al., 1997; Haber et al., 1993; Mariotti et al., 2001), and others that 
are believed to be interneurons (Bengtson & Osborne, 2000; Gritti et al., 1993) the 
distinction between SPNs and interneurons is mainly based on ionotrophic filling of 
neurons, which has revealed neurons with sparse intranuclear branches, akin to 
projection neurons, and those with a dense plexus of intranuclear branches, akin to 
interneurons (Pang et al., 1998). These subpopulations can be further divided based 
upon their expression of other neurochemicals and neuropeptides (Root et al., 2015). 
Immunohistochemical studies suggest VP neurons express calretinin, calbindin, PV, 
NPY and SOM (Zaborszky, 1989; Zaborszky et al., 2012).  
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As well as the presence of a number of GABAergic neurons, there is also the existence 
of cholinergic neurons, (with no evidence of colocalisation, between GAD and CHAT) 
within the VP (Gritti et al., 1993). These cholinergic neurons are a constituent part of 
the basal forebrain, magnocellular, cholinergic system (Kupchik & Kalivas, 2013a; 
Mallet et al., 2012; Zaborszky & Cullinan, 1992). Although they are considered to be 
extremely sparse in number, (Gritti et al., 1993). Others suggest they make up 
approximately 23% of the neurons in the VP and have been shown to have extensive 
collaterals with other neurons within the VP (Bengtson & Osborne, 2000; Duque et al., 
2007; Gritti et al., 1993). The cholinergic neurons of the VP are interesting as they are 
known to be heavily innervated by projections from several regions, including 
GABAergic projections from the NAc (Zaborszky & Cullinan, 1992) and dopaminergic 
inputs from the VTA (Smith & Kieval, 2000; Zaborszky et al., 2012). They are also 
known to express NK1 receptors (Chen et al., 2001; Gerfen, 1991), and therefore maybe 
implicated in the effects of substance P expressed by Nac projections to the VP 
(Mengual et al., 2008). Cholinergic neurons in the VP are also seen to be hyperpolarised 
by serotonin, while non cholinergic neurons in the VP are depolarized  (Bengtson et al., 
2004).  
Cholinergic neurons of the VP also project outside the VP, to both the cortex and 
amygdala (Duque et al., 2007; Lavin & Grace, 1996; McKinney et al., 1983), and 
therefore provide the intriguing potential for integrating information from basal 
forebrain regions, with ventral striatal regions and then providing a common final 
mechanism for the delivery of this information to cortical and subcortical regions. There 
local collaterals (Zaborszky & Duque, 2000) also provide the intriguing prospect that 
they may well interact with the other main population of neurons in the VP that are 
GABAergic, which have also been shown to project outside the VP. However the 
question remains as to whether they interact and modulate all the GABAergic neurons 
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within the VP or specific types, such as the NPY expressing type or the SOM 
expressing type.  
There is also evidence for the presence of glutamatergic neurons within the VP with 
immunohistochemical labelling for VGLUT1, VGLUT2 and VGLUT3 (Geisler et al., 
2007), however it is considered most likely that VGLUT1 and VGLUT2 consists of 
labelled projections emanating from the VTA (Root et al., 2015). There is however 
some labeling for VGLUT3 in the VP and this is thought to be labelling mainly 
cholinergic neurons within the VP (Poulin et al., 2006). 
 
1.7.1 Electrophysiological classification of VP neurons: 
 
 There have been several attempts to electrophysiologically characterise and group 
neurons within the VP in vivo and in vitro. One of the key in vivo studies was carried 
out by (Lavin & Grace, 1996), they focused on several key electrophysiological 
characteristics of VP neurons spike discharge. They found these to be able to reliably 
place all VP neurons studied into one of three groups, referred to as type, A, B and C. 
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Type of neuron 
(Lavin & Grace, 
1996) 
discharge Action potential  Afterhyperpolarisation 
(AHP) 
A  
(most 
common:29/55) 
Tonic 
(8.7Hz) 
Long duration No AHP 
B 14.5Hz Ramp-like 
depolarisation pre-
discharge. 
Short duration spike.  
Post-spike AHP 
C Fired in 
burst or 
couplets. 
Accommodation shown.  
Subsequent spikes lasted 
longer, but had reduced 
amplitude. 
No AHP 
 
TABLE 1.1: Key electrophysiological characteristics of the neuron types identified by 
Lavin and Grace (1996) 
 
Lavin and Grace, (1996) believe that type A and B are non-cholinergic neurons, 
therefore most likely GABAergic, while type C are believed to most likely be 
cholinergic neurons as they share firing patterns very similar to cholinergic neurons 
identified in other areas of the basal forebrain, which are part of the same magnocellular 
projection pathway (Bengtson & Osborne, 2000; Griffith & Matthews, 1986). Lavin and 
Grace, (1996) also suggest that there is a strong similarity between the neurons they 
have categorised as type A, B, C with those categorised as 3,2 and 1, respectively by 
Nambu and Llinas, (1994) in the GPe, with type C of Lavin and Grace, (1996) 
considered to be most like type 1 of Nambu and Llinas, (1994), as they shared a 
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bursting firing pattern. Interestingly, Lavin and Grace, (1996) also found that type A 
and C responded to NAc stimulation with excitation, and were suggested by Lavin and 
Grace, (1996) to be mediated by substance P, which is known to be expressed by the 
projections between NAc and VP.  
Bengtson and Osborne, (2000) also investigated the electrophysiological properties of 
neurons in the VP. They grouped neurons in the VP as cholinergic and non-cholinergic. 
They found that the cholinergic neurons had a very similar electrophysiological profile 
to cholinergic neurons found elsewhere in the basal forebrain. Some key features of 
these neurons include: 
 
Types  Tonic 
firing 
Spike 
accommodation  
Inward 
rectification 
Resting 
membrane 
potential 
After 
hyperpolarisati
on (AHP) 
Choline
rgic 
No Strong spike 
accommodation 
Fast and 
large 
Hyperpolar
ised resting 
membrane 
potential 
Prominent and 
long duration 
Non-
choline
rgic 
yes No spike 
accommodation 
 
Time 
dependent. 
Large h 
currents 
  
Those in bold are considered the distinguishing features of VP cholinergic neurons by 
Bengtson and Osborne, (2000) 
 
TABLE 1.2: Electrophysiological characteristics of non-cholinergic and cholinergic 
neurons identified by Bengtson and Osborne, (2000) 
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Because of the above profiles, Bengtson and Osborne, (2000) suggest that Lavin and 
Grace, (1996) assertion that there type C neurons in the VP are cholinergic is incorrect. 
One key feature difference is the lack of an AHP in the type C of Lavin and Grace, 
(1996), while Bengtson and Osborne, (2000) find cholinergic neurons to have a 
prominent AHP. Another difference is that type C of Lavin and Grace, (1996) have a 
bursting firing pattern, while Bengtson and Osborne, (2000) suggest cholinergic 
neurons in the VP to not tonically fire in a bursting pattern. There is therefore some 
controversy over the electrophysiological features of VP cholinergic and non-
cholinergic (likely GABAergic) neurons.  
Another study that tried to group VP neurons based on their electrophysiological 
characteristics was carried out by Pang et al., (1998).  As well as electrophysiological 
measures, Pang et al., (1998) also carried out immunohistochemically procedures and 
intracellular filling to morphologically examine the neurons. 
Type morphology Spontaneous 
firing rates 
Action 
potential 
duration 
Action 
potential 
waveform 
I Rarely branched Low (13.2+/-
7.3 Hz) 
2.4+/-0.2 ms Triphasic 
:Positive-
negative-
positive 
II Branched extensively Higher (35.5+/-
8.4 Hz) 
2.5+/-0.3 ms Triphasic  
 
TABLE 1.3:  morphological and electrophysiological characteristics of VP neuron 
types identified by Pang et al, (1998) 
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Pang et al, (1998) suggest that their type I neurons are likely the same as Lavin and 
Grace’s, (1996) type B neurons, and that they may well represent GABAergic 
projection neurons. They also suggest that type II neurons, in their study, are likely to 
correspond to Lavin and Grace’s, (1996) type A neurons and that the type II neurons are 
likely GABAergic interneurons, due to their large arbors.  
Recent research by Kupchik and Kalivas, (2013b) suggests there maybe regional 
difference within the VP as to the type of neurons present, therefore the 
electrophysiological profiles of neurons across the VP may vary. They identified two 
electrophysiologically distinct types of neurons (type 1 and type 2). Type one shared 
many characteristics with neurons already identified in the VP by Lavin and Grace, 
(1996) and Pang et al, (1998). These type 1 neurons were reminiscent of Lavin and 
Grace’s, (1996) type B neurons and of Pang et al’s (1998) type 1 neurons. They were 
also Immunoreactive for GAD, therefore are believed to be GABAergic. Type 2 
neurons however were distinct from anything previously identified in the VP, and 
shared more in common with the known electrophysiological profile of NAcS neurons. 
Because of their predominantly rostral location in the VP, bordering the NacS, Kupchik 
and Kalivas, (2013b) suggest they may be NacS neurons that have invaded the VP. This 
highlights the variety of potential neuronal types in the VP and suggests that the VP is 
not a homogenous structure. 
 
1.8 Neurochemicals and receptors in the VP 
 
In order to fully understand how the variety of neurons identified in the VP interact as 
well as the likely effects of its various inputs, it is important to consider the different 
neurotransmitters released into the VP and their known receptors, so we can fully 
understand the function of the VP as an integrative area.  
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1.8.1 GABA (GABAa and GABAb receptors): 
 
GABA is the main inhibitory neurotransmitter expressed throughout the CNS. There are 
both GABAA and GABAB receptors. GABAB receptors are thought to mediate a slower 
inhibition and GABAA is thought to mediate a fast inhibition (Kemppainen et al., 
2012a). Both GABAA  and GABAB receptors are known to be expressed within the VP 
(June et al., 2003).GABAA receptors have several isoforms, referred to as GABAA1-6 
(Barnard et al., 1998). These are all known to be expressed within the VP with the 
dominant expression being GABAA1 (June et al., 2003).   
The VP receives an extensive GABAergic input from the NAc (Churchill et al., 1990; 
Groenewegen & Russchen, 1984). There is also the suggestion of a number of 
potentially GABAergic interneurons within the VP (Root et al., 2015). Therefore 
GABA and its receptors are a likely contributory factor in the VP’s known functions 
and cellular responses to various neurotransmitters.  
 
1.8.1.1 Functional role of GABA in VP 
 
GABA levels in the VP are believed to be involved in its role in drug seeking 
behaviour. Research has found (Kemppainen et al., 2012a; McFarland & Kalivas, 2001) 
that GABA agonists, injected into the VP, significantly reduced animals drug seeking 
behaviour. This seems to be largely mediated by GABAa as GABAb agonists have been 
shown to have no effect on motor activity when injected into the VP (Austin & Kalivas, 
1990). A GABAA isoform (GABAA1) has also been shown to reduce alcohol seeking 
behaviours when injected into the VP (June et al., 2003). GABA levels in the VP have 
also been shown to modulate motivation, Farrar et al., (2008) have shown that the 
GABAA agonist muscimol reduced animals drive towards a preferred food and switched 
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their consumption to a less preferred food that was easier to obtain, suggesting that 
GABAA may play an integral role in the modulation of motivational behaviour towards 
reward stimuli via its modulation of the VP. Other neurotransmitters released into the 
VP, and by VP neurons, may also modulate these responses by modulation of pre-
synaptic receptors found on GABAergic inputs from the NAc into the VP. 
 
1.8.2 Glutamate  
 
Glutamate is an important neurotransmitter in the VP and, as previously discussed, 
glutamatergic inputs to the VP arrive from several locations and these are: the BLA, 
mPFC and the STN.  
There are two main groups of glutamate receptors. These are: ionotropic glutamate 
receptors and metabotropic glutamate receptors. Ionotropic receptors form ion-gated 
channels and are believed to control the majority of fast excitatory transmission in the 
CNS (Testa et al., 1994). Metabotropic glutamate receptors are C family, G protein 
coupled receptors (Niswender & Conn, 2010) and mediate their effects through 
modulation of internal secondary messengers, such as cAMP. They are considered to be 
involved in more long term processes, such long-term potentiation, synaptic plasticity 
and long term depression (Calabresi et al., 1992). 
Ionotropic receptors split into three subtypes: NMDA, AMPA and Kinate. Metabotropic 
glutamate receptors also spilt into three subtypes, however only one is considered 
excitatory (group 1) while two subtypes (group 2 and 3) are considered inhibitory. Testa 
et al's., (1994) data shows the presence of all the MGLuR receptors in the VP with high 
levels of mGluR1 and 5, compared to the NAc and GP.  
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1.8.2.1 Group 1: mGluR 1 and 5 
 
mGluR1 are mainly considered to be located in extrasynaptic and perisynaptic locations 
at the edge of the synaptic cleft and are thought to be modulated by glutamate that has 
escaped the synapse (Ferraguti et al., 2008; Ferraguti & Shigemoto, 2006). Little in the 
literature suggests they play a role in the modulation of functions the VP is known to be 
implicated in.  
mGluR5 are considered to be located postsynaptically and can also be found on non-
neuronal cells, such as astrocytes and microglia (Nicoletti et al., 2011). They are known 
FIGURE 1.2: Ionotropic and metabotropic glutamate receptors and their subtypes. 
The multiple receptor subtypes found in both the metabotropic glutamate receptor 
family and the ionotropic glutamate receptor family. All Ionotropic glutamate 
receptors are believed to be Excitatory, while only group one metabotropic glutamate 
receptors are believed to be excitatory. Adapted from Blackshaw et al., (2011). 
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to be heavily involved in both LTP and LTD and have been shown to enhance 
ionotropic glutamate receptor functions, specifically NMDA receptor function (Pisani et 
al., 2001). mGluR5 is involved in modulation of the basal ganglia circuitry and is well 
known in the cocaine literature as a modulator of cocaine seeking and withdrawal, 
indeed  research (Kenny et al., 2005; Kenny & Markou, 2004) suggests that mGluR5 
receptors activation is essential for incentive motivation towards drugs of abuse and 
mGluR5 antagonists are considered promising treatments for tobacco addiction (Kenny, 
2009). This fits well with the known involvement of the VP in drug seeking and 
sensitization, therefore mGluR5 receptors maybe a key mechanism underpinning the 
VP’s neuronal responses to drugs of abuse.   
 
1.8.2.2 Group 2: mGluR 2 and 3 
 
mGluR 2 and 3 are located at both pre and post synaptic locations (Nicoletti et al., 2011; 
Petralia et al., 1996) and are considered to have inhibitory effects through inhibition of 
cAMP formation, excitation of potassium channels and  inhibition of calcium channels 
(Pin & Duvoisin, 1995). Ohishi et al., (1994) and  Ohishi et al., (1993)  Mrna studies 
show that there is labelling for mGluR2 in the VP.  
These receptors are also implicated in behavioural functions similar to the VP, such as 
hedonic responses and reinforcing effects of drugs of abuse. For example mGluR2/3 
antagonists have been shown to elicit antidepressant effects (Yoshimizu et al., 2006) 
and mGluR2 receptors are implicated in regulating the reward pathway as cocaine is 
more reinforcing in mGluR2 knockout mice and mGluR2/3 agonists reduce the self-
administration of cocaine (Adewale et al., 2006). These receptors have also been 
implicated in other regions of the basal ganglia, especially areas upstream from the VP, 
such as the NAc. Kalivas, (2009) suggests that it is dysfunction of these receptors in the 
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NAc that results in the increased chance of relapse in addiction to drugs of abuse. Their 
role in the modulation of the VP circuitry therefore might be insightful.   
 
1.8.2.3 Group 3: mGluR 4, 6, 7 and 8 
 
mGluR 4,7 and 8 receptors are known to be located presynaptically in the active zone of 
the synaptic cleft, this combined with their inhibitory function, suggests they provide 
fast negative feedback, inhibiting further release of glutamate from the presynaptic 
neuron (Niswender & Conn, 2010).  
mGluR 6 receptors are exclusively found in the dendrites of on-polar cells of the retina 
(Nicoletti et al., 2011) and there is little evidence implicating mGluR 4 and 8 in any of 
the functions of the VP. However recent evidence suggests that mGluR 7 receptors may 
play some functional role in mediating drug seeking behaviour, something the VP is 
strongly linked with (Gong et al., 1996; Gong et al., 1997). Li et al., (2013) have also 
shown that a specific mGluR7 agonists modulates the GABAergic connections between 
the NAc and the VP and are able to inhibit cocaine induced reinstatement of cocaine 
seeking when directly injected into the VP. These effects were also shown to be 
reversed with mGluR7 antagonists.  
 
1.8.3 Opioids (enkephalin and dynorphin) and opioid receptors (δ, kappa and µ): 
 
One of the main inputs of the VP is from the NAc and these projections are GABAergic 
(Bolam et al., 1986; Churchill et al., 1990). These studies also show that the inputs from 
the NAc also release enkephalin and substance P into the VP. Recent evidence also 
shows that the projections from the NAc include D1 and D2 MSNs associated with the 
direct and indirect pathway respectively. Both D1 and D2 MSNs are also known to 
express substance P and enkephalin, respectively. The ventral striatum is therefore the 
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likely main source of enkephalin in the VP, especially as it is considered that very few 
neurons in the VP actually synthesise enkephalin (Mansour et al., 1993).    
There are two main opioid-receptors for enkephalin. These are the δ-opioid receptors 
(DORs) and the µ-opioid receptors (MORs). 
 
1.8.3.1 MORs in the VP 
 
MOR are considered to be one of the best markers for delineating the VP from other 
structures in the striatopalladial circuit and basal forebrain, especially in the rostrodorsal 
extent of the VP, where they are expressed in moderate levels (Mansour et al., 1994; 
Mansour et al., 1995; Olive et al., 1997). Mansour et al, (1997) also show that MORs 
are located presynaptically in the VP and therefore are likely to act as inhibitory 
autoreceptors.  This fits well with Kupchik et al’s., (2014) data, which shows that 
MORs activation with agonists inhibits the release of GABA from SPNs innervating the 
VP, most likely inhibiting the release of GABA from the inputs of the NAc. However, 
MORs are known to have dichotomous effects on interneurons within other striatal 
territories (Elghaba and Bracci, 2017) and Olive et al’s, (1997) data shows that MORs 
are in fact located at both pre and post synaptic locations in the VP, therefore their 
effects may be broader that reducing GABAergic input into the VP.  
 
1.8.3.2 DORs in the VP: 
 
Research has shown (Mansour et al., 1988; Mansour et al., 1993) that DORs are 
expressed in the VP. More specifically, Olive et al., (1997) have shown that DORs are 
found at postsynaptic locations, in the cell bodies of neurons in the VP. This 
postsynaptic location was found to be opposite enkephalin labelled fibre terminals.  
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Olive et al’s, (1997) data also suggests that DORs may well be expressed on fibres 
projecting back to the NAc from the VP as an inhibitory feedback loop. This certainly 
fits with Churchill and Kalivas, (1994) identification of a GABAergic input from the 
VP to the NAc.  
 
1.8.3.3 Functional roles of MORs and DORs in the VP: 
 
There is a strong link between MORs activation in the VP and consumption of drugs of 
abuse. For example Kemppainen et al., (2012b) study shows that MOR agonists injected 
into the VP reduce ethanol intake dose dependently and MOR antagonists increase 
ethanol intake. Research also suggest other effects of MOR modualtion in the VP.  
Skoubis and Maidment, (2003) found that blockade of VP opioid receptors with 
antagonists induced a place aversion, while reducing the conditioned place preference to 
cocaine. Further to this Tang et al., (2005) found that reinstatement of drug seeking 
correlated with reduced levels of extracellular GABA in the VP, and reinstatement of 
drug seeking requires MORs in the VP to be recruited, as MOR antagonists blocked 
reinstatement of lever pressing caused by intravenous cocaine administration. Indeed  
Kupchik et al., (2014) suggests that cocaine acts by dysregulating opioid gating of 
GABA inputs of the VP.  Kupchik et al., (2014) found, in cocaine extinguished animals, 
MOR agonists no longer reduced GABA release into the VP, but MOR antagonists, in 
these animals, still increased GABA release. They suggest this is due to cocaine 
increasing tone on the MOR receptors, they therefore continue to tonically supress 
GABA transmission in cocaine sensitized animals. This all suggests that opioid 
receptors in the VP are essential for expression of drug related behaviour, however their 
exact effect may differ depending upon the drug of abuse.  
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With DORs the research points towards a role in the modulation of hedonic responses. 
Inui and Shimura, (2014) found that antagonists for DORs in the VP increased the 
palatability and consumption of saccharin. However, DOR’s have also been shown to 
modulate how rewarding self-stimulation is, with Johnson and Stellar, (1994) finding 
increases of up to 31% in reward responses when DOR agonists were self-administered 
into the caudal VP. 
 
1.8.4 Substance P 
 
Substance P is part of a class of neuromodulators known as neurokinins. Neurokinins 
also include: neurokinin a, neurokinin b, substance K (SK,), and neuromedin K (NK,) in 
the mammalian brain (Chen et al., 2001). Substance P is known to be in high 
concentration in the VP and modulation of it in the VP, mainly via the use of NK-1 
receptor antagonists, effects behaviour related to the VP, including:  affective/anxiety 
responses as well as aspects of conditioning, such as responses to CPP tasks (Nikolaus 
et al., 1999a; Nikolaus et al., 1999b).  
The main source of substance P in the VP is thought be the D1 (direct) pathway inputs 
from the NAc (Bolam et al., 1986; Kupchik et al., 2014; Kupchik et al., 2015; Napier et 
al., 1995b) and there is evidence to suggest these inputs might directly target VP 
cholinergic neurons, which are known to express NK-1 receptors (Bolam et al., 1986; 
Gerfen, 1991). 
Research has shown that VP neurons are excited by substance P application. Napier et 
al, (1995a) found 40% of VP neurons were excited by ionotropic direct application of 
substance P or an agonist analog of substance P. Napier et al, (1995) suggest the type of 
excitation they observed as a result of substance P application was significantly 
different from glutamate induced excitation, with a slower onset and a longer duration. 
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However, Substance P has also been shown to modulate glutamatergic inputs from the 
amygdala into the VP (Mitrovic & Napier, 1998).  
 
1.8.4.1 NK receptor expression in the VP 
 
There are two key neurokinin receptors (NK) known to be expressed in the VP, these 
are NK1, and NK3 (Chen et al., 2001; Furuta et al., 2004). Substance P is considered 
the preferred ligand for NK1 receptors, while neurokinin B is for NK3 receptors (Furuta 
et al., 2004; Mantyh, 2002; Quirion & Dam, 1988).  
 
1.8.4.2 NK1 receptors: 
 
NK1 receptors have been shown to modulate the effects of substance P injections into 
the VP on both anxiolytic responses and conditioned place preferences (Nikolaus et al., 
1999a; Nikolaus et al., 1999b). These effects may be modulated by cholinergic neurons 
in the VP, as NK1 receptors in the VP are expressed by cholinergic neurons. In fact 
research (Chen et al., 2001; Gerfen, 1991; Mengual et al., 2008) suggests they are the 
main neurons in the VP express NK1 receptors. Cholinergic neurons of the VP are also 
therefore the likely target for substance P induced excitatory responses seen in 40% of 
VP neurons by Napier et al., (1995a). However  Mengual et al., (2008) data also 
suggests that NK1 receptors are found in non-cholinergic neurons in the VP and the 
glutamatergic terminal inputs to the VP, therefore possibly playing a role in modulation 
of other VP neuron populations and increasing glutamate levels within the VP. NK1 
receptors therefore have an intriguing role to play in the modulation of VP neurons and 
their inputs and therefore are an interesting target for future research. 
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1.8.4.3 NK3 receptors: 
 
Nikolaus et al's., (1999a) data suggests that substance P, via the administration of a 
substance P analog, was able to increase place preference responses when injected into 
the VP, however selective NK1 receptor antagonists did not abolish this increase in 
place preference, suggesting that substance P may also be having an impact at other 
receptor sites. In fact the substance P analog used in this study is known to have a high 
affinity for NK3 receptors. Therefore there is an interesting possibility that NK3 
receptors, known to be expressed in the VP (Furuta et al., 2004), may also be 
modulating the effect of substance P input from NAc fibres. In fact Furuta et al, (2004) 
found that NK3 receptors were expressed in both cholinergic and PV+ neurons in the 
VP.  Further, tentative support for this comes from Ciccocioppo et al., (1998) who 
found intravenous injections of a NK3 agonist could have rewarding effect in a place 
preference paradigm, and that it could reduce the intake of ethanol when microinjected 
into the nucleus basalis magnocellularis (a subdivision of the substantia innominata) of 
alcohol preferring rats.   
 
1.8.5 Dopamine: 
 
Dopamine belongs to the catecholamine group of neurotransmitters and constitutes 
approximately 80% of the catecholamines in the brain (Vallone et al., 2000). The areas 
that synthesise dopamine give rise to 4 neuronal pathways: the nigro-striatal (mainly 
projecting from the sustantia nigra pars compacta to the striatum), the 
tuberoinfundibular (from the arcuate nuclei of the hypothalamus and perventricular to 
the median eminence of the hypothalamus), the mesocortical (from the VTA to pre-
frontal contrical regions) and the mesolimbic (from the VTA to parts of the limbic 
system, ventral striatum and VP). 
47 
 
Dopaminergic projections into the VP are mainly from the VTA (Klitenick et al., 
1992b), although there is evidence to suggest that there is some input from the 
substantia nigra pars compacta (Beckstead et al., 1979; Root et al., 2015), this is limited 
compared to the dopaminergic input from the VTA.  
Stimulation of dopaminergic fibres from the VTA has been shown to both excite and 
inhibit neurons within the VP (Napier & Potter, 1989) and local ionotophoretic 
application of dopamine, into the VP, also produces this characteristic excitations and 
inhibitions in VP neurons (Napier & Maslowski-Cobuzzi, 1994; Napier & Potter, 1989)  
Other research has also shown that dopamine can modulate the effects of other 
neurotransmitters in the VP.  Johnson and Napier, (1997) used ionotophoretic injections 
of DA with glutamate or GABA into the VP. These data suggest that dopamine 
modulates the effect of both GA and GABA in the VP, although this was often seen at a 
sub-optimal level for the modulation of firing frequency. There is also evidence to 
suggest that dopamine modulates inputs from other regions in the VP. Maslowski-
Cobuzzi and Napier, (1994) for example have shown that dopamine attenuates 
responses evoked by amygdala inputs in VP neurons.  
 
1.8.5.1 Dopamine receptors and the VP: 
 
Evidence shows that D1, D2, D3 and D4 receptors are found within the VP (Beckstead 
et al., 1988; Mansour et al., 1990; Noain et al., 2006), although there is suggestion that 
the majority of dopamine receptors in the VP are D1-like (Root et al., 2015). 
Dopamine receptors are subdivided into two main groups. The D1-like, which 
comprises of D1 and D5 dopamine receptors and the D2-like groups, which consist of 
D2, D3 and D4 dopamine receptors (Vallone et al., 2000). 
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Classically D1-like receptors are considered to be excitatory and D2-like receptors 
inhibitory (Maslowski & Napier, 1991a). D1-like receptors are excitatory and have their 
effect by being positively coupled to adenylate cyclase. D2-like receptors are inhibitory 
and have their effect by being negatively coupled to adenylate cyclase and therefore 
reducing the secondary messenger, cAMP. Mengual and Pickel, (2002) carried out an 
ultrastructural electron microscopy study of the VP, which suggests that the majority of 
D2 receptors in the VP are located presynaptically and act as autoreceptors inhibiting 
the input to the VP from other regions. They suggest that they most likely modulate the 
GABAergic inputs from the NAc. Little else is known about the location of dopamine 
receptors within the VP.   
 
1.8.5.2 Effects of selective dopamine receptor agonists on the VP: 
 
Dopamine D1-like and D2-like receptors are thought to contribute to excitations and 
inhibitions seen in response to dopamine application in the VP (Napier & Potter, 1989). 
Maslowski and Napier, (1991) found D2-like receptor agonists reduced activity in 59% 
of neurons that responded to them and that D1-like receptor agonists excited 69% of 
neurons in the VP that responded to their application. This is also supported by 
Heidenreich et al's., (1995) data which shows a rate increase in VP neurons to the 
application of D1-like agonists by approximately 161-178%. However, Napier and 
Maslowski-Cobuzzi’s, (1994) data suggest that D1-like receptor agonists largely 
produce inhibitions in VP neurons and D2-like receptor agonist largely produce 
excitation. These differences may be a results of the techniques used to administer the 
agonists, as the research (Heidenreich et al., 1995; Maslowski & Napier, 1991a) 
involved systemic application of the agonists, therefore potentially resulting in 
modulation of areas upstream of the VP. On the other hand Napier and Maslowski-
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Cobuzzi, (1994) applied the specific receptor agonist directly into the VP via 
microiontophoretic injections, therefore reducing the impact of upstream modulation.  
 
1.8.5.3 Functional effects of dopamine, D1-like agonists and D2-like agonists in 
the VP on behaviour: 
 
Dopamine has been shown to modulate motor output via its effects in the VP. 
Experiments suggest that dopamine produces robust changes in motor behaviour when 
injected into the VP (Austin & Kalivas, 1991; Gong et al., 1999; Klitenick et al., 
1992b).  Gong et al., (1999) also found that small doses of D1-like agonists injected 
directly into the VP increase locomotion, while D2-like agonists suppressed 
locomotion. Specific D1-like and D2-like antagonists directly injected into the VP have 
also been shown to block increases in motor activity induced by opioid agonists 
application (Napier, 1992), therefore suggesting an interaction between the effect of 
opioids and dopamine in the VP.  
Dopamine is also known to play an essential role in the reward circuits (Schultz, 2002; 
Wise, 2002). Consistently, there are multiple studies suggesting that dopamine and 
dopaminergic inputs from the VTA modulate reward related behaviour in the VP. 
Lesioning studies of dopaminergic VTA inputs into the VP, such as that of Gong et al., 
(1997) shows that dopamine is involved in conditioned place preference (CPP) 
responses to drugs of abuse, as lesions of dopaminergic inputs reduced the CPP to I.P 
injections of amphetamine. Research also shows, that drugs of abuse, such as cocaine, 
increase dopamine levels in the VP (Sizemore et al., 2000; Stout et al., 2016),they 
therefore likely play a role in the reinforcing effects of drugs of abuse. Other researchers 
have found that inhibition of D2-like receptors, in the VP increases the 
seeking/anticipatory behaviour for a preferred substance (in this case ethanol) and 
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exciting, with D2-like agonists reduced the seeking/anticipatory behaviour for ethanol 
in ethanol preferring animals (Melendez et al., 2004). The self-stimulation literature also 
supports the role of dopamine and its receptors subtypes in the VP in reward. Research 
has shown (Panagis et al., 1995; Panagis & Spyraki, 1996) that D1-like and D2-like 
antagonists modulate the amount animals self-stimulate the VP, therefore suggesting 
that activation of dopamine receptors modulates how reinforcing self-stimulation is. 
There is also evidence to suggest D1-like and D2-like receptors are involved in negative 
reinforcement processes, learning and memory consolidation. Péczely et al., (2014) 
showed that D1-like agonist could dose-dependently enhance inhibitory avoidance 
learning, increasing the step through latencies in an inhibitory avoidance paradigm. 
Lénárd et al., (2017) also used this paradigm and found similar effects for D2-like 
receptor activation in the VP, suggesting that both D1-like and D2-like receptors are 
recruited in the VP during negative reinforcement.  
All these data point towards dopamine and its receptors having a profound effect on VP 
circuitry and the functional output of the VP. However, surprisingly little is known 
about the cellular mechanisms underlying dopamine’s effects in the VP. These therefore 
requires further investigation.  
 
1.8.6 Serotonin (5HT) 
 
Serotonin is a key monoamine found at the terminal of nerve cells. It belongs to a group 
of neurochemicals, including melatonin and tryptamine, sharing a similar chemical 
structure and known as indolalkylamines (Doggrell, 2003). The main source of 
serotonin in the VP is from the terminals of the dorsal raphe nuclei neurons (Vertes, 
1991).  
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There are multiple different serotonin receptor subtypes and their distribution is 
heterogeneous across the brain (Pytliak et al., 2011). It is generally accepted that there 
are seven subtypes (5HT1-7), with many being further divided. All bar one are G protein 
coupled, with 5HT3 being a ligand gated ion channel. Five out of the seven are 
excitatory with two (5HT1 and 5HT5) being inhibitory and decreasing the levels of 
cAMP (Berger et al., 2009).  
Studies have shown that serotonin differentially modulates different populations of 
neurons across basal ganglia territories (Blomeley and Bracci, 2005; Blomeley and 
Bracci, 2009; Cains et al., 2012). Bengtson et al., (2004) has shown it specifically 
modulates neurons within the VP, with the suggestion being that it hyperpolarises 
cholinergic neurons and depolarises GABAergic neurons within the VP. It may well be 
that these opposing effects are modulated by different serotonin receptor subtypes in the 
VP.  In fact several serotonin receptor subtypes have been detected within the VP, with 
some found on GABAergic terminals within the VP, where their function is believed to 
be inhibitory, reducing the release of GABA from these neurons onto cholinergic 
terminals (Nishijo et al., 2016). Indeed, In the dorsal extent of the pallidum (GPe) 
Hashimoto & Kita, (2008) have found that serotonin mainly has its effects through pre-
synaptic mechanism, modulating both GABAergic and Glutamatergic inputs. Although 
there is some suggestion of post synaptic, direct effects. The precise location of all the 
serotonin receptor subtypes in the VP is not however clear and therefore requires 
investigation, as it would provide novel insights into the cellular mechanism 
underpinning serotonin’s effects within the VP, as well as providing potential novel 
pharmacological targets. 
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1.8.6.1 Different classes of 5HT receptors: 
 
As previously mentioned, there are commonly considered to be seven subtypes of the 
serotonin receptor (Berger et al., 2009) many of which have further subtypes (Barnes & 
Sharp, 1999; Nichols & Nichols, 2008). Authoradiographic studies have identified the 
presence of many of these receptor subtypes within the architecture of the VP, although 
with differing degrees of expression, these include: 5ht2 receptors (Appel et al., 1990) 
5ht7 (To et al., 1995) 5ht4 (Vilaro et al., 1996) and 5ht1a, (Wright et al., 1995). 
1.8.6.1.1 5HT7: 
 
5HT7 receptors are GS protein coupled (Pytliak et al., 2011), their mechanism of action 
is to increase intracellular concentrations of cAMP.  Studies shows 5ht7 receptors are 
found in the ventral pallidum, although only at low-moderate levels (To et al., 1995). 
Hauser et al., (2014) suggests that the 5HT7 receptor may be key to mediating craving 
and reinforcing effects of drugs, such as alcohol. Something the VP is also heavily 
associated with (Perry & McNally, 2013; Tang et al., 2005). 5HT7 has also been 
implicated in the dichotomous responses seen in the VP to serotonin. Bengtson et al., 
(2004) suggest this as they found these dichotomous actions in response to 5-
Carboxamidotryptamine (5CT) application, which has high affinity at 5HT1, 5HT5a 
and 5HT7 receptor sites.  
1.8.6.1.2 5HT2c 
 
5HT2 receptors are a Gq11 protein coupled receptor and are largely considered to have 
excitatory effects, through increasing intracellular concentration of IP3 and DAG 
(Berger et al., 2009). A subpopulation of these receptors; 5HT2c are found in high 
concentration in the GP and VP (Appel et al., 1990). Agonists for 5HT2c receptors have 
also recently been shown to modulate the firing rate in a significant number of VP 
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neurons, producing increases in 58% of those neurons that responded (Napier & Istre, 
2008). 
This subpopulation are heavily associated with psychiatric disorders, particularly 
affective disorders. Agomelatine, which is a 5HT2c antagonist has been found to be an 
effective antidepressant (Goodwin et al., 2009; San & Arranz, 2008), and research by 
(Cryan & Lucki, 2000) also suggests a role for 5HT2c antagonism to modulate rat 
models of depression. This fits well with the VP’s known role in the modulation of 
pleasure responses and motivation. 
Recent research has shown definitively that 5HT2c receptors in the VP do indeed 
modulate some of its functional roles, including motor activity and sensitization to 
drugs of abuse. Specific 5HT2c agonists directly injected into the VP have been shown 
to attenuate motor activity (symptom of depression) (Graves et al., 2013) and Napier & 
Istre, (2008) have also recently shown that sensitization to methamphetamine produces 
an upregulation of 5HT2c receptors in the VP.  
Further elucidation of the cellular mechanisms underpinning 5HT2c receptors’ 
modulatory roles in the VP may well prove insightful and provide novel targets for 
pharmacological interventions.  
1.8.6.1.3 5HT1a 
 
5HT1A receptors are expressed in the rat brain (Wright et al., 1995), and are known to 
be both present and modulate firing rates within the VP. Heidenreich and Napier, (2000) 
found that 9/26 neurons activity was enhanced by 5HT1a agonist while 8/26 of the 
neurons activity was suppressed. Other research suggests that 5HT1a receptors are 
inextricably linked to major depressive disorder (Bhagwagar et al., 2004; Drevets et al., 
1999). Therefore their modulation of the VP may play some part in its known 
involvement in affective/pleasure responses. Little else is known about the location of 
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5HT1a receptors or the cellular mechanisms they modulate. This is therefore pertinent 
for further investigation. 
1.8.6.1.4 5HT5a 
 
Rodents express two subtypes of 5HT5 receptors, however in humans the 5HT5b has 
been shown to be non-functional, therefore the only one of relevance to humans is the 
5HT5a receptor (Pytliak et al., 2011). It is thought to be inhibitory and have its 
modulatory effects through the reduction of intracellular cAMP levels in the same 
manner as 5HT1 receptors. 5HT5a has been found to be expressed in moderate levels in 
the ventral pallidum of rats via immunohistochemical techniques (Oliver et al., 2000). 
Until recently little research had been carried out on 5HT5a receptors, due largely to the 
lack of a selective antagonists. However the highly selective antagonists SB699551 
(Thomas et al., 2006) is now available and recent research suggest 5HT5a may become 
a novel therapeutic target (Thomas, 2006). Therefore elucidation of its cellular effects 
within the VP will provide invaluable new knowledge. 
 
1.9 Connections between the NAc and the VP 
 
1.9.1 Anatomical connectivity: 
 
The VP is major output structure of the striatum and as such is innervated by afferents 
from its ventral division (NAc). Many consider the NAc afferents to be the main input 
of the VP (Bolam et al., 1986; Haber et al., 1985). Lesioning studies for instance 
suggest a strong area to area connection between the Nac and VP (Chrobak & Napier, 
1993; Churchill et al., 1990; Kupchik et al., 2014; Root et al., 2015) and 
anterograde/reterograde tract tracing research supports these conclusion (Groenewegen 
& Russchen, 1984; Thompson & Swanson, 2010; Zaborszky & Cullinan, 1992). Not 
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only are the NAc and VP heavily connected, but tract tracing studies find their 
connection pattern to be very specific, with extremely localised areas in the NAc 
targeting extremely localised, and topographically organised areas within the VP. Zahm 
and Brog, (1992) carried out extensive research, which shows that the projection 
patterns are different between the NAcC and the NAcS, with the shell providing the 
majority of input into the ventro-medial VP, whereas the NAcC projections are 
predominantly localised to the dorsolateral portions of the VP. This pattern of 
connectivity was also seen in the anterograde tracing work of Heimer et al., (1991). It is 
less clear if these differences in projection patterns confer to any differences in the 
modulatory effect of NAc inputs on to VP neurons. 
 
1.9.2 Functional connectivity  
 
The connections between the NAc and VP have become major targets for research, with 
much emphasising the fact these areas are not only anatomically connected, but also 
functionally connected. These connections are implicated in a variety of behaviours. For 
example Berridge and colleagues (Peciña et al., 2006; Smith & Berridge, 2007; Smith & 
Berridge, 2005; Tindell et al., 2006) have shown that these connections are essential for 
experience of pleasure-related behaviour. For example Smith and Berridge., (2007) 
found that stimulation of specific areas within both the VP and NAc, with the opioid 
agonist DAMGO, results in increased orofacial pleasure responses to sucrose ingestion. 
However, they also found that this increase in pleasure responses to DAMGO 
application, in either the NAc or VP, was abolished if the opioid antagonist naloxone 
was administered simultaneously in the other area, suggesting that the connections 
between both areas are reciprocal and both areas must be recruited for elevation of 
pleasure responses. Much research also suggests that these connections play an 
56 
 
instrumental part in responses to drugs of abuse. Tang et al's., (2005) research suggests 
the projection from the NAc to the VP regulate the reinstatement of cocaine seeking in 
animals that had been extinguished from self-administering cocaine. More recently 
Creed et al., (2016) have shown that  D1 and D2 connections between the NAc and VP 
are effected differently by cocaine, and result in different aspects of cocaine withdrawal 
and anhedonic aspects of motivational behaviour. Heinsbroek et al., (2016) also draws 
similar conclusions, suggesting that cocaine modulates the D1 but not the D2 
projections and occludes LTD in D1 inputs to the VP. Research on the connections 
between the NAc and VP also points to these connections playing a key functional role 
in learning responses. Leung and Balleine's, (2013) study investigated the connections 
between the NacS and VP with animals that had undergone the Pavlovian transfer task 
(PIT). They found that there was a significant increase in activity in the medial VP 
(Cfos expression) and in the activity of regions known to project to this area from the 
NacS in animals that had undergone the PIT task, but not controls. This suggests that 
these connections mediate predictive learning and choice.  
 
1.9.3 Neurochemistry and receptors of the connections between the NacS and 
VP: 
 
The pharmacology of these inputs, and the neurons/receptors they target in the VP, is 
essential knowledge as understanding the pharmacology of these connections may 
provide novel ways of modulating affective responses, learning responses and certain 
aspects of behaviour towards drugs of abuse. The NAc inputs into the VP are 
considered to be largely inhibitory. For example, recent research using optogenetics by 
Wang et al., (2014) found that optogenetic activation of SPNs in the NAc, produced a 
reduced activation in the VP. With a resultant, decrease in cFos expression in the VP. 
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Much of the research implementing immunohistochemical techniques and 
electrolytic/acid lesioning methodologies suggest that the connection between the NAc 
and VP are almost definitely GABAergic (Churchill et al., 1990b; Churchill & Kalivas, 
1994; Kitamura et al., 2001; Mogenson et al., 1983; Reiner & Anderson, 1990; Walaas 
& Fonnum, 1979; Yang & Mogenson, 1985; Zaborszky & Cullinan, 1992). As well as 
releasing GABA into the VP these connections have also been found to release other 
neuromodulators. Haber et al., (1985) found that approximately 40% of the connections 
between the NacS and VP express preproenkephalin, suggesting they release 
enkephalin. Substance P is also expressed in high levels within the VP. Indeed for many 
years staining for substance P has been used as a key way of delineating the VP from 
other anatomical regions. It was suggested that the NAc afferents of the VP may 
provide some of this substance P. Research has shown (Mitrovic & Napier, 1998; 
Napier et al., 1995a) that a significant proportion of the substance P in the VP is from 
the NAc afferents.  This is supported by In situ hybridization studies (Lu et al., 1997) 
which  confirm that a significant proportion of the connections between the NAc and 
VP express beta-preprotachykinin, which is a marker for substance P expression.  The 
release of enkephalin and substance P by NAc afferents into the VP has also recently 
been supported by definitive evidence that the NAc innervates the VP with both D2 
expressing MSNs (indirect pathway) and D1 expressing (direct pathway) MSN’s (Creed 
et al., 2016; Kupchik & Kalivas, 2016). This supports the idea that the inputs from the 
NAc express enkephalin and substance P, as indirect pathway neurons express 
enkephalin and direct pathway neurons express substance P.  
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1.9.4 Neuronal and receptor targets of the NAc input into the VP: 
 
Questions remain as to what neurons the afferent connections of the NAc target in the 
VP. A number of double immunohistochemical labelling studies (Grove et al., 1986; 
Zaborszky & Cullinan, 1992; Zaborszky et al., 1986) suggest GABA projections from 
the NAc directly target Cholinergic expressing neurons in the VP. There is less 
evidence supporting NAc afferents targeting other neuron populations in the VP, such 
as GABAergic neurons and PV+ neurons, although recent research by Root et al., 
(2015) suggests NAc afferents do directly innervate GABAergic neurons of the VP. 
Further research is needed to elucidate how NAc inputs modulate the VP neurons they 
FIGURE 1.3: Comparison of the classical canonical view of NAc projections and 
the revised view.(A) The canonical view of striatal projections sees only D2 MSNs 
projecting to the VP (B) The updated view, based upon recent data suggests both D1 
and D2 MSNs project to the VP. Adapted from Kupchik and Kalivas., (2016). 
A B 
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innervate, and whether the modulatory effects of NAc afferent stimulation differs 
between the neuron populations found in the VP.  
Stimulation of NAc afferents have been shown to inhibit VP neurons and this inhibition 
has been shown to be blocked via local application of GABA antagonists (Chrobak & 
Napier, 1993; Mogenson et al., 1980). However stimulation of these NAc afferents has 
also been shown to excite some neurons In the VP (Chrobak & Napier, 1993). This 
could well relate to the type of neuron they innervate and the receptors expressed by 
these neurons. As previously discussed the NAc afferents of the VP are known to 
release substance P and Enkephalin as well as GABA. Substance p is a known 
excitatory neurotransmitter and has been shown to excite VP neurons (Napier et al., 
1995a). This combined with the known innervation of VP cholinergic neurons by NAc 
afferents and the known expression of NK1 receptors on VP cholinergic neurons, 
suggests cholinergic neurons may be the main neuron population responding with 
excitation from stimulation of NAc inputs, as seen by Chrobak and Napier (1993). 
However substance P is also known to modulate glutamatergic inputs from the 
amygdala in the VP (Mitrovic & Napier, 1998) and in other basal ganglia structures 
(Blomeley & Bracci, 2008; Blomeley et al., 2009). This requires further investigation 
and clarification. Opioids have also been shown to modulate striatal projection neurons 
(Blomeley & Bracci, 2011) and have specifically been shown to modulate the inhibitory 
response induced by NAC afferent stimulation in the VP. This is because naloxone has 
been shown to reduce the inhibitions evoked by NAc afferent stimulation into pallidal 
regions (Napier et al., 1992; Napier et al., 1983), therefore suggesting that enkephalin 
may contribute to the inhibitory response seen as a result of NAc afferent stimulation in 
the VP. However MOR activation has been found to have dichotomous effects on 
neurons within other striatal regions (Elghaba and Bracci, 2017), therefore the effect of 
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enkephalin may be more complex than simple facilitation of the inhibition induced by 
GABA release within the VP.  
The NAc afferents of the VP are also known to express receptors for various different 
neurotransmitters, such as inhibitory 5HT1B serotonin receptors (Nishijo et al., 2016) , 
inhibitory mGluR7 metabotropic glutamate receptors (Li et al., 2013), D1-like receptors 
and D2-like receptors (Kupchik et al., 2015). This suggests that serotonergic, 
glutamatergic and dopaminergic inputs into the VP may provide a source of modulation 
for NAc afferent of the VP. Therefore considering their known role in aspects of 
addiction, focus on how these neurotransmitters modulate the inhibitory and excitatory 
effects of NAc stimulation in the VP would be pertinent.  
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2 Chapter 2: Materials and methods 
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2.1 Animals:All experiments were carried out in line with the 1986 Animals 
(Scientific procedures) Act, and with full approval from the UK Home Office.  
Extracellular in vitro recordings were obtained from C57 mice. In some instance, 
due to availability, mice from the transgenic line ChR2-NNos (Jackson 
Laboratory, USA) were used. No differences were found in the 
electrophysiological activity of VP neurons between these animals and the C57 
mice.   
Chapter Section Experiments Number 
of 
animals 
Number 
of slices 
used 
Number 
of 
recorded 
units 
Number 
of 
analysed 
units 
3 3.3.1 6 6 6 47 35 
3.3.2 11 8 11 82 55 
3.3.3 6 5 6 41 26 
3.3.4 4 4 4 38 34 
3.3.5 6 4 6 28 19 
3.3.6 2 2 2 12 7 
3.3.7 5 5 5 33 24 
3.3.8 4 3 4 17 8 
3.3.9 2 2 2 14 11 
4 4.3.1 10 8 10 105 76 
4.3.2 1 1 1 13 10 
4.3.3 3 3 3 11 9 
4.3.4 1 1 1 10 6 
4.3.5 3 2 3 16 12 
4.3.6 2 2 2 14 13 
4.3.7 1 1 1 10 8 
4.3.8 2 2 2 13 9 
5 5.3.1 13 10 13 67 52 
 5.3.2 10 6 10 31 17 
 5.3.3 12 8 12 41 26 
 5.3.4 8 8 8 22 16 
 5.3.5 3 3 3 15 8 
 
TABLE 2.1: Summary table of animals used and the related recorded units for each 
study
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2.2 Slice preparation: 
 
Mice aged between 28 and 42 days were killed by cervical dislocation and death 
confirmed by decapitation. The brain was rapidly removed from the skull and 
parasagittal slices of 400µm obtained using a vibroslicer (Cambden instruments) 
immersed in ice cold (5◦C), oxygenated (saturated 95 % O2 and 5 % CO2) Sucrose 
cutting solution. This solution was made up fresh daily and contained (in mM): Sucrose 
(184), NaH2PO4 (1.2), KCl (2.5), NaHCO3 (30), Glucose (25), sodium ascorbate (5), 
Thiourea (2), HEPES (20) MgSO4.7H2O (10), sodium pyruvate (3), CaCl2.2H2O (0.5). 
Once cut, slices were immediately transferred to a recovery chamber maintained at 
26◦C, containing a Tris recovery solution, which was continuously aerated with a 
carbogen mixture of 95 % O2 and 5 % CO2 gas. The Tris recovery solution was made 
up fresh daily and contained (in mM): Tris HCl (76), Tris base (19.5), KCl (2.5), 
Thiourea (2), Glucose (25),  NaHCO3 (30), HEPES (20), CaCl2.2H2O (0.5),  NaH2PO4 
(1.2), sodium pyruvate (3), sodium ascorbate (5),  MgSO4.7H2O (10). The slices 
remained in this chamber for 30 minutes, before being transferred to another chamber 
for storage. This chamber was also maintained at 26◦C and contained standard aCSF, 
which was continuously aerated with a carbogen mixture of 95 % O2 and 5 % CO2 gas. 
The standard aCSF was also made up fresh daily and contained (in mM): KCl (3), 
CaCl2 (2), NaHCO3 (26), Glucose (15), MgSO4.7H2O (2), NaH2PO4 (1.2), NaCl (124). 
Slices were then left for a minimum of 60 minutes to equilibrate and recover before 
electrophysiological recordings commenced.  
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2.3 pMEA (perforated Multi-Electrode Array) electrophysiological recordings:  
 
Neural network activity was monitored and recorded using a perforated multi-electrode 
array (pMEA, Multi-Channel Systems, Reutlingen, Germany). The pMEA contained 60 
embedded electrodes constructed of titanium nitrite. Each of these electrodes has a 
diameter of 30 µm and they are spaced at 200 µm. Recorded electrical activity for 
selected channels of interest was digitized at a sampling rate of 10 kHz using a 
MEA1060-Up-BC amplifier and MC Rack version(version: 4.6.2) software (Multi 
Channel Systems, Reutlingen, Germany).  
For recording slices were transferred to the pMEA chamber, already in position in the 
amplifier. Once the slice was moved into position over the electrodes on the MEA, the 
bottom flow was switched on to produce suction and fix the slice into position. A mesh 
harp was then placed on top of the slice and a top flow applied as quickly as possible to 
maintain healthy slices. Both the top and bottom flow (perfusion) contained 
continuously aerated aCSF. The bottom flow rate was maintained at 0.65 – 1 ml per 
minute and top flow was maintained at 3-5 ml/per minute. This imbalance in the top and 
bottom flow rate was maintained to produce suction, so the slice was firmly fixed to the 
pMEA (Figure 2.1 cross section).  Activity was monitored for 1 hour before recordings 
commenced.  
During recording aCSF was perfused and removed from the recording chamber, via the 
top flow, with a Gilson Minipuls 3 peristaltic pump. Inlet and outlet bath perfusion 
mounts, for the top flow perfusion system, were obtained from Scientifica 
(www.scientifica.uk.com). Insulated wire was soldered on to their bodies so they could 
be grounded to the microscopes mounting plate. The bottom inflow was gravity fed 
while aCSF was removed from the bottom flow with a Watson Marlow 120s peristaltic 
pump. All experiments was performed inside a grounded faraday cage open on one side.  
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Depending upon the experimental protocol, two types of aCSF were used to perfuse the 
slice once in the MEA recording chamber. One referred to as standard aCSF/control and 
a second with low Ca2+ levels referred to as low Ca2+ aCSF. The standard aCSF 
contained:  (in mM): KCl (3), NaH2PO4 (1.2), NaHCO3 (26), Glucose (15), NaCl (124),  
MgSO4.7H2O (2), CaCl2.2H2O (2). The low Ca2+ aCSF was the same as the “normal” 
aCSF, bar a reduced quantity of CaCl2 (0.2mM). 
 
 
FIGURE 2.1: Schematic of the multi-electrode array perfusion set up. (Top 
view) illustration of the upper perfusion flow over the slice. (Cross section) 
illustration of the upper perfusion flow direction, the direction of the bottom 
perfusion flow and the movement of the aCSF through the slice to produce 
suction  
66 
 
2.4 Slice visualisation: 
 
To identify the correct area of the mouse slice for recording of the VP neurons and 
stimulation of the NAc, the PMEA was placed in the amplifier and then under an 
Olympus BX51 microscope, with a 4 x lens.  The slice was viewed via a Tucson digital 
microscope camera, which was sending a live feed to a Viglen computer (4gb of 
memory and an i5 processor) running IS capture software.  
 
The VP was considered as any area ventral to the caudal anterior commissure and 
before the caudal edge of the rostral anterior commissure as it subdivides the striatum 
into its dorsal and ventral extents (figure 2.2) . The NAc was considered as any area 
directly ventral to the rostral extent of the anterior commissure and to the left of the 
identified VP region. For stimulation experiments (chapter 5) identification of the dorsal 
and ventral extents of the VP were necessary. The dorsal VP was defined as any 
electrode, located within the VP, which was within 500 µm of the caudal anterior 
commissure. The Ventral VP was defined as any region, located in the identified VP, 
over 600µm away from the ventral edge of the caudal anterior commissure. 
 
FIGURE 2.2: Adapted from, Allen mouse brain atlas 
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2.5 Stimulation methods and protocols: 
 
Stimulation was performed using a STG 1002 (Multichannel systems), which was 
programmable via MC_stimulus software (version 2.1.5). Stimulation was delivered via 
the internal electrodes of the MEA chip, the electrode to be used for stimulation was 
selected based upon the location of the slice in the MEA chip chamber, which was 
observed via the video stream from the camera mounted on the optic of the microscope. 
Electrodes were always chosen for stimulation that were at least 400microns away from 
the rostral edge of the identified VP. Once the correct area and the corresponding 
electrodes in this area were identified, MC_select software (version 1.3.0), which allows 
you to allocate the embedded electrodes as stimulating channels, was used to administer 
a biphasic stimulation. Two electrodes adjacent to one another in the MEA were always 
selected for the delivery of stimulation. The stimulation was always bipolar, with a 
negative followed by positive polarity, in line with multichannel systems suggestions 
(Wagenaar et al., 2005; Wagenaar et al., 2004). The voltage of stimulation never 
exceeded -/+ 3000 mv and lasted for a duration of: 
 1 stimulation of 200 µs duration followed by a 10 second gap, before the next 
trial. 
 HFS which was at 100 Hz: 5 stimulations of 300 µs duration with 9700 µs gap 
between each, giving a total stimulation time of 50 ms. Each trial was 10 
seconds apart. 
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FIGURE 2.3: differential effects of high and low-frequency stimulation 
protocols. Stimulation of neurons with a low frequency stimulation protocol is 
known to result in the preferential release of small neurotransmitters, while high 
frequency stimulation protocols are known to result in the release of both small 
neurotransmitters and larger neuropeptides. Figure adapted from Purves., 2001. 
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The HFS stimulation protocol was used for experiments using NK-1 receptor 
antagonists, as it had been shown to promote the release of neuropeptides (figure 2.3), 
such as SP (Purves, 2001). The low frequency stimulation was used in experiments 
involving, opioids and GABAa antagonists as it is known to favour the release of 
smaller neurotransmitters, such as GABA. 
2.6 Pharmacology: 
 
All drugs were obtained from either Tocris Biosciences (UK) or Sigma Aldrich and 
were bath applied into the header reservoir feeding the top perfusion flow of the pMEA 
at the following concentrations: 
1. (4aR-trans)-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H-pyrazolo[3,4-g]quinoline 
hydrochloride: (-)-Quinpirole hydrochloride (quinpirole), 20 µM. 
2. (±)-6-Chloro-2,3,4,5-tetrahydro-1-phenyl-1H-3-benzazepine hydrobromide: 
(SKF81297), 20 µM. 
3. (S)-(-)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-
methoxybenzamide (sulpiride), 20 µM.  
4. (6aS-trans)-11-Chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5H-
benzo[d]naphth[2,1-b]azepin-12-ol hydrobromide (SCH39166), 20 µM. 
5. 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX), 20 
µM  
6. D-(-)-2-Amino-5-phosphonopentanoic acid (AP5) 20 µM 
7. (RS)-α-Methyl-4-carboxyphenylglycine (MCPG), 20 µM 
8. (RS)-α-Methyl-4-sulfonophenylglycine (MSPG), 10 µM 
9. 3,4-Dihydroxyphenethylamine hydrochloride: (dopamine), 30 µM 
10. 5-Hydroxytryptamine hydrochloride (serotonin) 30 µM, as per (Bengtson et al., 
2004) 
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11. N-[2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl]-N-2-
pyridinylcyclohexanecarboxamide maleate: 5HT1a antagonist (WAY100635) 10 
nM, as per (Corradetti et al., 1996).  
12. 8-[5-(2,4-Dimethoxy-5-(4-trifluoromethylphenylsulphonamido)phenyl-5-
oxopentyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione hydrochloride: 5HT2c 
antagonists (RS102221) 1-3 µM, as per (Bonsi et al., 2007).   
13. N-[2-(Dimethylamino)ethyl]-N-[[4'-[[(2-phenylethyl)amino]methyl][1,1'-
biphenyl]-4-yl]methyl]cyclopentanepropanamide dihydrochloride: 5HT5a 
antagonists (SB699551) 1 µM.  
14. (2R)-1-[(3-Hydroxyphenyl)sulfonyl]-2-[2-(4-methyl-1-
piperidinyl)ethyl]pyrrolidine hydrochloride: 5HT7 antagonist (SB269970) 1-3 
µM, as per (Bonsi et al., 2007). 
15.  2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide: 
(NBQX) 20 µM.  
16. 2-APV, D-APV, D-2-amino-5-phosphonovalerate: D-AP5 (AP5) 20µm 
17. Picrotoxin: (Picrotoxin) 20 µM. 
18. N-Acetyl-L-tryptophan 3,5-bis(trifluoromethyl)benzyl ester: (L732,138) 20µm  
19. Substance P: (SP) 20 µM. 
20. (5α)-4,5-Epoxy-3,14-dihydro-17-(2-propenyl)morphinan-6-one hydrochloride: 
(Naloxone) 20 µM.  
21. [D-Ala2, NMe-Phe4, Gly-ol5]-enkephalin: (DAMGO) 20 µM. 
Washout of any pharmacological treatment was considered complete when firing 
frequency recorded over a period of 1200 s was not significantly different from that 
observed over a 1200 s period just before drug application. 
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2.7 Data Analysis for pharmacological experiments:  
 
Data was acquired using Mc_rack software (version: 4.6.2) and a MEA1060-Up-BC 
amplifier (Multi-Channel Systems, Reutlingen, Germany). These files (.mcd) were then 
converted to .ced files using multichannel data manager software (version: 1.9.7, Multi-
Channel Systems, Reutlingen, Germany) for off-line analysis using Spike 2 software 
(C.E.D) 
For all recordings, spike sorting was carried out offline using dedicated Spike2 (C.E.D.) 
software. This software uses an automated waveform matching system to construct 
waveform templates and allows the user to set an appropriate threshold for detection of 
individual units. When multiple units were detected in a trace, discrete clustering of 
waveforms within a template was verified through principal components analysis, also 
implemented by Spike2.  
See figure legends for information on result expression. All error bars are expressed as 
SEM. 
In order to assess differences in a neuron's firing frequency in different pharmacological 
conditions, we measured consecutive inter-spike intervals (ISIs) during the final 
1200seconds of each condition. Average ISIs for relevant conditions were then 
compared using a Student's t-test. A statistically significant difference was considered to 
be present if P<0.05. If a treatment caused a significant increase in ISI, we refer to this 
observation in the results as a significant decrease in firing frequency and an inhibitory 
effect of the treatment. If a treatment caused a significant decrease in ISI, we refer to 
this observation as a significant increase in firing frequency and an excitatory effect of 
the treatment.  
Coefficient of variation (CoV) was calculated as a measure of spike train variability in 
different pharmacological conditions and as a potential way of identifying different 
neuronal types in the VP. It was calculated as: standard deviation (ISI) / Mean ISI. 
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Threshold for spike detection was considered to be reached when the recorded voltage 
departed from baseline (0 mV in AC recording mode) by more than the standard 
deviation of the voltage recorded for that channel during an apparently quiescent period 
(of at least 3 s). Spikes consisted of a biphasic negative-positive waveform. Spike 
amplitude was defined as the difference between the negative voltage peak and the 
spike threshold level defined above. Spike half-width was defined as the time the value 
of the recorded voltage (measured from the threshold level) remained more negative 
than half of the spike amplitude (Figure 2.4) (Pettersen & Einevoll, 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2.4: Spike half-width calculation. (A) A raw data trace of tonic 
neuronal activity measured in the VP. (B) An example of a typical spike 
recorded in the VP with the reference point used for calculation of its spike 
half-width, halfway between baseline and maximum negative amplitude. 
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2.7.1 Data analysis for stimulation experiments:  
 
Pause duration was calculated as the amount of time taken for the neuron to return to 
90% of the pre-stimulation firing rate. If this occurred in < 100 ms these neurons were 
considered as non-pauses. If the pause duration was >100 ms these neurons were 
considered pauses. This was done to ensure the HFS, which lasted for 50 ms, was not 
falsely accepted as a pause in firing 
In order to assess differences in a neuron's firing frequency in different pharmacological 
treatments. We measured consecutive inter-spike intervals (ISIs) at the end of the 
stimulation protocol and during the final 60 s of each pharmacological condition. 
Average ISIs for relevant conditions were then compared using a Student's t-test. A 
statistically significant difference was considered to be present if P<0.05. If a treatment 
caused a significant increase in ISI, we refer to this observation in the results as a 
significant decrease in firing frequency and an inhibitory effect of the treatment. If a 
treatment caused a significant decrease in ISI, we refer to this observation as a 
significant increase in firing frequency and an excitatory effect of the 
treatment. Coefficient of variation and spike half-width were also calculated in different 
pharmacological treatments during the final 60 s of each pharmacological condition. 
These were calculated in the same manner as for pharmacological experiments (pg68-
69).  
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3 Chapter 3: Dopaminergic modulation of VP neurons 
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3.1 Abstract: 
 
The ventral pallidum (VP) is crucially involved in reward processing. Dopaminergic 
afferents reach the VP from the ventral tegmental area (VTA). Recent in vivo studies 
suggest systemic dopamine application increase the firing frequency of neuronal 
populations within the VP. However, little is known about the cellular effects of 
dopamine within the VP. The current study aimed to address this paucity of data using 
brain slices containing the VP and multi-electrode array (MEA) recordings.  Dopamine 
significantly affected firing in 86 % of spontaneously active VP neurons. Among the 
affected neurons, 84 % were excited, while 16 % were inhibited. The selective D1-like 
receptor agonist SKF81297 also had modulatory effects on the majority of VP neurons, 
but its effects were universally excitatory. However, the D2-like receptor agonist 
quinpirole had modulatory effects on 87 % of VP neurons studied. It caused significant 
inhibitory effects in 33 % of the cases and excitatory effects in the remaining 67 %. The 
effects of D1-like receptor activation were presynaptic as blocking synaptic 
transmission with low Ca2+ abolished the effects of SKF81297 application. 
Furthermore, SKF81297 effects were abolished by blocking ionotropic glutamate 
receptors, suggesting that D1-like receptors boost glutamate release, which in turn 
excites VP neurons through postsynaptic glutamate receptors. Effects caused by D2-like 
receptor activation were found to involve pre and postsynaptic mechanisms, as low Ca2+ 
abolished the excitatory effects of quinpirole but not the inhibitory ones. Increases in 
firing frequency to quinpirole application were abolished by a group 2/3 mGluR 
antagonist, suggesting that D2-like receptors cause presynaptic inhibition of glutamate 
release, resulting in reduced postsynaptic activation of inhibitory mGluRs. Conversely, 
the inhibitory effects of quinpirole persisted in low Ca2+ and therefore can be attributed 
to postsynaptic D2-like receptor activation. VP neurons excited by dopamine have 
shorter spike half-widths and are excited by D1-like receptors (presynaptically) and by 
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D2-like receptors (postsynaptically). VP neurons inhibited by dopamine have longer 
spike half-widths and while D1-like receptor activation has a presynaptic excitatory 
influence on them, D2-like receptor activation has a postsynaptic inhibitory effect that 
prevails, on balance. These data provide novel insights into the cellular mechanisms by 
which dopamine controls information processing within the VP. 
 
3.2 Introduction: 
 
The ventral pallidum (VP) is a key output structure for the ventral striatum (Smith, et 
al., 2009). It also forms multiple feedback loops with some of the key structures 
involved in reward signaling, including the nucleus accumbens (NAc), the medial pre-
frontal cortex, the basal lateral amygdala, the subthalamic nucleus and the ventral 
tegmental area (Root, et al. 2015). The VP is known to have populations of GABAergic 
interneurons and cholinergic neurons that belong to the forebrain magnocellular 
cholinergic system (Bengtson & Osborne, 2000; Gritti, et al., 1993; Pang, et al., 1998). 
 
Interest in the VP has increased recently as the VP, and its connective circuitry, is 
heavily associated with reward, aspects of reinforcement and motivational salience 
(Cromwell & Berridge, 1993; Itoga, et al., 2016; Richard, et al., 2016). Indeed Smith et 
al., (2009) conclude that it is an essential integrative region for reward and reward 
learning and may well be a “limbic final common pathway”.  The VP also plays a key 
role in addictive behaviour towards drugs of abuse (Fletcher, et al.,1998; Gong, et al., 
1996; Hiroi & White, 1993; Hubner & Koob, 1990; Robledo & Koob, 1993; Tang, et 
al., 2005),  
 
The VP has a substantial dopaminergic projection arising from the ventral tegmental 
area (VTA) (Klitenick, et al., 1992; Root et al., 2015; Smith & Kieval, 2000) and 
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dopamine receptor subtypes (D1, D2, D3) are known to be expressed within the VP 
(Mansour et al., 1990; Richtand et al., 1995). However, little is known about the effects 
of dopamine in the VP. Heidenreich et al., (1995) have shown that, in vivo, D1-like 
receptor agonists increase the firing frequency in approximately 45 % of VP neurons. 
Napier & Maslowski‐Cobuzzi, (1994) found that D2-like receptor agonists also 
modulated the firing frequency in the VP in vivo and Johnson & Napier, (1997) 
suggested that dopamine effects depend on modulation of GABA inputs into VP. 
However, the cellular mechanisms activated by dopamine in the VP are still obscure. In 
vivo experiments are not ideal to clarify this issue, as the concentrations of ligands 
cannot be precisely controlled and because the presence of multiple active inputs to both 
the VP and the dopaminergic neurons in the VTA, greatly complicate the interpretation 
of the results. 
 
Elucidating the cellular mechanisms underlying the dopamine action in the VP is an 
extremely important aim, as there is a strong connection between dopamine and the role 
of the VP in reward and addictive behaviour. Recently, manipulation of dopamine in the 
VP has been shown to dramatically affect avoidance learning. Lénárd et al., (2017) and 
Péczely et al., (2014) have shown that D1-like and D2-like receptors within the VP are 
involved in the formation and retention of avoidance learning. Further, research 
(Maslowski & Napier, 1991b; Stout et al., 2016) has illustrated the role of dopamine in 
the VP on the effects of drugs of abuse. Creed, et al., (2016) have suggested that 
targeted research on the VP is essential as it may provide novel strategies to treat 
addiction/addictive disorders.  
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3.3 Results: 
 
3.3.1 Dopamine application has dual effects on VP neurons 
 
From 6 experiments 35 VP neurons were selected for analysis as they responded to 
dopamine application. 29/35 neurons displayed significant (P<0.05) increases in firing 
frequency to application of dopamine (Figure 3.1B) while 5/35 displayed significant 
(P<0.05) decreases in firing frequency (Figure 3.1D). In the neurons that were excited 
by dopamine, the average increase in firing frequency was 78 ± 14% (Figure 3.1E). In 
the neurons that were inhibited by dopamine, the average decrease in firing frequency 
was -17 ± 3% (Figure 3.1E).   
 
Baseline firing frequency and spike half-width were calculated for all neurons. Two 
clusters of neurons, with different spike half-width profiles can be identified in figure 
3.1F, those with a shorter spike half-width (cluster I) in the range 0.12 – 0.24 ms and 
those with a longer spike half-width (cluster II), in the range 0.28 – 0.36 ms. Those 
neurons with a shorter spike half-width (cluster I) are all excited by dopamine, while 
neurons with a longer spike half-width (cluster II) show both excitatory and inhibitory 
responses to dopamine. The baseline firing frequency of VP neurons excited by 
dopamine was not significantly different (P>0.05) from that of those inhibited by 
dopamine (Figure 3.1G). However, spike half-width was significantly (P<0.01) larger 
0.32 ± 0.04 ms in neurons inhibited by dopamine than in those excited by dopamine 
0.19 ± 0.01 ms as illustrated in figure 3.1H.  
 
We concluded that there are two electrophysiologically distinct populations of VP 
neurons that could be consistently differentiated by their spike half-widths. Those with a 
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shorter half-width (cluster I) were consistently excited by dopamine, however, for 
cluster II, some neurons were excited by dopamine while others were inhibited by 
dopamine. 
FIGURE 3.1: dopamine application has dual effects on VP neurons. (A) 
Excitatory response to dopamine application in a VP neuron.  (B) Changes in firing 
frequency (ff) for 30 VP neurons in experiments similar to that illustrated in panel 
A. Firing frequency was measured before and during the application of dopamine. 
(C) Inhibitory response to dopamine application in a VP neuron. (D) Changes in 
firing frequency for 5 VP neurons in experiments similar to those illustrated in 
Panel C. Firing frequency was measured before and during the application of 
dopamine (E) Distribution of excitatory (yellow) and inhibitory (black) responses 
(% change compared to baseline) to dopamine application in VP neurons with their 
corresponding average values. (F) Relationship between change in firing frequency 
induced by dopamine (expressed as percentage of control) and spike half-widths 
(ms) for each neuron tested. (G) Average firing frequency for VP neurons excited 
by dopamine (yellow) and those inhibited (black). (H) Average spike half-width 
(ms) for VP neurons excited by dopamine application (yellow) and those inhibited 
(black). In this and following figures *P<0.05 and **P<0.01  
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3.3.2 Dopamine receptors responsible for its effects on VP neurons. 
 
Mansour et al., (1990) found that D1, D2 and D3 receptors are present within the VP. 
To identify the dopamine receptors involved in excitatory and inhibitory VP neurons 
responses, we carried out experiments using D1-like and D2-like receptor agonists. 
In 5 experiments 34 VP neurons were selected for analysis as they responded to 
application of the D2-like receptor agonist quinpirole. 28/34 of these neurons displayed 
significant (P<0.05) changes in firing frequency in response to quinpirole application 
with, 9/34 displaying significant (P<0.05) decreases in firing frequency and 19/34 
displaying significant (P<0.05) increases in firing frequency in response to quinpirole 
application. In a further 4 experiments 29 VP neurons were selected for analysis as they 
responded to application of the D1-like receptor agonist SKF81297. 22/29 of these 
neurons displayed significant (P<0.05) increases in firing frequency in response to 
SKF81297 application.    
In order to further explore the role of dopamine receptor types, we carried out 
experiments in which quinpirole and SKF81297 were applied sequentially (SKF81297 
was applied after complete washout of quinpirole).  
 
From 6 experiments 21 VP neurons were identified for analysis as they responded to 
quinpirole and SKF81297 application. Sequential application of quinpirole and 
SKF81297 resulted in 13/21 neurons displaying significant (P<0.05) increases in firing 
frequency to both SKF81297 and quinpirole (Figure 3.2B). 6/21 neurons displayed 
significant (P<0.05) decreases in firing frequency to quinpirole and significant (P<0.05) 
increases, in firing frequency, to SKF81297 (Figure 3.2D). This means that 62% of the 
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neurons in the VP were excited by both SKF81297 and quinpirole, while 29% of 
neurons were inhibited by quinpirole but excited by SKF81297 (Figure 3.2E). 
 
In order to ascertain if the responses to quinpirole and SKF81297 were produced by 
distinct types of neurons in the VP, baseline firing frequency (Figure 3.2F), coefficient 
of variation (Figure 3.2G) and spike half-width (Figure 3.2H) were measured for 
neurons that were excited by both quinpirole and SKF81297 and for those excited by 
SKF81297 but inhibited by quinpirole. Baseline firing frequency and coefficient of 
variation (Figure 3.2F, G) were not significantly (P>0.05) different in the two 
populations. On the other hand there was a significant (P<0.01) differences in spike 
half-width (Figure 3.2H). Neurons excited by both quinpirole and SKF81297 had a 
spike half-width of 0.15 ± 0.08 ms, while those excited by SKF81297 but inhibited by 
quinpirole had a spike half-width of 0.37 ± 0.03 ms. The range of spike half-widths for 
these populations was similar to those of cluster I and cluster II (Figure 3.1F). Cluster I 
had a spike half-width range of  0.12 -0.24 ms (Figure 3.1F), which compares well to  
neurons that were excited by both quinpirole and SKF81297 that had a spike half-width 
range of 0.10 –0.22 ms. On the other hand, cluster II had a spike half-width range of 
0.28-0.36 ms (Figure 3.1F), which compared well to neurons that were excited by 
SKF81297 but inhibited by quinpirole, which had a spike half-width range of 0.27 –
0.42 ms. This suggests that cluster I in Figure 3.1F correspond to those neurons excited 
by both quinpirole and SKF81297 (Figure 3.2B), while cluster II in Figure 3.1F 
correspond to those neurons excited by SKF81297, but inhibited by quinpirole (Figure 
3.2D). 
 
We concluded that D1-like and D2-like receptors can cause, independently, an increase 
in firing frequency in the majority of VP neurons, but that an electrophysiologically 
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distinct minority of neurons, characterised by longer spike half-width durations, are 
inhibited by D2-like receptors. Therefore, it appeared likely the effects of dopamine in 
the neurons inhibited by D2-like receptors is depended on the net balance between the 
excitatory influence of D1-like receptors and the inhibitory influence of D2-like 
receptors. 
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FIGURE 3.2: D1-like receptor agonists excite while D2-like receptor agonists 
excite and inhibit VP neurons. (A) Excitatory response to the application of 
quinpirole and SKF81297 (separated by complete washout out). (B) Changes in 
firing frequency for 14 VP neurons induced by quinpirole application and 
SKF81297 application similar to that illustrated in panel A. Firing frequency was 
measured; before the application of quinpirole, after the application of quinpirole 
and subsequently, after a period of wash out, for the application of SKF81297. 
Responses characterised by significant (P<0.05) changes in firing frequency are in 
grey, the other ones in yellow. (C) Inhibitory response to the application of 
quinpirole and excitatory response to the application of SKF81297 (separated by 
complete washout). (D) Changes in firing frequency for 7 VP neurons induced by 
quinpirole application and SKF81297 application similar to that illustrated in Panel 
C. Firing frequency was measured; before the application quinpirole, after the 
application of quinpirole and subsequently, after a period of wash out, for the 
application of SKF81297. Responses characterised by significant (P<0.05) changes 
in firing frequency are in grey, the other ones in yellow. (E) The majority of 
neurons analysed responded with increases in firing frequency in response to both 
quinpirole and SKF81297 (yellow), but a minority decreased their firing frequency 
in response to quinpirole and increased their firing frequency in response to 
SKF81297 (black). (F) Firing frequency for those neurons excited by both 
quinpirole and SKF81297 (Yellow) and those neurons that were inhibited by 
quinpirole (black). (G) Coefficient of variation (CoV) for those neurons excited by 
both quinpirole and SKF81297 (yellow) and those inhibited by quinpirole (black). 
(H) Significant (**=P<0.01) differences in spike half width (ms) for those neurons 
excited by both quinpirole and SKF81297 (yellow) and those that were inhibited by 
quinpirole (black). 
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3.3.3 Repeated application of dopamine and dopamine receptor agonists  
 
Preliminary experiments showed that application of dopamine caused strong increases 
or decreases in firing frequency in VP neurons. As the following experiments involved 
pharmacological protocols with repeated applications of dopamine (or dopamine 
receptor agonists) in the presence of different ligands, it was important to establish 
whether neuronal responses to subsequent short applications of dopamine were similar, 
or whether significant sensitisation or desensitisation (Calabresi et al., 2007; Chen et al., 
1996; Otani, et al., 1998) were observed. 
 
Dopamine was applied twice (the second application was carried out after complete 
washout of the first). In 2 experiments, 10 VP neurons were identified for analysis, as 
they responded to dopamine. In 7 of these neurons, dopamine significantly (P<0.05) 
increased firing, while in the other 3 dopamine significantly (P<0.05) decreased firing. 
In all cases, the second application of dopamine produced similar effects to the first one, 
as the firing frequencies measured during the first and the second application of 
dopamine were not significantly different for any of the 10 neurons (Figure 3.3D, E). 
We concluded that repeated exposure to dopamine elicited similar effects in VP 
neurons. 
 
Having established that repeated application of dopamine caused similar responses in 
VP neurons, we carried out the same protocol for D1-like and D2-like receptor agonists, 
to ensure the responses to these agonists did not undergo sensitisation or desensitisation 
upon repeated exposure.  
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Next quinpirole was applied twice (the second application was carried out after 
complete washout of the first). In 2 experiments, 9 VP neurons were identified for 
analysis, as they responded to quinpirole. In 6 of these neurons, quinpirole significantly 
(P<0.05) increased firing, while in the other 3 quinpirole significantly (P<0.05) 
decreased firing. In all cases, the second application of quinpirole produced similar 
effects to the first one, as the firing frequencies measured during the first and the second 
application of quinpirole were not significantly different for any of the 9 neurons 
(Figure 3.3I, J). We concluded that repeated exposure to D2-like receptor agonists 
elicited similar effects in VP neurons. 
 
Next SKF81297 was repeatedly applied (with the second application after complete 
wash out of the first) to test if differences were seen due to repeated exposure. In 2 
experiments 7 neurons in the VP were identified for analysis as they responded to 
SKF81297.  7/7 neurons in the VP studied showed a statistically significant (P<0.05) 
increase in firing frequency in response to SKF81297 application. In all cases, the 
second application of SKF81297 produced similar effects to the first one, as the firing 
frequencies measured during the first and the second application of SKF81297 were not 
significantly different for any of the 7 neurons (Figure 3.3M). We concluded that 
repeated exposure to D1-like receptor agonists elicited similar effects in VP neuron. 
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FIGURE 3.3: repeated application of dopamine, D1-like receptor agonists and D2-like receptor 
agonists produce no clear sensitisation effects in VP neurons (A) Excitatory responses to two similar 
dopamine applications (separated by complete washout) in a VP neuron. (B) Inhibitory responses to 
two dopamine applications in a different VP neuron.  (C) Changes in firing frequency for 10 VP 
neurons induced by repeated dopamine applications similar to that illustrated in panel A and B. 
Firing frequency was measured before the first application of dopamine, during the first application 
of dopamine, after dopamine wash out and finally during the second application of dopamine. 
Responses characterised by significant (P<0.05) changes in firing frequency are in grey, the other 
ones in yellow. (D) Firing frequency during first and second dopamine application for neurons 
excited by dopamine. (E) Firing frequency during first and second dopamine application for neurons 
inhibited by dopamine. (F) Excitatory responses to two quinpirole applications (separated by 
complete washout) in a VP neuron. (G) Inhibitory response to two quinpirole applications in a 
different neuron. (H) Changes in firing frequency for 9 VP neurons to the repeated application of 
quinpirole in experiments similar to that illustrated in panel A and B. Firing frequency was 
measured before the first application of quinpirole, during the application of quinpirole, after wash 
out, before the second application of quinpirole and finally during the second application of 
quinpirole. Responses characterised by significant (P<0.05) changes in firing frequency are in grey, 
the other ones in yellow (I) Firing frequency changes during first and second application of 
quinpirole in neurons excited by quinpirole. (J) Firing frequency changes during first and second 
application of quinpirole in neurons inhibited by quinpirole application. (K) Excitatory responses to 
two applications of SKF81297 (separated by complete washout) in a VP neuron. (L) Changes in 
firing frequency for 7 VP neurons in response to repeated SKF81297 application in experiments 
similar to that illustrated in panel A. Firing frequency was measured; before the first application of 
SKF81297, during the application of SKF81297, after wash out, before the second application of 
SKF81297 and finally during the second application of SKF81297. Responses characterised by 
significant (P<0.05) changes in firing frequency are in grey, the other ones in yellow (M) Firing 
frequency changes during first and second application of SKF81297 for neurons excited by 
SKF81297 application. 
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3.3.4 Role of D1-like and D2-like receptors in the modulation of VP neurons 
 
To dissect out the modulatory effects of D1-like and D2-like receptors on VP neurons 
and to confirm the ability to identify the neuron types based upon spike half-width, 
dopamine was applied in the presence of D1-like and D2-like receptor antagonists.  
 
Dopamine was applied twice, first alone and second (after complete washout of the first 
application) in the presence of the D2-like receptor antagonist sulpiride. In 2 
experiments, 23 VP neurons were identified for analysis, as they responded to 
dopamine. 16/ 23 of these neurons had a significantly P<0.05) smaller increase in firing 
in response to dopamine in the presence of sulpiride than to dopamine alone (Figure 
3.4C, D). On the other hand 7/23 of these neurons had a significantly (P<0.05) larger 
increase in firing in response to dopamine in the presence of sulpiride than to dopamine 
alone (Figure 3.4A, B).  
 
In order to ascertain if this effect of sulpiride on the excitatory effects of dopamine was 
related to classes of neurons within the VP, baseline firing frequency (Figure 3.4E), 
coefficient of variation (Figure 3.4F) and spike half-width (Figure 3.4G) were 
calculated. There was no significant (P>0.05)  difference in average baseline firing 
frequency for those neurons that had a larger increase in firing in response to dopamine 
in the presence of sulpiride, than those that had a smaller increase in firing in response 
to dopamine in the presence of sulpiride. There was also no significant (P>0.05) 
difference in the coefficient of variation for those neurons that had a larger increase in 
firing in response to dopamine in the presence of sulpiride, than those that had a smaller 
increase in firing in response to dopamine in the presence of sulpiride. On the other 
hand, there was a significant (P<0.01) difference in the spike half-width for those 
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neurons that had larger increase in firing in response to dopamine in the presence of 
sulpiride 0.29 ± 0.01 ms, with a range of 0.25 –0.34 ms (Figure 3.4G), than those that 
had a smaller increase in firing in response to dopamine in the presence of sulpiride 
0.19 ± 0.01 ms, with a range of 0.13 -0.24 ms. These results proved consistent with 
those seen in figure 3.1F, G, H and figure 3.2H. 
 
Next the same experimental protocol was applied as in figure 3.4A, C, but with the D1-
like receptor antagonist SCH39166. In 2 experiments, 11 VP neurons were identified 
for analysis, as they responded to dopamine. 5/11 of these neurons had a significantly 
(P<0.05) smaller increase in firing in response to dopamine in the presence of 
SCH39166 than to dopamine alone (Figure 3.4H, I). Moreover, 6/11 of these neurons 
had a significantly (P<0.05) inhibitory response to dopamine in the presence of 
SCH39166 while being excited by dopamine alone (Figure 3.4J, K).  
 
In order to ascertain if the responses to dopamine in the presence of SCH39166 were 
related to different classes of neurons within the VP, baseline firing frequency (Figure 
3.4L), coefficient of variation (Figure 3.4M) and spike half-width (Figure 3.4N) were 
calculated.  
 
There was no significant (P>0.05) difference in average baseline firing frequency 
(Figure 3.4L) for those neurons that had a smaller increase in firing (yellow) in response 
to dopamine in the presence of SCH39166 compared to those that displayed an 
inhibitory response to dopamine in the presence of SCH39166 (black). There was also 
no significant difference in coefficient of variation (Figure 3.4M) for those neurons that 
had a smaller increase in firing (yellow) in response to dopamine in the presence of 
SCH39166 compared to those that displayed an inhibitory response to dopamine in the 
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presence of SCH39166 (black). On the other hand, there was a statistically significant 
(P<0.01) difference in spike half-width (Figure 3.4N) between those neurons that had a 
smaller increase in firing (yellow) in response to dopamine in the presence of 
SCH39166 0.18 ± 0.01 ms, with a range of 0.12 –0.23 ms, compared to those that 
displayed an inhibitory response to dopamine in the presence of SCH39166 0.34 ± 0.01 
ms (black), with a range of 0.28 –0.39 ms. Again, these results proved consistent with 
those seen in figure 3.1F, G, H and figure 3.2H. 
 
We can conclude that D2-like receptors are responsible for both excitation and 
inhibition of VP neurons, and that these responses are in distinct groups of neurons, 
displaying different spike half-width profiles. We can confirm that these data supports 
the conclusion that those neurons with a longer spike half-width profile are excited by 
D1-like receptor agonists and inhibited by D2-like receptors agonists, while those with a 
shorter spike half-width profile are excited by both D1-like and D2-like receptor 
agonists. Those neurons excited by both D1 and D2 agonists and with a shorter spike 
half-width profile are referred to as type I neurons, while those neurons inhibited by D2 
agonists with a longer spike half-width profile are referred to as type II neurons. 
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FIGURE 3.4: D1-like and D2-like receptor antagonists modulate the effect of dopamine in the VP. 
(A) For some neurons, when dopamine was applied in the presence of sulpiride, it produced a larger 
increase in firing than when it was applied in the absence of sulpiride. (B) Firing frequency changes to 
dopamine application in control and in the presence of sulpiride, for neurons similar to that illustrated in 
panel (A). (C) For some neurons, when dopamine was applied in the presence of sulpiride, it produced a 
smaller increase in firing than when it was applied in the absence of sulpiride. (D) Firing frequency 
changes to dopamine application in control and in the presence of sulpiride, for neurons similar to that 
illustrated in panel C. (E) Firing frequency changes to doapmine application for neurons that showed a 
larger increase in firing to dopamine application (black) in the presence of sulpiride and neurons that 
showed a smaller increase in firing to dopamine application in the presence of sulpiride (yellow). (F) 
Coefficient of variation for neurons that showed a larger increase in firing to dopamine in the presence of 
sulpiride (black) and those that showed a smaller increase in firing to dopamine in the presence of 
sulpiride (yellow). (G) Significant differences (P<0.01) in spike half width (ms) for neurons that showed 
a larger increase in firing to dopamine in sulpiride (black) compared to those that showed a smaller 
increase in firing to dopamine in sulpiride (yellow). (H) For some neurons, when dopamine was applied 
in the presence of SCH39166, it produced a smaller increase in firing than when it was applied in the 
absence of SCH39166. (I) Firing frequency changes during dopamine application and dopamine in the 
presence of SCH39166, for neurons similar to that illustrated in panel (H). (J) Excitatory responses to 
dopamine application followed (after complete washout of dopamine) by inhibitory responses to 
dopamine application in the presence of SCH39166. (K) Firing frequency changes during application of 
dopamine and dopamine in the presence of SCH39166, for neurons similar to those illustrated in panel J. 
(L) Firing frequency changes to dopamine application for those neurons that showed a smaller increase 
in firing to the application of dopamine in the presence of SCH39166 (yellow), and those that showed a 
decrease in firing frequency to dopamine in the presence SCH39166 (black). (M) Coefficient of 
variation for neurons that showed a smaller increase in firing to dopamine in the presence of SCH39166 
(yellow), and those that showed a decrease in firing frequency to dopamine in the presence of SCH39166 
(black). (N) Significant (P<0.01) differences in spike half width (ms) for those neurons that showed a 
smaller increase in firing to dopamine in the presence of SCH39166 (yellow), compared to those that 
showed a decrease in firing frequency to dopamine in the presence of SCH39166 (black). 
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3.3.5 D1-like receptors exert their effects presynaptically, while D2-like receptors 
cause excitation presynaptically and inhibition postsynpatically. 
 
Because of the GABAergic and Glutamatergic inputs of the VP (Root et al., 2015) and 
the number of different interneurons, including cholinergic neurons (Pang et al., 1998; 
Zaborszky & Duque, 2000). It could be that D1-like receptors have their modulatory 
effects, presynaptically, postsynaptically or at both points. To identify whether D1-like 
receptors caused the increase in firing frequency in VP neurons acting pre- or 
postsynaptically, SKF81297 was applied in a solution of aCSF with low levels of Ca2+, 
used to block presynaptic transmission. This was compared to application of SKF81297 
in standard aCSF. 
 
SKF81297 was applied twice, first in the presence of low Ca2+ aCSF and second (after 
complete washout of the first) in standard aCSF. In 2 experiments 7/7 spontaneously 
active neurons in the VP showed no significant change in firing frequency in response 
to SKF81297 in low Ca2+ conditions (Figure 3.5B). However, 5/7 neurons, showed 
strong significant (P<0.05) increases in excitation 2856 ± 1079 % in response to 
SKF81297 when subsequently applied in standard aCSF (Figure 3.5B). These 5 neurons 
also showed statistically significant (P<0.05) decreases in firing in response to wash-in 
of standard aCSF after prolonged exposure to low Ca2+.  
 
We can therefore conclude that D1-like receptors largely have their effects 
presynaptically. However the question remains as to whether this is through 
disinhibition, facilitation, or through another neurochemical mechanism. 
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Next the D2-like receptor mediated responses were investigated. D2-like receptor 
agonists have been shown in Figure 3 to produce both excitation and inhibition in the 
firing of VP neurons. Mengual & Pickel, (2002) have shown that some D2-like 
receptors are located presynaptically in the VP. Little else is known about their site of 
action within the VP. It was therefore imperative to investigate this further. To clarify 
the mechanism of action of D2-like receptors in the VP, and to investigate how this 
relates to their dichotomous effects on firing frequency, the effects of quinpirole in 
standard aCSF were compared to those in low Ca2+ aCSF, which was used to block 
presynaptic transmission.  
 
From 4 experiments 12 neurons were identified in the VP for analysis that responded to 
quinpirole application. 8/12 of these neurons responded with significant (P<0.05) 
increases in firing frequency to the application of quinpirole and 4/12 of these neurons 
responded with significant (P<0.05) decreases in firing frequency to the application of 
quinpirole.  
 
Of the 8 that were excited by quinpirole application 6/8 showed non-significant 
responses to quinipriole application in the presence of low Ca2+ aCSF, and 2/8 show 
significant (P<0.05) increases in firing frequency to quinpirole application in the 
presence of low Ca2+. For these 8 neurons, the application of quinpirole alone produced 
an average percentage increase in firing frequency of 111 ± 34 % compared to 42 ± 11 
% for the application of quinpirole in the presence of low Ca2+ (Figure 3.5D). In 6/8 
cases the first application of quinpirole (alone) produced significantly (P<0.05) different 
responses to the second application (in low Ca2+) as the firing frequencies measured 
during the first (alone) and second (in the presence of low Ca2+) application of 
quinpirole were significantly different (Figure 3.5D). In 2/8 cases the second application 
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of quinpirole (in low Ca2+) produced similar effects to the first one (alone) as the firing 
frequencies measured during the first and second application of quinpirole, for these 2 
neurons, were not significantly different.  
 
Of the 4 that were inhibited by quinpirole application all 4 continued to show significant 
(P<0.05) decreases in firing frequency to quinpirole application in the presence of low 
Ca2+. For these 4 neurons, the average decrease in firing frequency was -65 ± 13 % in 
response to quinpirole application alone and -67 ± 10 % to quinpirole application in the 
presence of low Ca2+ (Figure 3.5F). In all 4 cases the second application of quinpirole 
(in low Ca2+) produced similar effects to the first one (alone) as the firing frequencies 
measured during the first and second application of quinpirole were not significantly 
different (Figure 3.5F). 
 
We conclude that D2-like receptors mediate an increase in firing frequency, acting 
presynaptically in the majority of VP neurons, while D2-like receptors mediate a 
decrease in firing frequency acting postsynaptically in a minority of VP neurons.  
94 
 
 
FIGURE 3.5: low Ca2+ aCSF blocks the excitatory effects of D1-like and D2-like 
receptor agonists but not the inhibitory effects of D2-like receptor agonists. 
(A) Excitatory response to SKF81297 application in standard aCSF, which is not 
present in low calcium. (B) Significant (*=P<0.05) differences in firing frequency 
for SKF81297 application in low calcium compared to the application of 
SKF81297 in standard aCSF. (C) Excitatory responses to quinpirole application 
alone were occluded in response to quinpirole application in low calcium aCSF. 
(D) Significant (*=P<0.05) difference in firing frequency for quinpirole 
application alone compared to quinpirole application in low calcium aCSF. (E) 
Inhibitory responses to quinpirole application persevere to quinpirole application 
in the presence of low calcium aCSF. (F) Firing frequency responses to quinpirole 
alone compared to quinpirole application in low calcium aCSF. 
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3.3.6 D1-like receptors excite VP neurons through presynaptic modulation of 
GA. 
 
Because the VP has both GABAergic and glutamatergic inputs (Root, et al., 2015), 
these transmitters were potentially involved in the D1-like receptor agonist action in the 
VP. As current research suggests that D1 receptors are located presynaptically in the 
VP, and D1-like receptors are largely considered to be excitatory (Vallone, et al., 2000), 
it seemed possible that they were modulating glutamatergic inputs and therefore 
increasing neuronal firing in the VP via increased release of GA (Figure 1.1). To test 
this hypothesis, SKF81297 was applied twice, first alone and then in the presence of 
ionotropic glutamate receptor antagonists (NBQX and AP5). The second application 
was carried out after complete washout of the first. 
 
In 2 experiments 7 spontaneously active VP neurons were identified for analysis as they 
responded to SKF81297. All 7 neurons studied in the VP showed strong significant 
(P<0.05) increases in firing frequency in response to SKF81297 (Figure 3.6B). 
However, all 7 showed no significant change in firing frequency in response to NBQX 
and AP5 application, and no significant change in firing frequency in response to 
subsequent SKF81297 application in the presence of NBQX and AP5 (Figure 3.6B). In 
all cases the firing frequencies measured during the first and the second application of 
SKF81297 were significantly (P<0.05) different. The first application of SKF81297 
produced an average increase in excitation of 439 ± 144 % compared to 6 ± 6 % for the 
second application of SKF81297 (Figure 3.6C), in the presence of NBQX and AP5. 
  
We can therefore conclude that the increase in firing frequency produced in the VP as a 
result of D1-like receptor agonists application is a result of facilitation of presynaptic 
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glutamate terminals and the subsequent increase in activation of ionotropic receptors on 
VP neurons 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.6: D1-like receptor mediated excitation requires ionotropic glutamate 
receptors. (A) Excitatory responses to SKF81297 application alone that are no 
longer present in response to SKF81297 in the presence of NBQX and AP5 (B) 
firing frequency for (ff) 7 VP neurons in response to SKF81297 application and 
SKF81297 application in the presence of NBQX and AP5, similar to that illustrated 
in panel A. Firing frequency was measured before the application of SKF81297, 
during the application of SKF81297, after a period of wash out, in response to the 
application of NBQX and AP5 and finally in response to SKF81297 in the presence 
of NBQX and AP5. Responses characterised by significant (P<0.05) changes in 
firing frequency are in grey, the other ones in yellow.  (C) Significant (P<0.05) 
differences in firing frequency (ff) to SKF81297 alone compared to the application 
of SKF81297 in the presence of NBQX and AP5.  
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3.3.7 Excitatory effects of D2-like receptor agonists require mGluRs   
 
In order to establish the likely neurotransmitter, and receptor group that quinpirole was 
modulating to increase firing frequency in VP neurons, quinpirole was applied in the 
presence of MCPG, which is a non-selective mGluR antagonist. Because the current 
research has identified that quinpirole has its excitatory effects by modulation of 
presynaptic mechanisms (Figure 6) and D2-like receptors presynaptically are largely 
considered inhibitory (Mengual & Pickel, 2002; Vallone et al., 2000). Our hypothesis 
was that D2-like receptors might be modulating glutamate release (figure 1.1). Group 2 
and 3 mGluRs are known to be inhibitory (Benarroch, 2008) and therefore provide a 
potential mechanism by which presynaptic inhibition of glutamate by D2-like receptors 
agonists might disinhibit neurons in the VP and therefore increase firing frequency in a 
number of VP neurons.  
 
In 2 experiments 13 VP neurons were identified for analysis as they responded to 
quinpirole. All 13 neurons studied in the VP showed strong significant (P<0.05) 
increases in firing frequency in response to quinpirole. After a period of wash out a 
further significant (P<0.05) change was seen in 9/13 of those neurons studied in 
response to application of the non-selective mGluR antagonist MCPG. Subsequently 
only 4/13 of these neurons showed any significant (P<0.05) increase in firing frequency 
in response to quinpirole in the presence of MCPG (Figure 3.7B). In the majority of 
cases the first application of quinpirole resulted in distinctly different responses to the 
second, as the firing frequencies measured during the first and the second application of 
quinpirole were significantly (P<0.05) different for 12/13 neurons. The first application 
of quinpirole producing an average percentage increase in excitation of 588 ± 232 % 
compared to 41 ± 27 % for the second application of quinpirole, in the presence of 
MCPG (Figure 3.7C).  
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To further explore the role of mGluRs in the excitatory effects of D2-like receptor 
agonists we applied quinpirole alone and in the presence of MSPG, which is a selective 
antagonists for group 2 and 3 mGlu receptors, which are known to have inhibitory 
effects (Nicoletti et al., 2011) and be located postsynaptically (Petralia, et al., 1996). 
   
From 3 experiments 11 neurons were identified for analysis as they responded to 
quinpirole application.  All 11 neurons studied in the VP showed strong significant 
(P<0.05) increase in firing frequency in response to quinpirole. After a period of wash 
out a further significant (P<0.05) change was seen in 3/11 of those neurons studied in 
response to MSPG application. Subsequently only 2/11 of these neurons showed any 
significant (P<0.05) change in firing frequency in response to quinpirole in the presence 
of MSPG (Figure 3.7E). In all cases the firing frequencies measured during the first 
(alone) and second (presence of MSPG) application of quinpirole were significantly 
(P<0.05) different.  
 
We therefore concluded that D2-like receptors inhibit the release of glutamate 
presynaptically, which in turn disinhibits VP neurons, which express inhibitory group 
2/3 mGluRs, increasing their firing frequency. 
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FIGURE 3.7: excitatory effects of D2-like receptor agonists require metabotropic 
glutamate receptors. (A) Excitatory responses to quinpirole that are not present for 
the same neuron in response to quinpirole in the presence of MCPG (B) Changes in 
firing frequency for 13 VP neurons to application of quinpirole and quinpirole in 
the presence of MCPG, similar to that illustrated in panel A. Firing frequency was 
measured before the application of quinpirole, during the application of quinpirole, 
after wash out of quinpirole, during application of MCPG and finally during the 
application of quinpirole in the presence of MCPG. Responses characterised by 
significant (P<0.05) changes in firing frequency are in grey, the other ones in 
yellow. (C) Significant (*=P<0.05) differences in firing frequency in response to 
quinpirole compared to quinpirole in the presence of MCPG (D) Excitatory 
responses to quinpirole that are not present for the same neuron in response to 
quinpirole in the presence of MSPG (E) Changes in firing frequency for 11 VP 
neurons to the application of quinpirole and quinpirole in the presence of MSPG, 
similar to that illustrated in panel A. Firing frequency was measured; before the 
application of quinpirole, during the application of quinpirole, after wash out of 
quinpirole, during application of MSPG and finally during the application of 
quinpirole in the presence of MSPG. Responses characterised by significant 
(P<0.05) changes in firing frequency are in grey, the other ones in yellow. (F) 
Significant (*=P<0.05) differences in firing frequency in response to quinpirole 
compared to quinpirole in the presence of MSPG.  
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3.3.8 Inhibitory effects of D2-like receptor agonists persevere in the presence of 
mGluR receptor antagonists 
 
While excitation in VP neurons, as a result of quinpirole application, has been shown in 
the current study to be modulated by presynaptic mechanisms (Figure 3.5C, D). The 
current study suggests that inhibition of firing frequency in the minority of VP neurons 
is likely to be as a result of postsynaptic /direct inhibition (Figure 3.5E, F). This should 
mean that MCPG has no effect on the reduction in firing frequency seen in response to 
quinpirole.  
 
In 3 experiments 5 VP neurons were identified for analysis as they responded to 
quinpirole application. 5/5 of these neurons measured in the VP displayed significant 
(P<0.01) decreases in firing frequency in response to quinpirole. After a period of wash 
out MCPG application evoked significant changes in firing frequency in 2/5 neurons, 
subsequently application of quinpirole in the presence of MCPG evoked a further 
significant (P<0.05) decrease in firing frequency in 5/5 of these VP neurons. In the 
majority of cases, the second application of quinpirole produced similar effects to the 
first one, as the firing frequencies measured during the first and the second application 
of quinpirole were not significantly different for 4/5 neurons (Figure 3.8B, C). The first 
application of quinpirole producing an average percentage inhibition of -69 ± 8 % 
compared to -66 ± 9 % for the second application of quinpirole, in the presence of 
MCPG (Figure 3.8C).  
 
To further ensure that the inhibitory effect of D2-like receptor agonists were not 
mediated presynaptically or through mGlu receptors, we applied quinpirole in the 
presence of low Ca2+ aCSF and in the presence of low Ca2+ aCSF and MCPG. 
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From 1 experiment 3 neurons were identified for analysis. 3/3 displayed significant 
(P<0.05) decreases in firing frequency in response to application of quinpirole. After a 
period of wash out 3/3 of the neurons responded with non-significant (P>0.05) changes 
in response to MCPG application, subsequent application of the quinpirole in the 
presence of low Ca2+ and MCPG evoked further significant (P<0.05) decreases in firing 
frequency in 3/3 of the neurons. In all cases, the second application of quinpirole (in the 
presence of MCPG and low Ca2+) produced similar effects to the first one (Figure 3.8 E, 
F), as the firing frequencies measured during the first and the second application of 
quinpirole were not significantly different for 3/3 neurons. 
 
We can conclude that mGluR are not involved in the inhibition seen in the VP to 
quinpirole application. 
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FIGURE 3.8: inhibitory effects of D2-like receptor agonists continue in the presence 
of mGluR receptor antagonists and low calcium aCSF. (A) Inhibitory responses to 
quinpirole application alone and in the presence of MCPG. (B) Changes in firing 
frequency for 5 VP neurons to application of quinpirole and quinpirole in the 
presence of MCPG, similar to that illustrated in panel A. Firing frequency was 
measured before the application of quinpirole, during the application of quinpirole, 
after wash out of quinpirole, during application of MCPG and finally during the 
application of quinpirole in the presence of MCPG. Responses characterised by 
significant (P<0.05) changes in firing frequency are in grey, the other ones in yellow. 
(C) Firing frequency in response to quinpirole compared to quinpirole in the 
presence of MCPG. (D) Inhibitory responses to quinpirole application in the 
presence of low calcium aCSF are repeated in the presence of low calcium aCSF and 
MCPG. (E) Changes in firing frequency for 3 VP neurons to application of 
quinpirole and quinpirole in the presence of MCPG, similar to that illustrated in 
panel A. Firing frequency was measured; before the application of quinpirole, during 
the application of quinpirole, after wash out of quinpirole, during application of 
MCPG and finally during the application of quinpirole in the presence of MCPG. 
Responses characterised by significant (P<0.05) changes in firing frequency are in 
grey, the other ones in yellow. (F) Firing frequency in response to quinpirole in low 
calcium aCSF compared to quinpirole in the presence of low calcium aCSF and 
MCPG.  
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3.3.9 Excitatory responses to D1-like receptor agonists are not effected by 
metabotropic glutamate receptor antagonists   
 
We have already established that increases in firing frequency as a result of SKF81297 
application are largely modulated by glutamate and ionotropic glutamate receptors. To 
ensure mGluRs do not interfere with this response, experiments were carried out with 
SKF81297 in the presence of MCPG. From 2 experiments 11 neurons were identified 
for analysis. 10/11 of these neurons were excited (P<0.05) by SKF81297 application. 
After a period of wash out 4/11 neurons responded with significant (P<0.05) changes in 
response to MCPG application, subsequent application of SKF81297, evoked a further 
significant increase in firing frequency in 11/11 of the VP neurons observed. In the 
majority of cases, the second application of SKF81297 (in the presence of MCPG) 
produced similar responses to the first one, as the firing frequencies measured during 
the first and the second application of SKF81297 were not significantly different for 
10/11 neurons (Figure 3.9B, C). The first application of SKF81297 producing an 
average percentage excitation of 322 ± 105 % compared to 361 ± 153 % for the second 
application of SKF81297, in the presence of MCPG (Figure 3.9C). 
  
We can therefore rule out the involvement of mGluRs in the excitation observed in 
response to SKF81297 in the VP. 
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FIGURE 3.9: D1-like receptor agonists continue to excite VP neurons in the 
presence of MCPG. (A) Excitatory responses to SKF81297 application alone and 
in the presence of MCPG. (B) Changes in firing frequency for 11 VP neurons to 
application of SKF81297 and SKF81297 in the presence of MCPG, similar to that 
illustrated in panel A. Firing frequency was measured; before the application of 
SKF81297, during the application of SKF81297, after wash out of SKF81297, 
during application of MCPG and finally during the application of SKF81297 in the 
presence of MCPG. Responses characterised by significant (P<0.05) changes in 
firing frequency are in grey, the other ones in yellow. (C) Firing frequency in 
response to SKF81297 compared to SKF81297 in the presence of MCPG.  
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3.4 Discussion  
This study investigated the effects of dopamine on the tonic firing of VP neurons in 
vitro. Our data shows that dopamine has dual effects in the VP, producing increases and 
decreases in firing frequency in VP neurons. Two populations of neurons in the VP 
were identified based upon their spike half-width profile. Type I neurons displaying a 
markedly shorter spike half-width profile and being excited by both D1-like and D2-like 
receptor agonists (Figure 3.10). This resulted in a net excitatory effect in response to 
dopamine in type I neurons. Type II neurons however had a markedly longer spike half-
width profile, were inhibited by D2-like agonists and excited by D1-like agonists 
(Figure 3.10). For type II neurons the net balance of inhibitory D2-like receptor 
activation and excitatory D1-like receptor activation, through application of dopamine, 
resulted in a net effect of increased firing rates in some type II neurons and decreased 
firing rates in others.   
 
 
3.4.1 Presynaptic and postsynaptic effects of dopamine. 
Previous studies of the dopaminergic modulation of VP neurons had been carried out in 
vivo. These studies showed that dopamine can exert both excitatory and inhibitory 
influences on VP neurons. Electrical stimulation of the VTA or SNc caused inhibitions 
or excitations of VP neurons, in a roughly 2:1 ratio (Mitrovic & Napier, 2002; Napier & 
Maslowski-Cobuzzi, 1994). Similar responses were observed with local 
microiontophoretic applications of dopamine (Mitrovic & Napier, 2002; Napier & 
Potter, 1989). Dopamine D1-like and D2-like receptors are thought to contribute to 
these responses, however it is unclear, which modulate excitations and which modulate 
inhibitions. Maslowski & Napier, (1991a) found D2-like receptor agonists reduced 
activity in 59 % of neurons studied and that D1-like receptor agonists excited 69 % of 
neurons. However, Napier & Maslowski-Cobuzzi's, (1994) data suggest that D1-like 
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receptor agonists largely produce inhibitions in VP neurons and D2-like receptor 
agonist largely produce excitation.  
 
Both direct and indirect effects of dopamine are considered likely involved (Root et al., 
2015) in modulation of VP neurons. However, a dissection of these effects and of the 
other neurotransmitters involved had not been possible in in vivo experiments. Our data 
clearly indicated that D1-like receptors acted at a presynaptic level, as a D1-like 
receptor agonist produced no significant effects in low Ca2+ (a condition in which 
synaptic transmission is blocked), even in neurons in which D1-like receptor agonist 
had previously elicited strong excitatory effects when applied in normal Ca2+. 
Furthermore, we were able to show that D1-like receptors exerted their presynaptic 
effects by increasing ionotropic glutamate receptors activation, as antagonists of 
ionotropic glutamate receptors (NBQX and AP5) also consistently blocked the 
excitatory effects of D1-like receptor agonists. Thus, a facilitation of glutamate release 
from terminals impinging on VP neurons (figure 1.1) appears to underlie the excitatory 
effects of D1-like receptors in both groups of VP neurons.  
 
On the other hand, D2-like receptors engaged both presynaptic and postsynaptic 
mechanisms. Low Ca2+ failed to block the decreases in firing frequency observed in the 
neurons of the second group in response to D2-like receptor agonist application. Thus, 
D2-like receptors caused their inhibitory effects acting postsynaptically on VP neurons 
of the second group. However, the excitatory effects of a D2-like receptor agonist were 
no longer observed (in neurons of the first group) in low Ca2+ aCSF, showing that these 
effects were mediated presynaptically. A study by Mengual and Pickel, (2002) showed 
that D2-like receptors are located at presynaptic locations on GABAergic terminals in 
the VP. However, the excitatory effects of D2-like receptor agonists persisted in the 
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presence of GABAA and GABAB receptor antagonists, showing that they did not result 
from inhibition of GABA release. On the other hand, a broad-spectrum mGluR 
antagonist completely prevented the excitatory effects of D2-like receptor agonists. 
Furthermore, a ligand that selectively blocks group 1 and group 2 mGluRs also 
prevented any excitatory action of D2-like receptor agonists. These observations 
suggested that the excitatory effects of D2-like receptors were caused by inhibition of 
glutamate release and reduced postsynaptic activation of inhibitory mGluRs.  MGluRs 
are present in the VP (Testa, et al., 1994) and some mGluR groups are inhibitory 
(Anwyl, 1999). There is a paucity of data on mGluR action within the VP, but Ohishi, et 
al's., (1993) data suggests there is labelling for multiple mGluR in the VP, including the 
inhibitory mGluR2 group. They are also a likely candidate as Holmes, et al., (1996) 
found mGluR2 receptors to be the mediator of postsynaptic hyperpolarisations within 
the basal lateral amygdala.  
 
The observation that NBQX and AP5 did not affect VP neurons firing but prevented the 
excitatory effects of D1 agonists, suggests that the glutamate terminals facilitated by D1 
receptors were not spontaneously active in brain slices. We tentatively propose that a 
different set of glutamate terminals (figure 1.1) were responsible for the activation of 
postsynaptic inhibitory mGluRs in those VP neurons in which mGluR antagonists 
prevented inhibition by D2 agonists (as illustrated in Figure 3.10). These terminals are 
expected to release glutamate spontaneously, keeping postsynaptic inhibitory group 2 
and/or 3 mGluRs in a state of basal activation. However, the lack of effects of mGluR 
antagonists on the firing frequency of these VP neurons was unexpected. It is possible 
that the excitatory influence caused by reduce activity of mGluRs was compensated by 
an inhibitory influence caused by reduced activity of other pre or postsynaptic mGluRs 
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affecting VP neurons through different mechanisms. Further experiments will be needed 
to test this hypothesis. 
 
3.4.2 Identity of VP neurons modulated by dopamine 
As mentioned above, VP neurons displayed two distinct responses to D1-like and D2-
like receptor agonists. Type I neurons responded with increases in firing frequency to 
both specific D1-like and D2-like receptor agonists, while type II neurons were excited 
by D1-like receptor agonists and inhibited by D2-like receptor agonist (Figure 3.10). 
These responses can be attributed unambiguously to two distinct neuronal populations 
based on their spike half-width profile, with the type I neurons having a shorter spike 
half-width than type II neurons.  
 
Further supporting this distinction, neurons with a shorter spike half-width displayed a 
decreased increase in firing frequency to dopamine in the presence of either D1-like or 
D2-like receptor antagonists, suggesting that both receptor classes contributed to 
increases in firing frequency for these neurons. Conversely, neurons with a longer spike 
half-width showed an increased excitatory response to dopamine in the presence of D2-
like receptor antagonists and were inhibited by the application of dopamine in the 
presence of D1-like receptor antagonists, confirming that D2-like receptors inhibit these 
neurons.  
 
Several studies have investigated spike half-width profiles in the VP and its dorsal 
extent, the GPe (Abdi et al., 2015; Bengtson, et al., 2004; Bengtson & Osborne, 2000; 
Hernández et al., 2015). VP neurons include prominent cholinergic and GABAergic 
populations (Duque, et al., 2007; Root et al., 2015; Zaborszky & Duque, 2000)). 
Cholinergic cells have sparse axons and project to the cortex and the amygdala (Carlsen, 
et al., 2004; Zaborszky, et al., 1986), while GABAergic neurons can have dense axonal 
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arborisation and are thought to include both interneurons and projection neurons 
(Zaborszky, et al., 2012). The electrophysiological features of these neuronal types have 
not been completely identified. Bengtson and Osborne, (2000) found that only 2/13 
cholinergic neurons in the VP had any tonic firing activity. Bugaysen et al, (2010) 
suggested that it is impossible to separate neuron populations from extracellular 
recordings in the rat GPe based on action potential half-width, although Becchetti et al, 
(2012) suggests that spike half-width maybe a viable way of distinguishing inhibitory 
from excitatory neurons in mature animals using MEA data.  
 
Pang et al, (1998) identified “Type l” neurons in vivo, with features resembling those of 
noncholinergic neurons described by Bengtson and Osborne, (2000). Type B neurons of 
Lavín and Grace, (1996) also have features similar to these cells, and have short spike 
duration (approximately 1.3 ms). These neurons are probably GABAergic projection 
neurons (Root et al., 2015). Conversely, “Type II” neurons of Pang et al., (1998) and 
“Type A” neurons of Lavín and Grace, (1996) had relatively similar features, including 
slower spikes (approximately 2.8 ms). Pang et al. (1998) identified these neurons as 
noncholinergic (possibly GABAergic) interneurons. Based on this complex picture, we 
can tentatively classify our type I neurons as GABAergic projection neurons 
corresponding to type I of Pang et al., (1998) and type B of Lavin and Grace, (1996) 
and our type II neurons as GABAergic interneurons corresponding to type II of Pang et 
al., (1998) and type A of Lavin and Grace, (1996). Further investigation is needed to 
confirm the neurochemical and morphological identity of the two groups of neurons 
identified by this study based on their dopaminergic responses. 
 
In some previous in vivo experiments dopamine inhibitions of VP neurons were more 
frequent than dopamine excitations (Napier & Maslowski-Cobuzzi, 1994), while we 
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found a prevalence of excitations. It is likely that this discrepancy results from the fact 
that in the intact brain the VP receives a number of external inputs (including glutamate) 
that are silent in brain slices and could be modulated presynaptically by dopamine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.10: A minimal model explaining the differential effects of D1-like and 
D2-like receptor activation on type I and type II VP neurons in the VP. 
(A) Presynaptic D1-like receptors facilitate glutamate release and excite type I VP 
neurons through increased activation of ionotropic glutamate receptors. Another 
glutamatergic input to type I neurons activates inhibitory metabotropic glutamate 
receptors. Presynaptic D2-like receptors have an inhibitory effect on this glutamate 
input, reducing glutamate release and disinhibiting type I neurons. Thus, both D1-
like and D2-like receptor have excitatory influences on type I neurons. 
(B) Presynaptic D1-like receptors facilitate glutamate release and excite type II VP 
neurons by increasing activation of ionotropic glutamate receptors. Postsynaptic D2-
like receptors have direct inhibitory effects on type II VP neurons. The net influence 
of dopamine on type II neurons results from the balance of excitatory D1-like 
receptor effects and inhibitory D2-like receptor effects. 
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3.4.3 Functional implications:  
 
The VP is crucially involved in reward processing (Smith et al., 2009) and drug-seeking 
behaviour (Kalivas & Volkow, 2005; Prasad & McNally, 2016). Dopamine levels rise 
dramatically within the VP as a result of sensitization to drugs of abuse (Stout et al., 
2016) and dopaminergic mechanisms in the VP underlie morphine-induced conditioned 
place preferences (Gong, et al., 1996; Zarrindast, et al., 2007). The 
current study provides novel and clear insights into the cellular mechanisms by which 
dopamine modulates neuronal activity in the VP. Given the prominence of the VP in the 
reward circuits, understanding how dopamine works in this area is of primary 
theoretical value, and can also help developing rational pharmacological approaches to 
fight addiction and other dysfunctions of the reward system. 
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4 Chapter 4: Serotonergic modulation of VP neurons 
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4.1 Abstract: 
 
Serotonergic afferents reach the VP from the dorsal raphe nuclei. Recent in vitro 
research suggests that serotonin produces dichotomous responses within the VP, 
however little else is known about the cellular effects of serotonin within the VP. The 
current study aimed to address this paucity of data using brain slices containing the VP 
and multi-electrode array (MEA) recordings.  Our data supports the intracellular 
research of Bengtson et al., (2004). Serotonin affected firing in 100% of spontaneously 
active VP neurons. 72% of these neurons were excited and 28% were inhibited by 
serotonin application. The excitatory effects of serotonin were pre-synaptic in origin as 
blocking synaptic transmission with low- Ca2+ aCSF abolished these effects. 
Conversely, the inhibitory effects of serotonin persisted in low Ca2+ aCSF and therefore 
can be attributed to direct postsynaptic receptor activation. 5HT1a (WAY100635), 
5HT5a (SB699551) and 5HT7 (SB269970) receptor antagonists modulated the 
excitatory effects of serotonin application, suggesting that they were all involved in the 
excitatory responses within the VP. In the presence of 5HT1a antagonists, 63% of 
neurons previously excited by serotonin showed no significant responses to serotonin 
application and 37% of neurons previously excited by serotonin showed significant 
inhibitory responses to serotonin application. In the presence of a 5HT7 antagonists, 
72% of neurons previously excited by serotonin showed no significant responses to 
serotonin application and 28% of neurons previously excited by serotonin showed 
excitatory responses to serotonin application, but significantly reduced in magnitude 
compared to excitatory response to serotonin application alone. In the presence of a 
5HT5a antagonists 83% of neurons, excited by serotonin application alone, continued to 
show significant excitation to serotonin application, however these neurons showed a 
significantly reduced magnitude of excitation to serotonin in the presence of 5HT5a 
antagonist compared to serotonin application alone.  
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Conversely, 5HT1a antagonists had no effect on the majority of inhibitory responses to 
serotonin application, with 75% showing similar significant decreases in firing 
frequency to serotonin application in the absence or presence of 5HT1a antagonist. The 
effect of 5HT7 and 5HT5a antagonists on inhibitory responses was inconclusive.  
The inhibitory responses to serotonin application were found to be modulated by 5HT2c 
receptors, with 50% of neurons that had been inhibited by previous serotonin 
application showing no significant effects in response to serotonin application in the 
presence of 5HT2c antagonists (RS102221) and 33% responding with a significant 
increase in firing frequency to serotonin in the presence of 5HT2c antagonists. A 5HT2c 
antagonist had no effect on the excitatory responses to serotonin application, with 100% 
continuing to express significant increases in firing frequency to serotonin application in 
the presence of 5HT2c antagonists.  
These data provide novel insights into the cellular mechanism by which serotonin 
modulates reward and affective responses and provides potential target receptors for 
pharmacological interventions.  
 
4.2 Introduction: 
 
Besides its strong dopaminergic projections, the VP also receives substantial 
serotonergic projections from the dorsal raphe nuclei (Vertes, 1991). Like dopamine, 
serotonin is heavily implicated in affective disorders, reward learning and responses to 
drugs of abuse (Der-Ghazarian et al., 2017; Kranz et al., 2010; Nakamura et al., 2008). 
Recent research suggests that the interaction between serotonin and dopamine are 
essential for reward and reward related behaviour such as drug addiction (Fischer & 
Ullsperger, 2017). The VP is a key site for research into drugs of abuse and reward 
(Creed et al., 2016; James & Aston-Jones, 2016; Root et al., 2015; Smith et al., 2009), it 
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therefore seems a likely site for the interaction between dopamine and serotonin to 
influence these behaviours.   
Like the dual effects of dopamine, we have observed on VP neurons,  Bengtson et al., 
(2004) have shown that serotonin has dual effects on neurons in the VP, with both 
increases and decrease in firing as a result of serotonin application. Bengtson et al., 
(2004) suggest that the dual effects of serotonin relate directly to two distinct 
populations of neurons in the VP, with serotonin decreasing firing in cholinergic 
neurons and increasing firing in non-cholinergic neurons of the VP. However the degree 
to which these distinctions maintain when serotonin is administered to both neuron 
types at once is questionable as cholinergic neurons in the VP are believed to innervate 
other populations of neurons within the VP (Duque et al., 2007). Collateral inhibition or 
excitation may therefore modulate the dichotomous response seen to serotonin  in VP 
neurons by Bengtson et al., (2004). This can be investigated effectively using our MEA 
setup.  
Our observations with dopamine suggest it too effects two distinct populations of 
neurons in the VP, with specific inhibitory effects being produced by D2-like agonists 
in neurons identified as having a larger spike half-width profile than those excited by 
D1-like and D2-like agonists. We could not however conclude if these differences in 
spike half-width profiles related to cholinergic or non-cholinergic neurons of the VP. In 
the current study we aimed to identify the spike half-width profile of those neurons that 
increase firing and those that decrease firing in response to serotonin application, so as 
to elucidate the potential modulatory interaction between serotonin and dopamine in the 
VP.   
The VP is known to expresses multiple serotonin receptor subtypes, including: 5HT4 
(Waeber et al., 1994), 5HT2 (Appel et al., 1990), 5HT1a (Drevets et al., 2007; 
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Heidenreich & Napier, 2000; Wright et al., 1995), 5HT1B(Murrough et al., 2011), 
5HT7 (To et al., 1995) and 5HT5a (Oliver et al., 2000). These specific serotonin 
receptor subtypes, may well play specific roles in modulation of the VP circuitry. 
Indeed Heidenreich & Napier, (2000) have shown the specific 5HT1a receptor subtype, 
modulate the firing of VP neurons, with increases and decreases in firing potentials. 
Nishijo & Momiyama, (2016) have also suggested that 5HT1b receptors act as 
heteroreceptors on GABAergic terminals projecting into the VP, thus inhibiting the 
release of tonic GABA. Little else is known about how other specific serotonin receptor 
subtypes, known to be expressed in the VP, modulate the dichotomous responses 
identified by Bengtson et al., (2004). It is also not known whether serotonin’s 
modulatory effects are pre/post synaptic, or indeed a combination of both. This is 
essential knowledge as the serotonin receptor subtypes, and their differential modulation 
of the VPs circuitry, may well play a key role in the modulation of affective disorders, 
responses to drugs of abuse and reward learning. Indeed  Murrough et al., (2011) has 
recently suggested that there is a strong link between the specific Serotonin receptor; 
5HT1b binding in the VP and major depressive disorder. We suggest that serotonin and 
its receptor subtypes that mediate its effects in the VP, are critical in terms of 
pharmacological interventions for major depressive disorder, responses to drugs of 
abuse and reward learning. In the current research we seek to elucidate the specific 
contribution several of these serotonin receptor subtypes play in modulating increases 
and decrease in firing observed in response to serotonin in the VP.  
 
 
 
 
117 
 
4.3 Results: 
 
4.3.1 Serotonin application has dual effects on VP neurons. 
 
To investigate the dichotomous responses seen by Bengtson et al., (2004) further we 
applied serotonin to a slice preparation, recording activity from multiple neurons across 
the VPs territories using a multielectrode array.  
From 10 experiments, 76 neurons were analysed in the VP. 55/76 neurons displayed 
significant (P<0.05) increases in firing frequency to the application of serotonin (Figure 
4.1B and C). However, a minority 21/76 displayed significant (P<0.05) decreases in 
firing frequency to serotonin application (Figure 4.1A, C). In the neurons that were 
excited by serotonin, the average increase in firing frequency was 88 ± 68 %. In the 
neurons that were inhibited by serotonin, the average decrease in firing frequency was   
-26 ± 2 %.   
In order to ascertain if excitatory and inhibitory responses to serotonin were elicited in 
different types of neurons within the VP, baseline firing frequency, coefficient of 
variation and spike half-width were calculated for the two subpopulations. Baseline 
firing frequency and coefficient of variation (Figure 4.1D, E) were not significantly 
(P>0.05) different for the two populations. There was also no significant differences in 
spike half-width (ms) between those neurons that were excited by serotonin application 
and those inhibited by serotonin application.   
We can conclude that the dichotomous responses seen in the VP to serotonin by 
Bengtson et al., (2004) persist when serotonin is administered to the area as a whole. 
However there was no evidence to suggest that these responses were from two unique 
populations of neurons in the VP. 
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FIGURE 4.1: Serotonin application has dual effects on VP neurons. (A) 
Inhibitory response to serotonin application in a VP neuron, reversed after 
washout. (B) Excitatory response to serotonin application in a VP neuron, 
reversed after washout. (C) The majority of neurons analysed responded 
with increases in firing frequency in response to serotonin (orange), but a 
minority decreased their firing frequency in response to serotonin (black) 
(D) Firing frequency for those neurons excited by serotonin (orange) and 
those neurons that were inhibited by serotonin (black). (E) Coefficient of 
variation for those neurons excited by serotonin application (orange) and 
those inhibited by serotonin application (black). (F) Spike half-width (ms) 
for those neurons excited by serotonin application (orange) and those 
inhibited by serotonin application (black). 
 
 
Figure 4.1: serotonin application has dual effects on VP neurons 
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4.3.2 Repeated application of serotonin produces no clear sensitisation effects in 
VP neurons 
 
Preliminary experiments showed that application of serotonin caused strong increases or 
decreases in firing frequency in VP neurons. As the following experiments involved 
pharmacological protocols with repeated applications of serotonin, in the presence of 
different specific serotonin receptor antagonists and in the presence of low Ca2+ aCSF, it 
was important to establish whether neuronal responses to subsequent short applications 
of serotonin were similar or whether significant sensitisation or desensitisations were 
observed. 
Serotonin was applied twice (the second application was carried out after complete 
washout of the first). In 1 experiment, 10 VP neurons were analysed. In 7/10 of 
these neurons, serotonin significantly (P<0.05) increased firing (Figure 4.2B), while in 
the other 3/10 serotonin significantly (P<0.05) decreased firing (Figure 4.3B). In all 
cases, the second application of serotonin produced similar effects to the first one, as the 
firing frequencies measured during the first and the second application of serotonin 
were not significantly different for any of the 10 neurons (Figure 4.2C and 4.3C). We 
concluded that repeated exposure to serotonin elicited similar effects in VP neurons. 
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FIGURE 4.2: repeated application of serotonin produces no clear sensitisation  
affects in VP neurons excited by serotonin application. (A) Excitatory 
responses to two similar serotonin applications (separated by complete 
washout) in a VP neuron. (B) Changes in firing frequency for 7 VP neurons 
induced by repeated serotonin applications similar to that illustrated in panel A. 
Firing frequency was measured before the first application of serotonin, during 
the first application of serotonin, after serotonin wash out and finally during the 
second application of serotonin. Responses characterised by significant 
(P<0.05) changes in firing frequency are in grey. (C) Firing frequency during 
first and second serotonin application for neurons excited by serotonin.  
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FIGURE 4.3: Repeated application of serotonin has no clear sensitisation affects 
in VP neurons inhibited by serotonin application. (A) Inhibitory responses to two 
similar serotonin applications (separated by complete washout) in a VP neuron. 
(B) Changes in firing frequency for 3 VP neurons induced by repeated serotonin 
applications similar to that illustrated in panel A. Firing frequency was measured 
before the first application of serotonin, during the first application of serotonin, 
after serotonin wash out and finally during the second application of serotonin. 
Responses characterised by significant (P<0.05) changes in firing frequency are 
in grey. (C) Firing frequency during first and second serotonin application for 
neurons inhibited by serotonin.  
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4.3.3 Serotonin produces excitatory effects on VP neurons through presynaptic 
modulation  
 
To further explore the location of serotonin receptors and clarify the mechanism of 
action in the VP, the effects of serotonin in standard aCSF were compared to those in 
low Ca2+ aCSF. Low Ca2+ aCSF was used to block presynaptic transmission and reduce 
the impact of serotonin’s potential presynaptic effects. Experiments were first carried 
out with serotonin in low Ca2+  aCSF followed by application of serotonin alone (Figure 
4.4A). The treatment order was counterbalanced with serotonin alone first, followed by 
application of serotonin in low Ca2+ aCSF (Figure 4.4B) to ensure residual differences 
in Ca2+ levels were not effecting the response of VP neurons to serotonin alone.   
From 3 experiments 9 neurons were analysed in the VP. Application of serotonin 
resulted in a significant (P<0.05) increase in firing frequency in 7/9 neurons studied 
(figure 4.4A, B and C). Of these 7/7 showed no significant changes in firing frequency 
to serotonin application in the presence of low Ca2+ aCSF. In all cases the application of 
serotonin alone resulted in distinctly different responses to the application of serotonin 
in low Ca2+ aCSF, as the firing frequencies measured during serotonin alone and  
serotonin in low Ca2+ aCSF were significantly (P<0.05) different for 7/7 neurons. The 
average percentage change in firing frequency for those neurons that increased firing to 
serotonin was 243 ± 91 % and 9 ± 3 % (Figure 4.4D) to the application of serotonin in 
low Ca2+ aCSF.  
We therefore conclude that the increase in firing frequency is largely mediated by 
presynaptic processes.  
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FIGURE 4.4: blocking synaptic transmission with low Ca2+ aCSF prevents the 
excitatory effect of serotonin application in the VP. (A) Excitatory responses to 
serotonin application alone were occluded in response to serotonin application in low 
Ca2+ aCSF (B) Another neuron in a different, but similar experiment to panel A, with 
the reverse order application of low Ca2+ aCSF. (C) Changes in firing frequency for 
9 VP neurons in response to serotonin application in low Ca2+ aCSF and standard 
aCSF, similar to that illustrated in panel A. Firing frequency was measured; before 
the application of serotonin, during the application of serotonin in low Ca2+ aCSF, 
after the application of standard aCSF and finally during the second application of 
serotonin in standard aCSF. Responses characterised by significant (P<0.05) changes 
in firing frequency are in grey, the other ones in yellow. (D) Significant (*=P<0.05) 
firing frequency changes to the application of serotonin in low Ca2+ aCSF compared 
to serotonin in standard aCSF.  
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4.3.4 Inhibitory responses to serotonin application persist in the presence of low 
Ca2+ aCSF 
 
Those neurons that decreased firing frequency in response to serotonin application were 
also investigated in the presence of low Ca2+ aCSF to reduce the impact of presynaptic 
effects, and therefore to investigate there potential pre/postsynaptic modulation.  
From 1 experiment 6 neurons were identified for analysis as they decreased in firing 
frequency in response to serotonin application. 6/6 neurons displayed a significant 
(P<0.05) decrease in firing frequency to the application of serotonin. 6/6 of these 
neurons also showed a significant decrease in firing frequency to serotonin application 
in low Ca2+ aCSF (Figure 4.5B and C). In all cases the second application of serotonin 
(in low Ca2+ aCSF) produced similar effects to the first one (alone) as the firing 
frequencies measured during the first and second application of serotonin were not 
significantly different (Figure 4.5B and C). 
We therefore conclude that the decrease in firing frequency in response to serotonin 
application is modulated postsynaptically and is therefore a direct effect on VP neurons.
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FIGURE 4.5: Inhibitory responses to serotonin application maintain in the 
presence of low Ca2+ aCSF. (A) Inhibitory responses to the application of 
serotonin occurred in the presence of low Ca2+ aCSF and standard aCSF. (B) 
Changes in firing frequency for 6 VP neurons in response to serotonin 
application in low Ca2+ aCSF and standard aCSF, similar to that illustrated in 
panel A. Firing frequency was measured; before the application of serotonin, 
during the application of serotonin in low calcium aCSF, after the application 
of standard aCSF and finally during the second application of serotonin in 
standard aCSF. Responses characterised by significant (P<0.05) changes in 
firing frequency are in grey, the other ones in yellow. (C) Firing frequency 
changes to the application of serotonin in low Ca2+ aCSF and to serotonin in 
standard aCSF.  
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4.3.5 5HT1a receptors are required for the excitatory responses of VP neurons to 
serotonin 
 
5HT1a receptors are known to be expressed in the VP (Wright et al., 1995) and have 
been shown to mediate the firing potential of neurons in the VP (Heidenreich & Napier, 
2000). In other areas of the rat brain 5HT1a receptors are known to be located 
presynaptically acting as autoreceptors. One such areas is the DRN (dorsal raphe nuclei) 
(Haj-Dahmane et al., 1991). 5HT1a receptors may therefore be a good candidate for the 
presynaptic increase in firing frequency that we identified in figure 4.4. To investigate 
their modulatory role in the VP, we applied serotonin in the presence of the 5HT1a 
antagonist WAY100635. 
From 3 experiments 12 neurons were analysed in the VP. 8/12 VP neurons responded 
with a significant (P<0.05) increase in firing frequency to the application of serotonin 
(Figure 4.6A and B) of these, 5/8 showed no significant change in firing frequency 
(Figure 4.6B) in response to serotonin application in the presence of WAY100635, and 
3/8 showed a significant (P<0.05) decrease in firing frequency to serotonin application 
in the presence of WAY100635. In all cases the firing frequencies measured during the 
first and the second application of serotonin were significantly (P<0.05) different 
(Figure 4.6B). The first application of serotonin produced an average increase in 
excitation of 94 ± 42 % compared to an average decrease in firing frequency of -22 ± 5 
% for the second application of serotonin, in the presence of WAY100635.  
From the same experiments, 4/12 neurons in the VP displayed a significant decrease in 
firing frequency to the application of serotonin (Figure 4.6C and D), of these 3/4 also 
displayed a significant (P<0.05) decrease in firing frequency (Figure 4.6D) in response 
to serotonin application in the presence of WAY100635. In the majority of cases (3/4) 
the firing frequencies measured during the first and the second application of serotonin 
127 
 
were significantly (P<0.05) different, with a larger decrease in firing frequency 
occurring to the application of serotonin in the presence of WAY100635 (Figure 4.6D). 
The first application of serotonin produced an average decrease in firing frequency of -
26 ± 8 % compared to -39 ± 9 % for the second application of serotonin, in the presence 
of WAY100635. 
We can therefore conclude that the increase in firing frequency seen in response to 
serotonin application is mediated by 5HT1a receptors, likely located presynaptically, 
and that the decrease in firing frequency seen in response to serotonin application does 
not depend on 5HT1a receptors. We also suggest that as 5HT1a receptors are known to 
have inhibitory influences, it is likely that they have their excitatory effects on VP 
neurons through presynaptic reduction of inhibitory inputs, perhaps through inhibition 
of the GABAergic inputs from the NAc. Further experiments will be needed to test this 
hypothesis. We can also suggest that there may be some interaction effects of 5HT1a 
receptors blockade on the inhibitory responses in the VP, as those VP neurons that were 
inhibited by serotonin application alone decreased to a greater extent (Figure 4.6D) in 
the presence of 5HT1a antagonists WAY100635, suggesting that antagonising 5HT1a 
receptors unmasks the full direct effect of serotonin on VP neurons. 
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FIGURE 4.6: 5HT1a antagonists block excitatory responses to serotonin 
application but do not block inhibitory responses to serotonin application in the 
VP. (A)  Excitatory responses to serotonin application alone that are no longer 
present in response to serotonin in the presence of WAY100635. (B) Percentage 
change in firing frequency for 8 neurons in the VP in response to serotonin 
application and serotonin application in the presence of WAY100635 (C) 
Inhibitory responses to serotonin application alone and in response to serotonin in 
the presence of WAY100635. (D) Percentage change in firing frequency for 4 
neurons in the VP in response to serotonin application and serotonin application in 
the presence of WAY100635. 
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4.3.6 5HT2c receptors have an inhibitory influence on VP neurons   
 
5HT2 receptors are Gq11 protein coupled and are considered to have a largely excitatory 
effect (Berger et al., 2009). A subpopulation of these receptors, 5HT2c receptors, are 
known to be expressed in the VP and are considered to be expressed in relatively high 
concentrations (Appel et al., 1990). We therefore applied serotonin in the presence of 
the 5HT2c antagonists RS102221 in order to investigate the possible involvement of 
this receptor in the dual effects of serotonin in the VP.  
From 2 experiments 13 VP neurons were analysed. 7/13 responded with a significant 
(P<0.05) increase in firing frequency, while 6/13 responded with a significant (P<0.05) 
decrease in firing frequency to serotonin application.  
Of the 7 that were excited by serotonin application 7/7 also showed a significant 
(P<0.05) increases in firing frequency to the application of serotonin in the presence of 
RS102221 (Figure 4.7A). In the majority of cases the firing frequencies measured 
during the first and the second application of serotonin were significantly (P<0.05) 
different, with a larger increase in firing frequency occurring to the application of 
serotonin in the presence of RS102221 in 6/7 (Figure 4.7B). The first application of 
serotonin produced an average percentage increase in firing frequency of 29 +/- 7 % 
compared to 46 ± 8 % for the second application of serotonin, in the presence of 
RS102221 (Figure 4.7B).  
Of the 6 that were inhibited by serotonin application, 3/6  showed further significant 
changes in firing frequency to the application of serotonin in the presence of RS102221, 
however 2 of these were significant (P<0.05) increases in firing frequency and only one 
was a further significant (P<0.05) decrease in firing frequency. The remaining 3/6 
showed no significant response to serotonin application in the presence of RS102221. In 
the majority of cases (5/6) the firing frequencies measured during the first (without 
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RS102221) and the second application of serotonin (in the presence of RS102221) were 
significantly (P<0.05) different, with either a smaller decrease or an increase in firing 
frequency occurring serotonin was applied in the presence of RS102221 (Figure 4.7D). 
The first application of serotonin produced an average decrease in firing frequency of 
-20 ± 5 % compared to an average increase of 17 ± 12 % for the second application of 
serotonin, in the presence of RS102221 (Figure 4.7D).  
We can therefore conclude that activation of 5HT2c receptors in the VP has an 
inhibitory influence on VP neurons firing frequency seen to the application of serotonin.  
Further experiments will be needed to ascertain whether this influence is due to the 
activation of pre- or postsynaptic mechanisms. 
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FIGURE 4.7: 5HT2c antagonists modulate inhibitory responses to serotonin 
application, but do not block excitatory responses to serotonin application in the VP. 
(A) Excitatory responses to serotonin application alone and in the presence of 
RS102221. (B) Percentage change in firing frequency for 7 neurons in the VP in 
response to serotonin application and serotonin application in the presence of 
RS102221. (C) Inhibitory responses to serotonin application that are no longer 
present in response to serotonin application in the presence of RS102221. (D) 
Percentage change in firing frequency for 6 neurons in the VP in response to 
serotonin application and serotonin application in the presence of RS102221. 
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4.3.7 5HT5a receptors contribute to the excitatory effects of serotonin  
 
Of the 7 subtypes of serotonin receptor only 5HT1 and 5HT5 are considered to be 
inhibitory (Berger et al., 2009), both by the reduction of intracellualr cAMP levels 
(Thomas, 2006). Like 5HT1a, 5HT5a receptors are known to be expressed in the VP in 
moderate levels (Oliver et al., 2000). To invetsigate the role of these receptors, 
serotonin was therefore applied twice, first alone and then in the presence of the 5HT5a 
antagonists SB699551.  
From 1 experiment 8 neurons were analysed. 6/8 neurons significantly (P<0.05) 
increased their firing frequency in response to serotonin application, while 2/11 
significantly (P<0.05) decreased their firing frequency in response to serotonin 
application. Of those that were excited by serotonin application, 6/6 also showed 
significant changes in their firing frequency to the application of serotonin in the 
presence of SB699551, 5/6 maintaining a significant (P<0.05) excitation, while 1/6 
displayed a significant (P<0.05) inhibition. In the majority of cases (5/6) the firing 
frequencies measured during the first and the second application of serotonin were 
significantly (P<0.05) different with a smaller increase or a decrease in firing frequency 
to the application of serotonin in the presence of SB699551 (Figure 4.8B). The first 
application of serotonin produced an average increase in excitation of 57 ± 12 % 
compared to 28 ± 12 % for the second application of serotonin, in the presence of 
SB699551 (Figure 4.8B).  
Of the 2 that were inhibited by serotonin application, both also displayed a significant 
decrease in firing frequency to the application of serotonin in the presence of SB699551 
(Figure 4.8C). In both cases the second application of serotonin (in SB699551) 
produced similar effects to the first one (alone) as the firing frequencies measured 
during the first and second application of serotonin were not significantly different 
(Figure 4.8D). The first application of serotonin produced an average decrease in 
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excitation of -73 ± 10 % compared to -75 ± 0.5 % for the second application of 
serotonin, in the presence of SB699551. 
As serotonin produced a smaller increase in firing frequency when applied in the 
presence of SB699551, we conclude that 5HT5a receptors contribute to the excitatory 
response of VP neurons to serotonin application, but that other serotonin receptor must 
be responsible for the residual excitatory effects. 
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FIGURE 4.8: 5HT5a receptors contribute to the excitatory responses of serotonin 
in the VP. (A) Excitatory responses to serotonin application alone and in the 
presence of SB699551. (B) Percentage change in firing frequency for 6 neurons in 
the VP in response to serotonin application alone and serotonin application in the 
presence of SB699551. (C) Inhibitory responses to serotonin application alone and 
in the presence of SB699551. (D) Percentage change in firing frequency for 2 
neurons in the VP in response to serotonin application alone and serotonin 
application in the presence of SB699551. 
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4.3.8 5HT7 receptors contribute to VP excitatory response to serotonin  
 
5HT7 receptors are the most recently identified members of the serotonin receptor 
extended family (Bard et al., 1993) and is a GS protein coupled receptor thats’ mode of 
action is to increase intracellular levels of cAMP. 5HT7 receptors are known to be 
expressed in the VP (To et al., 1995). We therefore applied serotonin in the presence of 
5HT7 antagonists SB269970 in order to investigate the possible involvement in 
mediating the dichotomous responses to serotonin seen in the VP. 
From 2 experiment 9 neurons were analysed. 7/9 responded with significant (P<0.05) 
increases in firing frequency to the application of serotonin and 2/9 responded with 
significant (P<0.05) decreases in firing frequency to the application of serotonin (Figure 
4.9A and C).  
Of those neurons that were excited by serotonin application, only 2/7 showed a 
statistically significant (P<0.05) increase in firing frequency to the application of 
serotonin in the presence of SB269970. In all cases the firing frequencies measured 
during the first and the second application of serotonin were significantly (P<0.05) 
different with a smaller increase or a decrease in firing frequency to the application of 
serotonin in the presence of SB269970 (Figure 4.9B).  The average percentage change 
in firing frequency was 51 ± 9 % to the application of serotonin alone, while it was 9 ± 
4 % in response to the application of serotonin in the presence of SB269970 (Figure 
4.9B).  
Of those neurons that were inhibited by serotonin application, 1 showed a significant 
(P<0.05) decrease in firing frequency to the application of serotonin in SB269970, 
while the other showed no significant response to serotonin in the presence of 
SB269970. In both cases the first application of serotonin resulted in a significantly 
(P<0.05) different responses to the second (in the presence of SB269970), as one neuron 
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displayed a larger decrease in firing frequency and the other a smaller decrease in firing 
frequency to serotonin in the presence of SB269970 (Figure 4.9D).  
We conclude that the 5HT7, along with 5HT1a and 5HT5a receptors, contribute to the 
increase in firing frequency observed in response to serotonin application in the VP.  
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FIGURE 4.9: 5HT7 antagonist modulates the increase in firing frequency seen to 
serotonin application in the VP. (A) Excitatory responses to serotonin application 
alone that is no longer present in response to serotonin in the presence of SB699770. 
(B) Percentage change in firing frequency for 6 neurons in the VP in response to 
serotonin application alone and serotonin application in the presence of SB699770. 
(C) Inhibitory responses to serotonin application alone and in the presence of 
SB699770. (D) Percentage change in firing frequency for 2 neurons in the VP in 
response to serotonin application alone and serotonin application in the presence of 
SB699770. 
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4.4 Discussion: 
 
Our study investigated the role serotonin and its receptor subtypes play in the 
modulation of VP neuronal circuitry. Our data indicates that the dichotomous response 
seen by Bengtson et al., (2004) to serotonin application persists when measured 
extracellularly and as population responses. We were however unable to find any 
consistent electrophysiological differences (spike half-width, firing frequency and 
coefficient of variation) between those neurons that increased firing frequency to 
serotonin application and those that decreased firing frequency. This means that the dual 
effects of serotonin observed in the current study were probably not exerted on the same 
neuronal subpopulation that were differentially affected by dopamine in the VP (as 
described in the previous chapter). We can also not support directly Bengtson et al., 
(2004) assertions that the responses correspond to cholinergic and non-cholinergic VP 
neuron populations.   
4.4.1 Pre and postsynaptic effects of serotonin application 
 
Our data suggest that the serotonin receptors responsible for the increases in firing 
frequency to serotonin application have an indirect effect through pre-synaptic 
modulation. We concluded this as neurons identified as increasing firing frequency to 
serotonin application in the VP, did not show any increase in firing when synaptic 
transmission was inhibited by a low Ca2+ aCSF solution. This supports Nishijo et al's., 
(2016) research, which suggests that serotonin receptors, acting as pre-synaptic 
heteroreceptors, inhibit GABA release onto the cholinergic neurons of the VP, thus 
disinhibiting these VP neurons. On the other hand those neurons that reduced their 
firing frequency in response to serotonin application continued to show significant 
reductions in firing frequency to serotonin application in the presence of low Ca2+ 
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aCSF. Our data therefore suggests that the serotonin receptors mediating the inhibitory 
effects of serotonin, are located postsynaptically on VP neurons.  
4.4.2 Contribution of different serotonin receptors to serotonin responses in VP 
neurons 
 
Our data reveals the contribution of several serotonin receptor subtypes to the dual 
response seen to serotonin application in the VP. We suggest that there are at least four 
distinct receptor subtypes responsible for the effects of serotonin. Our data suggests 
three of these mediate the increase in firing frequency (5HT1a, 5HT7 and 5HT5a) and 
one mediates the decrease (5HT2c) in firing frequency seen in response to serotonin 
application.  
Our data are consistent with Nishijo and Momiyama's (2016) findings that excitatory 
responses to serotonin in the VP are a result of presynaptic modulation. However, 
Nishijo and Momiyama, (2016) suggest the 5HT1b receptors mediate this excitatory 
response to serotonin, while our data suggests that 5HT1a, 5HT5a and 5HT7 receptors 
also contribute to this net increase in excitation. This is because 5HT1a, 5HT5a and 
5HT7 antagonists were capable of decreasing increases in firing frequency seen in 
response to serotonin application in the VP. Further research is undoubtedly required, 
however it is conceivable that 5HT1a receptors may act in a similar manner and at a 
similar location to 5HT1b receptors in the VP as 5HT1a receptors are largely considered 
to be inhibitory (Pytliak et al., 2011), therefore to modulate an increase in firing in the 
VP, 5HT1a receptors may, like 5HT1b receptors, be inhibiting GABAergic 
neurotransmission, therefore disinhibiting the target cells. Although 5HT1a receptors 
are most likely localised to GABAergic inputs in the VP, they could also act pre-
synaptically at GA terminals, inhibiting GA release (figure 1.1), if the target neurons in 
the VP expressed one of the inhibitory mGlu receptors (Ohishi et al., 1993; Testa et al., 
1994). Indeed this is the mechanism by which we have shown D2 agonists modulate 
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excitatory responses in the VP. This would be a potentially important factor for future 
research to clarify and could be a mechanism by which serotonin and dopamine interact 
at the cellular level in the VP.  
As for 5HT7, our data suggests that 5HT7 receptors also play a role in the excitatory 
response to serotonin application in the VP. 5HT7 antagonists were able to partially 
block the increase in firing frequency seen in response to serotonin application in some 
neurons of the VP. Research has shown (Chen et al., 2008; Hashimoto & Kita, 2008) 
that 5HT7 receptors have a postsynaptic depolarising effect in the GPe, we therefore 
suggest that this may well be the case for some neurons in the ventral extents of the 
pallidum, although our data seems to largely suggest excitatory responses in the VP are 
modulated through pre-synaptic mechanisms, as excitatory responses did not occur in 
response to serotonin application in low Ca2+ aCSF. Further research with 5HT7 
agonists within the VP would be useful to elucidate this.  
Finally, our data suggests that 5HT5a receptors also contribute to the excitatory 
response to serotonin application in the VP. 5HT5a receptors are known to be located 
presynapitcally and modulate inhibition, by inhibiting Ca2+ channels (Millan et al., 
2008).  Recent research also suggests that these receptors are found on both 
dopaminergic neurons and GABAergic interneurons in the VTA (Yamazaki et al., 
2018). This provides an intriguing mechanism by which 5HT5a receptors may be 
interacting with dopamine transmission in the VP and could prove a fruitful target for 
future research, potentially elucidating, at the cellular level, interactions between 
serotonin and dopamine in the VP.   
Our studies suggest that activation of 5HT1a, 5HT7 and 5HT5a receptors all contribute 
to the excitation of VP neurons in response to serotonin. Residual excitation in response 
to serotonin application in the presence of 5HT7 and 5HT5a antagonists supports the 
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contribution of multiple serotonin receptor subtypes; however the lack of residual 
excitation in response to serotonin in the presence of 5HT1a antagonist does not. A 
possible explanation for this lack of residual excitation, in the presence of 5HT1a 
antagonists, is a complex interaction between 5HT1a, 5HT5a and 5H7 receptors, which 
means 5HT1a activation is required for the excitatory effects of 5HT7 and 5HT5a to be 
revealed. Research suggests that G-protein coupled receptors can form dimeric and 
oligomeric complexes (Devi, 2001). These dimeric and oligomeric complexes can result 
in changed receptor pharmacology, and result in different G-protein coupled responses 
to activation of one or all receptors in the complex (Franco et al., 2009; Renner et al., 
2012).  Recent research suggests that this could be the case for certain 5HT receptors. 
Renner et al., (2012) has shown that 5HT1a and 5HT7 receptors form functional 
heterodimers, and that this results in modulation of the 5HT1a receptors ability to 
activate G-protein gated potassium channels in hippocampal neurons. Functional 
crosstalk between these receptors in VP neurons is therefore possible, and provides a 
tentative explanation for the lack of residual excitation in response to serotonin in the 
presence of 5HT1a antagonists. It could be that 5HT5a receptors are also part of an 
oligomeric complex with 5HT1a and 5HT7 receptors. There is research which suggests 
an interaction between 5HT5a and 5HT1a receptors in cortical regions (Goodfellow et 
al., 2012). In this study depletion of 5HT5a receptors, in knockout mice, increased the 
inhibitory serotonin currents mediated by 5HT1a receptors in cortical regions. This may 
therefore provide tentative evidence for a heterodimeric relationship between 5HT1a 
and 5HT5a, providing a potential reason for the lack of residual excitation in response 
to serotonin in the presence of 5HT1a antagonists in VP neurons. Clearly, however 
further research is needed on this topic to elucidate these mechanisms in the VP.  
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4.4.3 Contribution of specific serotonin receptors to inhibitory serotonin 
responses in VP neurons 
 
As for the neurons that decrease in firing frequency in response to serotonin application. 
Our data suggests that the most likely candidate for mediating this post-synaptic 
decrease in firing frequency is the 5HT2c receptor. This is as inhibitory responses in VP 
neurons were blocked by 5HT2c antagonists. The 5HT2 group are largely considered 
excitatory (Berger et al., 2009), therefore it would seem unusual for these to be capable 
of inhibiting the VP neurons directly. However 5HT2c receptors are known in the NAc 
to decrease the release of DA (De Deurwaerdère & Spampinato, 1999) and they have 
tonic inhibitory control over the mesolimbic dopamine pathway (Di Giovanni et al., 
1999). Alex et al., (2005) have also shown that 5HT2c receptors directly inhibit 
dopamine release in the striatum with increases in dopamine release produced by 5HT2c 
antagonists. We, therefore, tentatively suggest that serotonin may produce inhibitory 
responses in a set of dopaminergic neurons within the VP. This provides an intriguing 
target for future research aimed at the interaction of dopamine and serotonin within the 
VP. 
4.4.4 The 5HT1a receptor antagonist WAY100635 is also a D4 receptor agonists 
 
A caveat of our data on the role of 5HT1a receptors in the VP is that the antagonists 
used for these experiments: WAY100635, is also a D4 agonist. This may be a problem 
as D4 agonism may contribute to the lack of excitatory responses seen to serotonin 
application in the presence of WAY100635. We cannot therefore definitively conclude 
that 5HT1a receptors modulate the excitatory responses to serotonin application in the 
VP. Indeed D4 receptors are inhibitory (Neve et al., 2004) and are expressed in the VP 
(Noain et al., 2006). Our research has shown (chapter 3) that D2-like (including D2, D3 
and D4) receptor agonists can produce inhibition of some VP neurons. This may 
therefore provide an explanation for the lack of excitation in the presence of 
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WAY100635, rather than it being a result of 5HT1a receptor inhibition.  D4 receptors 
are also known to inhibit glutamatergic inputs from the BLA (basolateral amygdala) in 
the mPFC (medial pre-frontal cortex) (Laviolette et al., 2005). The VP has similar 
glutamatergic inputs from the BLA (figure1.1). It could be that the lack of an excitatory 
response in VP neurons to serotonin, in the presence of WAY100635, is at least partly 
due to its agonism of D4 receptors, at pre-synaptic glutamate terminals, therefore 
inhibiting GA release from these terminals into the VP, resulting in a net response of no 
change in firing frequency.  
4.4.5 Functional implications: 
 
As previously mentioned in chapter 3, the VP is crucially involved in reward processing 
(Smith et al., 2009) and drug-seeking behaviour (Kalivas & Volkow, 2005; Prasad & 
McNally, 2016). Serotonin is also known to be involved in the modulation of these 
responses (Kranz et al., 2010), and serotonin levels are seen to increase in the VP when 
cocaine is self –administered (Sizemore et al., 2000).  
The current study provides novel and clear insights into the serotonin receptor subtypes 
involved in the dichotomous responses to serotonin seen in the VP (Bengtson et al., 
2004) and provides evidence for their pre and postsynaptic location of effect.  
This information is of primary theoretical value and could also help to develop rational 
pharmacological approaches to fight addiction and other dysfunctions of the reward 
system, such as affective disorders. 
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5 Chapter 5: Effects of electrical stimulation of NAc 
afferents on VP neurons’ firing  
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5.1 Abstract:  
 
Afferents from the NAc are considered to be a major source of input into the VP. 
Research reveals that these afferents are GABAergic, however stimulation of these 
afferents induces both excitatory and inhibitory responses within the VP. These are 
likely to be partially mediated by enkepahlin and substance P, which are also released 
by these afferents, and are known to modulate VP neurons. However less is known 
about the potentially differential effects stimulation of these afferents has on 
subpopulations of neurons within the VP and the cellular mechanisms by which they 
exert their effects. The current study aimed to research this further using brain slices 
containing the VP, stimulation of the NAc afferents and multi-electrode array (MEA) 
recordings of their VP targets. Stimulation of the NAc afferents induced a pause in the 
tonic firing in 58 % of the neurons studied in the VP, while 42 % were not affected. 
Measures used to reveal electrophysiological difference between these groups found no 
significant differences in firing frequency, coefficient of variation and spike half-width. 
There was however significant differences in the pause duration between neurons  in the 
dorsal and ventral VP, with stimulation of NAc afferents producing a significantly 
longer pause (0.48 ± 0.06 s) in tonic firing in dorsal VP neurons, compared to neurons 
in the ventral VP (0.21 ± 0.09 s).  Pauses in the tonic firing of VP neurons, as a result of 
NAc afferent stimulation, were found to be largely mediated by GABAA receptors, as 
application of picrotoxin significantly reduced their duration. Opioid agonists and 
antagonists were found to have no significant effects on the pause in tonic activity 
induced by NAc afferent stimulation. However, NK-1 receptor antagonists caused 
significant decreases in the pause duration, suggesting that substance P may contribute 
to the inhibitory effect of NAc afferent stimulation via activation of NK-1 receptors.  
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5.2 Introduction:  
 
The VP is a major output structure of the striatum and is innervated by afferents from 
the NAc. Many consider these afferents to be the main input of the VP (Bolam et al., 
1986; Haber et al., 1985). Activation of these afferents has been shown to be involved 
pleasurable responses and sensitization to drugs of abuse (Creed et al., 2016; Smith & 
Berridge, 2005).  These afferents affect VP neurons through release of associated 
neurotransmitters and peptides. The NAc afferents of the VP release GABA (Churchill 
et al., 1990b; Churchill & Kalivas, 1994; Kitamura et al., 2001; Mogenson et al., 1983; 
Reiner & Anderson, 1990; Walaas & Fonnum, 1979; Yang & Mogenson, 1985; 
Zaborszky & Cullinan, 1992). However research has shown that stimulation of  these 
afferents produces both inhibition and excitation of VP neurons (Chrobak & Napier, 
1993). Enkepahlin and substance P, as well as GABA, are probably involved in these 
responses as both are known to be released by these afferents (Haber et al., 1985; Lu et 
al., 1997; Napier et al., 1995a). Enkephalin, has been shown to contribute (along with 
GABA) to the inhibition of VP neurons seen in response to stimulation of NAc afferents 
(Napier et al., 1992), and substance P is known to produce excitatory responses in the 
VP (Napier et al., 1995a), therefore substance P is a likely candidate to be involved in 
the excitation of VP neurons as a result of NAc afferent stimulation.  
Questions remain as to what neurons the afferent connections of the NAc target in the 
VP. Research suggests they may directly target cholinergic interneurons in the VP 
(Grove et al., 1986; Zaborszky & Cullinan, 1992; Zaborszky et al., 1986), although 
recent research by Root et al., (2015) suggests NAc afferents also directly innervate 
GABAergic neurons of the VP. Further research needs to elucidate how stimulation of 
these afferents modulates the VP neurons they innervate. The question also remains as 
to what receptors are involved in the modulatory effects of NAc inputs to the VP. The 
research suggest a strong involvement of GABAA receptors (Chrobak & Napier, 1993). 
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However NK-1 receptors (Chen et al., 2001; Maeno et al., 1993), δ-opioid receptors and 
µ-opioid receptors (Lahti, Mickelson, Jodelis, & McCall, 1989; Mitrovic & Napier, 
1995) are also known to be present in the VP and neurons in the VP are responsive to 
their activation (Chrobak & Napier, 1993; Napier et al., 1995a). It can be hypothesised 
that substance P and enkephalin, released by NAc afferents to the VP (figure1.1) target 
these receptors and modulate the effects of GABA on these neurons, however this has 
not been demonstrated.  
It is important to understand further how activation of NAc inputs into the VP, and the 
neuromodulators released, impact on VP neurons. Unravelling the potentially divergent, 
modulatory effects these connections have on the interneurons and projection neurons 
of the VP may reveal important information relating to drugs of abuse, affective 
disorders and aspects of reward learning, as that these areas and their connections are 
heavily involved in these processes.   
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5.3 Results: 
 
5.3.1 Stimulation of the NAc inhibits tonic firing in some VP neurons 
 
In order to explore the effect that NAc afferents have on VP neurons, we stimulated the 
NAc every 10 seconds and measured the changes in tonic firing activity within the 
dorsal and ventral extents of the VP.  
From 13 experiments 52 neurons were identified for analysis as they had a stable tonic 
firing rate after 1 hour of slice accommodation in the multielectrode array. Stimulation 
of the NAc induced a pause (referred to as responders) in firing in 30/52 of these 
neurons (Figure 5.1A and B), with 53 % being located in dorsal extents of the VP and 
47% being located in ventral extents of the VP (Figure 5.1E). 22/52 were not affected 
by NAc stimulation (referred to as non-responders) with 41 % being located in the 
dorsal extent of the VP and 59 % being located in the ventral extent of the VP (Figure 
5.1E). Pause duration was 0.29 +/- 0.03 s for those classed as responders (Figure 5.1C).  
In order to ascertain if pauses were elicited in different types of neurons within the VP, 
firing frequency, coefficient and variation and spike half-widths were calculated for 
responders and non-responders. There was no significant (P>0.05) difference in the 
average baseline firing frequency rates between responders 18.16  ± 3.16 Hz and non-
responders 15.27 ± 2.83 Hz (Figure 5.1F). There was no significant (P>0.05) difference 
in the coefficient of variation between responders 27.07 ± 9.61 and non-responders 
19.27 ± 2.51 (Figure 5.1G). Finally, there was no significant difference in spike half-
width (ms) between responders 0.32 ± 0.02 ms and non-responders 0.35 ± 0.03 ms 
(Figure 5.1D). 
We conclude that a significant populations of neurons in the VP are directly inhibited 
by afferents from the NAc, and that these neurons are fairly evenly dispersed between 
the dorsal and ventral extents of the VP. There is however a significant population that 
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were not directly inhibited by NAc stimulation. We could not find any marker that 
identified these neuron as separate types of neurons and it is possible that the NAc 
fibres impinging on these neurons were cut or absent in the brain slices used in these 
experiments. 
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FIGURE 5.1: stimulation of the NAc results in inhibition of tonic firing in some VP 
neurons. (A) A typical example of a raw data trace from a neuron in the VP with a 
pause (responder) in tonic activity after stimulation of the NAc. (B) A typical 
example raster plot (above) and peri-stimulus time histogram (PTSH, below, in bins 
of 10 ms) of tonic firing activity in a VP neuron 0.5 s pre stimulation and 0.5 s post 
stimulation of the NAc. The raster plot exemplifies one neuron response during 400 
applications of stimulation. (C) Bar chart representing average pause duration for 
those neurons that were responders to NAc stimulation (D) Bar chart representing 
non-significant difference in spike half-width (ms) for neurons that responded to 
NAc stimulation (green) and those that were non-responders (yellow) (E) Pie charts 
representing the proportion of neurons identified in the VP for analysis that 
responded to NAc stimulation, and the proportions that were located ventrally versus 
dorsally within the VP. (F) Bar chart representing non-significant differences in 
baseline firing frequency rates for neurons that responded to NAc stimulation (green) 
and those that were non-responders (yellow). (G) Bar chart representing non-
significant difference in baseline coefficient of variation for those neurons that 
responded to NAc stimulation (green) and those that were non-responders (yellow).  
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5.3.2 NAc stimulation induces pauses of different durations dorsally compared to 
ventrally in the VP 
 
In order to ascertain if there were any regional differences in pause duration between 
dorsal and ventral extents of the VP, the pause duration of neurons identified as in 
dorsal portions of the VP were compared to neurons in ventral portions of the VP.  
From 10 experiments we identified 17 neurons in the VP for analysis as they responded 
to NAc stimulation. 7/17 of these were classified as being located dorsally (Figure 
5.2A) in the VP and 10/17 of these were classified as located ventrally within the VP 
(Figure 5.2B). Ventrally located neurons paused for an average duration of 0.21 ± 0.09 s 
while dorsally located neurons paused for an average duration of 0.48 ± 0.06 s. This was 
significantly different (P<0.05) (Figure 5.2C).  
In order to ascertain if these differences represented different populations of neurons in 
the dorsal VP compared to the ventral VP we compared them based on the baseline 
firing frequency, coefficient of variation and spike half-width profiles. There was no 
significant difference in the average baseline firing frequency rates between those 
neurons located dorsally within the VP 17.13 ± 4.06 Hz and those located ventrally 
within the VP 16.13 ± 2.08 Hz (Figure 5.2D). There was no significant  difference in the 
coefficient of variation between those neurons located dorsally 24.85 ± 11.06 and those 
located ventrally 22.05 ± 8.53 (Figure 5.2E). Finally, there was no significant difference 
in spike half-width (ms) between those located dorsally 0.29 ± 0.04 s and those located 
ventrally 0.36 ± 0.05 s (Figure 5.2F). 
We tentatively conclude that inputs arriving from the NAc to dorsal regions in the VP 
have a greater inhibitory effect on the VP’s tonic firing than those inputs from the NAc 
arriving in more ventral regions of the VP, but this does not appear to be related to the 
type of neuron they innervate within the VP
152 
 
FIGURE 5.2: NAc stimulation induces a longer pause duration in dorsal VP neurons 
than ventral. (A) A typical example raster plot of tonic firing activity in a VP neuron 
0.5 s pre stimulation and 1.0 s post stimulation of the NAc. The raster plot 
exemplifies one neurons response in the dorsal VP during 150 applications of 
stimulation. (B) A typical example raster plot of tonic firing activity in a VP neuron 
0.5 s pre stimulation and 1.0 s post stimulation of the NAc. The raster plot 
exemplifies one neurons response in the Ventral VP during 150 applications of 
stimulation. (C) Bar chart representing significant differences (*= P<0.05) in pause 
duration between those neurons studied in the dorsal VP compared to those in the 
ventral VP. (D) Bar chart representing no-significant difference (P>0.05) in firing 
frequency (Hz) for neurons that paused in response to NAc stimulation in the dorsal 
VP compared to those in the ventral VP. (E) Coefficient of variation for neurons that 
paused in response to NAc stimulation in the dorsal VP and  those in the ventral VP. 
(F) Spike half-width (ms) for neurons that paused in response to NAc stimulation in 
the dorsal VP compared to those in the ventral VP. 
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5.3.3 Picrotoxin abolishes VP neurons inhibition by NAc stimulation. 
 
Research suggests that afferent projections from the NAc innervating the VP are 
GABAergic. This should mean that application of GABAa antagonists should largely 
ameliorate the inhibition in tonic firing seen in response to NAc stimulation. In order to 
explore the role of GABA in the inhibition of VP neurons, the GABAa antagonist 
picrotoxin was applied during stimulation of the NAc. 
From 12 experiments 26 neurons in the VP were identified for analysis that paused in 
response to NAc stimulation (Figure 5.3A and B).  The average pause duration for these 
26 neurons was 0.34 ± 0.04 s. For these 26 neurons, after the application of picrotoxin, 
the pause duration was 0.06 ± 0.01 s (Figure 5.3E). As the pause duration measured 
after the application of picrotoxin was significantly (P<0.001) shorter than before the 
application of picrotoxin (Figure 5.3E) we can conclude that the inhibition induced in 
tonically active VP neurons by NAc stimulation is largely a result of GABA release and 
subsequently activation of GABAa receptors. 
In order to investigate if the application of picrotoxin had any effect on 
electrophysiological characteristics of the VP neurons we measured baseline firing 
frequency rates and coefficient of variation for the VP neurons. The firing frequency 
(Hz) rates were not significantly (P>0.05) different for any (pauses and non-pauses) VP 
neurons studied in the presence of picrotoxin 21.52 ± 0.49 Hz compared to control 
conditions 18.59 ± 1.97 Hz (Figure 5.3C). Coefficient of variation was also not 
significantly (P>0.05) different for any (pauses and non-pauses) VP neurons studied in 
the presence of picrotoxin 29.75 ± 10.42 compared to control conditions 35.39 ± 4.34 
(Figure 5.3D). 
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We can therefore conclude that application of picrotoxin has no significant (P>0.05) 
effects on the electrophysiological characteristics of the VP neurons, but abolishes the 
inhibitory influence stimulation of NAc neurons has on VP neurons. 
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  FIGURE 5.3: Picrotoxin substantially disinhibits VP neurons inhibited by NAc 
stimulation. (A) A typical example of a raw data trace from a neuron in the VP 
with a pause in tonic activity after stimulation of the NAc and a raw trace from 
the same neuron after the application of picrotoxin with no pause in tonic activity. 
(B) A typical example raster plot of tonic firing activity in a VP neuron from 0.5 s 
pre stimulation to 0.5 s post stimulation of the NAc. The raster plot exemplifies 
one neurons response during 600 applications of stimulation in control conditions 
and 600 stimulations after the application of picrotoxin. (C) Bar chart 
representing no-significant difference in baseline firing frequency (Hz) for 
neurons that pause and those that didn’t pause in response to NAc stimulation, in 
control conditions and in the presence of picrotoxin. (D) Bar chart representing 
no-significant differences in baseline coefficient of variation for neurons that 
pause and those that didn’t pause in response to NAc stimulation, in control 
conditions and in the presence of picrotoxin. (E) Bar chart representing 
significant differences (***= P<0.001) in pause duration for those neurons that 
paused in response to NAc stimulation (green) compared to the same neurons in 
the presence of picrotoxin, and compared to those neurons that did not pause in 
response to stimulation (yellow) in control conditions and in the presence of 
picrotoxin. 
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5.3.4 Inhibition of VP neurons by NAc stimulation is not affected by Opioid 
antagonists 
 
In order to investigate the role of opioids and opioid receptors in the inhibition of VP 
neurons by NAc stimulation, opioid agonists (DAMGO) and the non-specific opioid 
receptor antagonist, naloxone, were applied during stimulation of the NAc.  
From 5 experiments 11 neurons were identified for analysis that paused in response to 
NAc stimulation (Figure 5.4A). In control conditions the average pause duration for 
these 11 neurons was 0.32 ± 0.06 s. For these 11 neurons after the application of 
naloxone the average pause duration was 0.31 ± 0.07 s. The pause duration after the 
application of naloxone was not significantly (P>0.05) different to the pause duration 
before the application of naloxone (Figure 5.4C). However the pause duration 
(consistent with Figure 5.3) was significantly (P<0.05) reduced, compared to control 
conditions and naloxone, after the application of picrotoxin 0.04 ± 0.07 s (Figure 5.4C). 
We therefore conclude that opioid receptors do not modulate the pause in firing seen in 
VP neurons, induced by stimulation of the NAc afferents. 
In order to investigate if the application of naloxone had any effect on 
electrophysiological characteristics of the VP neurons we measured baseline firing 
frequency rates and coefficient of variation for the VP neurons (Figure 5.4E and F). The 
firing frequency (Hz) rates were not significantly (P>0.05) different for the VP neurons 
studied in the presence of naloxone 19.35 ± 2.91 Hz compared to control conditions 
18.00 ± 3.02 Hz and the presence of picrotoxin 19.82 ± 3.75 Hz. Coefficient of variation 
was also not significantly (P>0.05) different for the VP neurons studied in the presence 
of naloxone 40.72 ± 16.79 compared to control conditions 27.07 ± 9.52 and picrotoxin 
51.32 ± 22.93. 
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To verify that opioids did not play a role in modulation of the pause duration induced by 
NAc stimulation, we also applied DAMGO during stimulation of the NAc.  
From 3 experiments 5 neurons were identified for analysis that paused in response to 
NAc stimulation (Figure 5.4B). In control conditions the average pause duration for 
these 5 neurons was 0.40 ± 0.11 s. For these 5 neurons after the application of DAMGO 
the average pause duration was 0.31 ± 0.08 s (Figure 5.4D). The pause duration after the 
application of DAMGO was not significantly (P>0.05) different to the pause duration 
before the application of DAMGO. The pause duration was, however significantly 
(P<0.05) reduced, compared to control conditions and DAMGO, after the application of 
picrotoxin 0.04 ± 0.07 ms (Figure 5.4C).  
To check if DAMGO affected the electrophysiological characteristics of VP neurons we 
measured baseline firing frequency rates and coefficient of variation for the VP neurons 
(Figure 5.4G and H). The firing frequency (Hz) rates were not significantly (P>0.05) 
different for the VP neurons studied in the presence of DAMGO 14.01 ± 4.26 Hz 
compared to control conditions 15.89 ± 3.79 Hz. Coefficient of variation was also not 
significantly (P>0.05) different for the VP neurons studied in the presence of DAMGO 
60.89 ± 24.69 compared to control conditions 39.95 ± 8.63.  
We therefore conclude that opioid receptors appear to have no modulatory effect on the 
pause in firing seen in VP neurons, induced by stimulation of the NAc afferents. 
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FIGURE 5.4: Inhibition of VP neurons by NAc stimulation is not effected by opioid 
agonists. (A) A typical example of raster plot of tonic firing activity in a VP neuron (from -
0.5 s to 0.5 s post stimulation of the NAc). The raster plot shows a neuron’s response during 
800 applications of stimulation in control conditions, 800 stimulations after the application 
of naloxone and 800 stimulations after the application of picrotoxin. (B) A typical example 
raster plot of tonic firing activity in a VP neuron 0.5 s pre stimulation and 0.5 s post 
stimulation of the NAc. The raster plot exemplifies one neurons response during 800 
applications of stimulation in control conditions, 800 stimulations after the application of 
DAMGO and 800 stimulations after the application of picrotoxin (C) Bar chart representing 
significant differences (** = P<0.01) in pause duration for neurons in control conditions, the 
presence of naloxone and the presence of Picrotoxin. (D) Bar chart representing significant 
differences (** = P<0.01 and * = P<0.05) in pause duration for neurons in control 
conditions, the presence of DAMGO and the presence of Picrotoxin. (E) Bar chart 
representing non-significant (P>0.05) differences in the average firing frequencies for 
neurons in control conditions, in the presence of naloxone and in the presence of picrotoxin.  
(F) Bar chart representing non-significant (P>0.05) differences in the coefficient of variation 
for neurons in control conditions, in the presence of naloxone and in the presence of 
picrotoxin.  (G) Bar chart representing non-significant (P>0.05) differences in the average 
firing frequencies for neurons in control conditions, in the presence of DAMGO and in the 
presence of picrotoxin.  (H) Bar chart representing non-significant (P>0.05) differences in 
the coefficient of variation for neurons in control conditions, in the presence of DAMGO and 
in the presence of picrotoxin. 
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5.3.5 NK-1 receptors modulate the effect of NAc stimulation on VP tonic firing 
 
In order to investigate the effects of substance P receptors on the inhibition of VP 
neurons by NAc stimulation, we applied L732,138, which is a NK-1 receptor 
antagonists, during stimulation of the NAc. 
From 3 experiments 8 neurons were identified for analysis that paused in response to 
NAc stimulation (Figure 5.5A). In control conditions the average pause duration for 
these neurons was 0.39 ± 0.06 s, for these 8 neurons, after the application of L732,138 
the average pause duration was 0.26 ± 0.06 s. The pause duration, after the application 
of L732.138 was significantly (P<0.05) reduced compared to the pause duration in 
control conditions (Figure 5.5B). The pause duration was further significantly (P<0.001) 
reduced, compared to control conditions, with the application of picrotoxin 0.07 ± 0.02 
s (Figure 5.5B).  
In order to investigate if the application of L732,138 had any effect on 
electrophysiological characteristics of the VP neurons we measured baseline firing 
frequency rates and coefficient of variation for the VP neurons. The firing frequency 
(Hz) rates were not significantly (P>0.05) different for the VP neurons studied in the 
presence of L732,138 20.15 ± 3.67 Hz compared to control conditions 20.75 ± 1.69 Hz 
and the presence of picrotoxin 22.77 ± 3.15 Hz (Figure 5.5C). Coefficient of variation 
was also not significantly (P>0.05) different for the VP neurons studied in the presence 
of L732,138 13.55 ± 1.57 compared to control conditions 12.90 ± 1.53 and picrotoxin 
13.93 ± 2.9 (Figure 5.5D). 
We conclude that substance P, released from NAc afferents into the VP, contribute to 
the pause duration produced as a result of NAc stimulation through activation of NK-1 
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receptors. This is unexpected as blocking a known excitatory influence was expected to 
prolong the pause duration.  
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FIGURE 5.5: Inhibition of VP neurons by NAc stimulation is modulated by NK-
1 receptor. (A) A typical example raster plot of tonic firing activity in a VP 
neuron from 0.5 s to 1.0 s post stimulation of the NAc. The raster plot exemplifies 
one neurons response during 200 applications of stimulation in control conditions, 
200 stimulations after the application of L732,138 and 200 stimulations after the 
application of picrotoxin. (B) Bar chart representing significant (* =P<0.05 *** = 
P<0.001) differences in the average pause duration (ms) for neurons in the VP 
after NAc stimulation. Each bar represents the average pause duration in different 
pharmacological conditions: in control conditions, in the presence of L732,138 
and in the presence of Picrotoxin. (C) Bar chart representing non-significant 
(P>0.05) differences in the average firing frequencies for neurons in control 
conditions, in the presence of L732,138 and in the presence of picrotoxin. (D) Bar 
chart representing non-significant (P>0.05) difference in the coefficient of 
variation for neurons in control conditions, in the presence of L732,138 and in the 
presence of picrotoxin. 
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5.4 Discussion: 
 
The present research concludes that MEA setup can be used successfully to study the 
connections between the striatum and its output nuclei. In this case, specifically 
between the NAc and the VP (figure1.1). We provide support, using a novel method, for 
previous research (Wang et al., 2014) suggesting that the NAc afferents of the VP have 
an inhibitory impact on VP neurons, as activation of the NAc afferents produced 
inhibition in tonic firing for a number of VP neurons. The current study also identified a 
number of, tonically active neurons, across all VP territories that were not inhibited by 
activation of afferents from the NAc.  
We tentatively conclude that activation of NAc afferents does not inhibit all the neurons 
in the VP and this may relate to a type of neuron not directly targeted by NAc afferents. 
However, caution should be taken with these conclusions as brain slices are likely to 
only preserve a fraction of the connections between the NAc and VP. Therefore it is 
conceivable that those neurons that did not respond to NAc stimulation were simply 
inhibited by NAc fibres that were lost in the slice preparation.  
Our findings, also revealed no distinct difference in any of our electrophysiological 
measures (firing frequency, coefficient of variation and spike half-width) for those 
neurons that responded to activation of NAc afferents and those that were non-
responders. This may well support the fact that the difference between responders and 
non-responders was an artefact of the brain slice preparation, preserving some 
connections between the NAc and VP, while severing others.   
Alternatively, the lack of electrophysiological differences between those neurons that 
responded to NAc stimulation and those that were non-responders may also be masked 
by within group variability. Research suggests NAc afferents target multiple different 
types of neurons in the VP, including GABAergic and cholinergic (Grove et al., 1986; 
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Root et al., 2015; Zaborszky, 1989), therefore the electrophysiological measures used 
may be distorted by this within group variability. Future research could use BAC 
transgenic animals with a GFP (green fluorescent protein) promoter for fluorescence in 
cholinergic neurons, so as to identify these in the slice. 
 
5.4.1 Difference in pause duration dorsal to ventral within the VP: 
 
The current study has also shown that the inhibitory effects of NAc inputs of the VP are 
evenly dispersed, with a similar number of neurons being inhibited in dorsal regions of 
the VP as were inhibited in more ventral regions of the VP. This even distribution 
across the VP is also the case for the neurons that were not inhibited by activation of 
NAc afferents. On the other hand there was, a significance difference in the duration of 
the inhibition between neurons in dorsal and ventral territories of the VP, with the 
dorsal regions exhibiting a significantly longer pause in firing in response to activation 
of the NAc afferents than did ventrally located neurons in the VP. This could relate to 
the differences in the functional roles of these territories or code an imbalance in 
projections from dorsal regions and from ventral regions to their prospective targets.   
Root et al., (2015) suggests that the connections between the NAcS and ventro-medial 
VP are involved in initiation of drug seeking (identifying the conditions for drug use) 
while NAcC to dorsolateral VP are involved in the continuation of drug seeking 
(addiction). We may therefore speculate that drugs of abuse alter this imbalance in 
pause duration between ventral and dorsal VP neurons resulting in a shift from initiation 
to continuation of drug seeking. Further research would be pertinent in slices from drug 
sensitised animals, to investigate if the difference in pause duration between dorsal and 
ventral VP territories, is altered by sensitization to drugs of abuse.  
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The fact that brain slice preparations are likely to only preserve a small proportion of 
the connections between brain regions, could again account for the differences in pause 
duration dorsally to ventrally within the VP. Therefore caution should be taken as these 
results could be due to more afferents to dorsal VP being intact in our brain slice 
preparations compared to the number of afferents to ventral VP. This is likely as the 
slice preparation technique used in the current study was based on that of Beurrier et al., 
(2006), whose aim was to persevere connections between more dorsal regions of the 
striatum and the GP. The current study investigated more ventral regions of the striatum 
(NAc) and the ventral pallidum, and therefore our findings, to some extent, may be an 
artefact of the preparation technique.  
 
5.4.2 Neurotransmitters and neuropeptides modulating pause duration: 
 
As for the pharmacology of these inhibitory effects on VP neurons, we found that the 
GABAa antagonists (picrotoxin) largely removed the pause in tonic firing, seen in some 
VP neurons, induced by activation of the NAc afferents. We conclude that the inhibitory 
effect of NAc afferent activation on a subset of VP neurons is predominantly mediated 
by the release of GABA and the activation of GABAa receptors on target VP neurons, 
thus resulting in a pause in tonic activity. This makes sense in the light of the dominant 
labelling/expression of GABAa as opposed to GABAb in the VP (Henderson, 1995; 
Zilles et al., 1991). This also supports the immunohistochemical research (Churchill & 
Kalivas, 1994) and the previous electrophysiological work of Chrobak and Napier, 
(1993), which suggests GABA antagonists disinhibit VP neurons.   
Recent research suggests both direct and indirect pathway MSN’s project into the VP 
(figure 1.1) (Creed et al., 2016; Kupchik & Kalivas, 2016). These release enkephalin 
(indirect) and substance P (direct) and therefore these neuropeptides would seem likely 
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candidates to contribute to the pause in tonic firing induced by activation of the NAc 
afferents. The current study found there to be no effect of opioid antagonists on the 
pause induced by stimulation of afferents from the NAc. We conclude that, although 
enkephalin may be released by these neurons (figure 1.1), it has no apparent modulatory 
effect on the neurons directly inhibited by activation of these afferents. Opioid 
antagonists were also not found to have any significant effect on the firing frequency 
and coefficient of variation for those neurons that paused. This is contrary to much of 
the research, which suggest enkephalin modulates VP neurons (Chrobak & Napier, 
1993; Napier & Mitrovic, 1999). Indeed, caution is needed in the interpretation of our 
results. The stimulation technique used in our studies on opioids is known to favour the 
release of GABA/glutamate and not neuropeptides, such as enkephalin. Therefore, the 
lack of modulatory effect seen in response to opioid antagonists could simply be an 
artefact of the stimulation protocol not resulting in neuropeptide release. However 
Mitrovic and Napier, (1995) has shown that a significant proportion of VP neurons do 
not respond to any opioid agonist. It could therefore be that those neurons directly 
inhibited by NAc afferents are those that are not modulated by enkephalin.   
5.4.3 Methodological issues with stimulation protocols: 
 
The stimulation protocol used for the experiments involving opioid antagonists was 
probably biased against the release of neuropeptides, as it involved the use of a low 
frequency stimulation, which is known to favour the release of GABA and glutamate 
and not neuropeptides, such as enkephalin (Purves, 2001). Further to this we also used 
the non-selective opioid antagonist Naloxone. This meant that other opioid receptors 
(kappa and delta), which are known to be present in the VP (Mitrovic & Napier, 1995; 
Olive et al., 1997), would have been inhibited, thus potentially masking the effects of 
enkephalin by also modulating the effects of dynorphin. Future research should include 
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high frequency stimulation protocols, such as that used in our experiments with NK-1 
antagonists, and selective enkephalin antagonists to avoid these issues.  
 
5.4.4 Substance P modulation of pause duration: 
 
The current study suggested, unexpectedly, that substance P contributes to the inhibitory 
effect of NAc input activation. Pause duration of VP neurons in response to NAc 
stimulation was significantly reduced by the application of NK-1 receptor antagonists, 
suggesting that substance P released from these NAc afferents contribute to the 
inhibitory effect of NAc afferent activation, via activation of NK-1 receptors. This 
contradicts previous research showing that substance P increases the firing rate of VP 
neurons and substance P antagonists block increases in firing rate seen in response to 
NAc stimulation (Mitrovic & Napier, 1998). However the research of Mitrovic and 
Napier, (1998) was carried out in vivo, therefore it plausible that the discrepancy results 
from the fact that in the intact brain the VP receives a number of other external inputs 
that are silent in brain slices and could be modulated presynaptically by substance P. 
Despite our data showing NK-1 receptor antagonists reduced the duration of the 
inhibition, they were not found to have any significant effect on the baseline firing 
frequency or coefficient of variation of the VP neurons, suggesting that there is little 
endogenous activation of these receptors in the VP in the absence of stimulation. Chen 
et al's., (2001) suggested that the majority of NK-1 receptors found in the VP are 
localised to cholinergic neurons. These cells could be involved in the effects reported 
here. Alternatively, substance P may have caused presynaptic facilitation of GABA 
release from NAc fibres, thus prolonging the GABA-induced pauses. Further 
experiments should be aimed at testing this intriguing hypothesis. Furthermore, it could 
be that substance P also has an effect at other tachykinin receptors in the VP, as NK-3 
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receptors are known to be found in the VP (Maeno et al., 1993; Shughrue et al., 1996) 
and this alters the effect seen as they were not blocked in the current study. Future 
research could target these receptors or repeat the current work with the application of 
NK-3 receptor antagonists.  
 
5.4.5 Implications: 
 
In the current study we have shown a novel method for investigation of the basal 
ganglia connections, which can be used to collect large amounts of data in relatively 
short periods of time, and also provides the ability to stimulate regions of interest and 
measure the effects in other afferent regions, providing insights into the modulatory 
connections and circuitry of brain regions. 
We also provide evidence to show that NK-1 receptors modulate the inhibition in tonic 
firing as a result of NAc stimulation, which provides an intriguing mechanism, that 
could contribute to our understanding of how substance P application has reinforcing 
effects when applied to the VP (Nikolaus et al., 1999a). We tentatively suggests that this 
may be due to its facilitatory effect on inhibition produced by the NAc afferents of the 
VP, and may modulate reinforcement related signals between the NAc and VP, by 
increasing the duration of inhibition exerted by these inputs on the VP. 
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6 Chapter 6: General Discussion: 
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In this section the main overall findings of our studies will be summarised and links 
made to the potential implications of these results to our understanding of the VP and its 
role in both modulation of reward related responses and responses to drugs of abuse. 
Technical considerations will also be discussed and suggestions for future work 
outlined.  
 
6.1.1 Dopaminergic modulation of VP neurons and their cellular mechanism 
 
In chapter three of this thesis we examined the effect of dopamine and modulation of 
D1-like and D2-like dopamine receptors on the tonic firing of VP neurons. We revealed 
important cellular mechanisms underpinning their effects within the VP. These may 
provide insights into the cellular mechanism underpinning a range of functions 
dopamine has been associated with in the VP, such as avoidance learning (Lénárd et al., 
2017; Péczely et al., 2014) and sensitization to drugs of abuse (Stout et al., 2016).  
Further to this we were also able to consistently identify neuronal populations in the VP 
that had differential responses to D2-like receptor modulation based on their spike half-
width profile. We found that neurons that decrease firing rates in response to D2-like 
agonist’s application had a larger spike half-width profile (type II) than those that 
increased firing rates in response to D2 agonists (type I). This therefore provides a 
mechanism by which future research can aim to identify separate populations of neurons 
within the VP from extracellular recordings and via electrophysiological means. These 
data may also relate to those of Avila & Lin, (2014), whose  findings suggests that there 
are two populations of neurons in the VP, each of which modulates different 
behavioural responses. They identified one populations with slow rates of firing and 
narrower spike waveforms coding motivational salience and one with faster rates of 
firing and more complex waveforms coding movement. These may have some relation 
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to the populations we have identified as type I and type II, that are modulated in 
different manners by D2-like receptor agonists and have shorter and longer spike half-
width profiles respectively.  
Other research has also identified two distinct populations of neurons within the VP that 
modulate separate symptoms of major depressive disorder. Knowland et al., (2017) 
identified that manipulation of either population resulted in social withdrawal or 
behavioural despair but not both.  Investigation of these populations’ spike half-width 
profiles and responses to D2-like agonists may prove insightful for future research.  
Dopamine’s effects in the VP have also been implicated in drug seeking behaviour. 
Stout et al (2016) has shown that upon exposure to cocaine, after sensitization, 
dopamine levels increase dramatically in the VP.  Our data provides information on the 
likely cellular effects, in the VP, of this increased dopamine in response to cocaine, and 
therefore reveals likely cellular mechanisms for the role of dopamine in drug seeking 
behaviour in the VP. Our data reveals dopamine increases the activation of Type I 
neurons via presynaptic modulation of glutamatergic inputs and subsequent activation 
and deactivation of ionotropic and metabotropic glutamate receptors on type I neurons 
(Figure 3.10). Our data also reveals that dopamine results in both excitation and 
inhibition of type II neurons through presynaptic effects of D1-like receptors on 
glutamatergic terminals, facilitating the release of glutamate and excitation, via 
ionotropic glutamate receptors, and inhibitory effect via direct activation of D2-like 
receptors on type II VP neurons (Figure 3.10). These data may suggest fruitful and 
novel receptors to target in relation to pharmacological control of drug seeking 
behaviour.   
Our data also suggests a possible cellular scenario for the cellular mechanism 
underpinning dopamine’s role in avoidance learning. Lénárd et al., (2017) data suggest 
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that D2-like agonists injected into the VP directly increase memory and learning 
processes in avoidance learning tasks, therefore, according to our data, this may be 
modulated through the reduction in firing frequency of type II VP neurons, via direct 
effects and through increased activation of type I VP neurons via reduced activation of 
metabotropic glutamate receptors.  
 
6.1.2 Serotonin receptor subtypes role in the dichotomous effects of serotonin on 
VP neurons 
 
In chapter four of this thesis we examined the effect serotonin and several serotonin 
receptor subtypes have on the tonic firing of VP neurons. Understanding the role that 
these receptor subtypes play in the modulation of VP neuronal circuitry will shed light 
on potential pharmacological interventions for issues such as anhedonia and drug 
addiction that the VP is known to play a pivotal role in modulating. Our data suggests 
that the known excitatory responses to serotonin application in the VP (Bengtson et al., 
2004) were largely modulated presynaptically by 5HT1a, 5HT5a and 5HT7 receptors, 
while inhibitory responses to serotonin application were largely modulated 
postsynaptically by 5HT2c receptors. Specific targeting of these serotonin receptor 
subtypes could therefore prove effective in the development of pharmacological 
interventions for anhedonia and drug addiction. Certainly 5HT2c antagonists (Goodwin 
et al., 2009) are known as affective antidepressants, however exploration of 5HT1a, 
5HT5a and 5HT7 modulation may also prove fruitful. 
5HT2c have also been implicated in the VP in drug sensitization (Napier & Istre, 2008). 
Napier and Istre (2008) found that 5HT2c receptors are upregulated in 
methamphetamine sensitized animals. Our data casts light onto the cellular mechanisms 
of this phenomenon, suggesting upregulation of 5HT2c receptors would result in an 
increase in neuronal inhibition within the VP, which is modulated at post-synaptic 
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locations. Our data may also provide insights into the cellular mechanisms underpinning 
5HT2c known modulation of locomotor activity. Recent research has implicated the 
5HT2c receptor in the VP in modulation of locomotor activity and rearing behaviour, 
with 5HT2c agonists attenuating both (Graves et al., 2013).  Our data would suggest 
that 5HT2c activation reduced the activity of some VP neurons and this may well be the 
cellular mechanism for 5HT2c agonist’s effects on locomotor activity.  
 
6.1.3 Modulation of VP neurons tonic firing by stimulation of NAc afferents 
 
In chapter five of this thesis we examined the effects of stimulation of the NAc afferents 
on the tonic firing of VP neurons. We provide evidence to support the fact that these 
afferents produce inhibitory responses in some VP neurons and that substance P 
contributes to this response by increasing the pause duration. We also provide evidence 
to show that some neurons in the VP are not modulated by NAc afferents and therefore 
may be involved in a separate circuit running through the VP which may be involved in 
the processing of different information.  
We also identified that activation of NAc afferents to dorsal and ventral regions of the 
VP result in different pause durations. However, there is a major caveat of this 
conclusion as in vitro slice preparations, used in this study, only result in the 
preservation of a limited number of connections between regions, while severing others. 
It is therefore possible that the differences in pause duration between dorsal and ventral 
regions may simply be an artefact of the methodology employed in this study. On the 
other hand, we may also conceive, that if this finding is not simply an artefact of the 
method employed, it may link to evidence suggesting the dorsal and ventral VP regions 
are innervated by different inputs, with the medial NAcS innervating the ventromedial 
VP and the lateral NAcS and olfactory tubercle innervating the ventrolateral VP, while 
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the NAcC inputs innervate the dorsolateral VP subregion (Heimer et al., 1991; Zahm & 
Brog, 1992). The imbalance in pause duration seen between dorsal and ventral regions 
of the VP may therefore play some part in the role NAc inputs into the VP have in 
integration of firing.  
 
6.1.4 Technical considerations 
 
The main focus of the current research project was to investigate the cellular mechanism 
underpinning the effects of dopamine and serotonin within the VP and to elucidate the 
receptor types involved in these responses. We also wished to explore the effects of 
NAc afferent stimulation on VP neurons, and cast light on the modulatory role of 
various neuromodulators in the VP responses to activation of these inputs. 
The main electrophysiological method used to answer these questions was in vitro 
multi-electrode array recordings with bath application of various pharmacological 
agents. We also employed the multi-electrode array as a method to stimulate the NAc 
afferents of the VP. While the multi-electrode arrays provide an opportunity to collect 
large amounts of data with a relatively high temporal and spatial precision, they do have 
some caveats. One issues stems from the fact multi-electrode arrays provide 
extracellular recordings of neuron populations, as such untangling the signal to reveal 
the unitary elements requires some skill and precision as well as a degree of judgement.   
There are also some practical issues with this system. The MEA recordings required at 
least an hour for the slice to stabilise and to fix onto the electrode array. However, often 
part way through recording, some channels could become active, perhaps due to delayed 
fixation on the Multi-electrode array. It was impossible to include these channels in any 
analysis, therefore missing a potentially interesting population of neurons.  Also despite 
waiting an hour for the slice to fix upon the multi-electrode array, some neurons showed 
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increases in spike amplitude over the course of an experiment, which often lasted 
several hours. This could have been a potential confound, as neurons that at the start of 
the study did not pass the threshold for spike detection, may have done so as the 
experiment progressed and the slice attached more to the MEA, moving closer to the 
electrodes and therefore having a higher amplitude. This therefore could have been 
misinterpreted as a result of the pharmacological agents being applied, rather than as a 
result of slice fixation. For this reason a significant number of neurons across all 
experiments had to be discounted from analysis.   
Further to this several populations of neurons within the VP are known to be tonically 
silent (Bengtson & Osbourne, 2000). Due to the nature of the multi-electrode array, 
focus was on those neurons that were tonically active. This therefore excludes 
populations of neurons within the VP from my results. For example cholinergic neurons 
in the VP are considered to be tonically silent (Bengtson & Osborne, 2000), therefore it 
is unlikely that my data sheds any light on the role of these neuronal populations within 
the VP, despite evidence suggesting that they are effected by serotonin modulation 
(Bengtson et al., 2004).  
Another restriction of in vitro techniques, such as the multi-electrode array is that it 
relies on healthy brain slices. There are multiple factors that can affect the viability and 
health of these slices, including PH, osmolarity, oxygenation levels. In vivo techniques 
can avoid some of these issues and allow you to study the brain in an intact state, 
however they have issues of their own, which results in difficulty to interpret the results 
of studies involving the mechanism of drug action. One major caveat to in vivo studies 
is the likely effects upstream and the effect of intact inputs into areas, such as the VP.    
Another caveat of in vitro slice preparations is that many connections between regions 
are severed during slice preparation. This therefore undermines all studies carried out in 
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chapter 5 with stimulation of the NAc. Therefore all studies in chapter 5 and 
interpretation of these results must be treated with caution as the results and 
conclusions, at least to some extent, maybe an artefact of the preparation technique. It 
may be that, on balance, a more appropriate methodology for the type of studies in 
chapter 5 would involve in vivo techniques, where all connections and circuitry are 
intact. 
 
6.1.5 Future work 
 
6.1.5.1 Confirmation of neuronal populations identified by spike half-width 
profiles 
 
In the current research we identified that two populations of neurons in the VP could be 
consistently identified based on the spike half-width profile and responses to D2-like 
receptor modulation. We speculated that these neurons are perhaps GABAergic 
projection neurons and GABAergic interneurons, however we were unable to provide 
conclusive evidence that this was the case. Future research will be needed to elucidate 
the biochemical identity of these subpopulations, probably by carrying out intracellular 
recordings of these two neuron populations and post-recording immunohistochemical 
labelling.  
 
6.1.5.2 Interplay between serotonin and dopamine 
 
Recent research has identified that focusing on the interaction between dopamine and 
serotonin in the VP may prove insightful to our understanding of reward related 
behaviour and responses to drugs of abuse (McDaid et al., 2007; Fischer & Ullsperger, 
2017). The current research project has shown that both these neurotransmitters 
modulate neurons in the VP. An intriguing next step would be to study how dopamine 
176 
 
and serotonin agonists interact with each other at cellular level and whether there are 
differential interaction effects that relate to the two neuron population we identified in 
the VP (based on their spike half-width profile and response to D2-like receptor 
modulation).   
 
6.1.5.3 Modulation of NAc inputs to the VP by serotonin and dopamine 
 
In the current research project we managed to establish reliable techniques to stimulate 
the NAc and monitor the effects this has on tonic activity within the VP. However due 
to time restrictions we were unable to explore the effects that serotoninergic and 
dopaminergic modulation had on these NAc inputs of the VP. Future research should 
focus on the role that serotonin and dopamine modulation has on these inputs from the 
VP, and perhaps look at the interplay between these two neurotransmitters in the 
modulation of NAc inputs of the VP. 
 
6.1.6 Concluding remarks 
 
Recent years have seen a surge in research focused on the VP and an identification of 
this area as crucially involved in reward-related behaviour, pleasure responses and 
addiction to drugs of abuse. However many of the cellular mechanism underpinning the 
VP’s function are still unclear.  
This thesis provides important novel insights into the cellular mechanisms responsible 
for dopamine’s and serotonin’s modulatory effects within the VP. It provides ideas on 
both future research directions and potential novel pharmacological targets for 
interventions, to treat dysfunction of affective responses and sensitization to drugs of 
abuse. As well as this, the current research project shows how multi-electrode arrays 
can be used to investigate the circuitry of the basal ganglia. It therefore provides a 
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demonstration of how this technique, is suitable to collect large quantities of data on 
tonic active brain areas, and can be used to study the responses of VP neurons to 
pharmacological intervention and modulation by activation of afferent inputs.  
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